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Abstract 
Reactive oxygen species (ROS) are generated via endogenous and exogenous sources.  
ROS are involved in essential cellular processes but when present in excess, can 
overwhelm antioxidant defences and induce a range of damaging DNA lesions.  The 
most commonly oxidised DNA base is guanine.  This generates products including 7,8-
dihydro-8-oxodeoxyguanine (8-oxo dG) which can result in G:CT:A transversion 
mutations, frequently found in human cancers.  Oxidative damage is also implicated in 
normal cellular ageing and degenerative diseases.  8-oxo dG repair is initiated by the base 
excision repair enzyme 8-oxoguanine DNA glycosylase 1 (OGG1).  Modulation of 
OGG1 activity in oxidising conditions has implications for mutation prevention.  This 
thesis investigates regulation of OGG1 under oxidising conditions using BSO, which 
increases intracellular ROS.  Chapter 3 shows that following BSO treatment, mouse 
OGG1 activity in mouse embryonic fibroblast (MEF) cells increases with no change in 
mRNA levels, whereas identical treatment has no effect on rat OGG1 activity in MH1C1 
cells but modulates protein levels.  A human OGG1 (hOGG1) variant with serine 
exchanged for cysteine at codon 326 (Cys326-hOGG1) is associated with reduced repair 
ability under oxidising conditions.  Chapter 4 describes the development of mOGG1
-/-
 
MEF cells stably expressing Ser326- or Cys326-hOGG1 and in chapter 5 these cells are 
used to investigate Ser326- and Cys326-hOGG1 activity, gene expression, protein 
localisation, homo-dimer formation and retention within an insoluble nuclear fraction 
following BSO treatment.  Data presented shows that the activity of both Ser326- and 
Cys326-hOGG1 increase following BSO treatment but Ser326-hOGG1 peak activity 
occurs 12 hours prior to that of Cys326-hOGG1.  This increased activity is not associated 
with increased gene expression or protein, or any protein localisation change; however, 
Cys326-hOGG1 is retained to a lesser extent in an insoluble nuclear fraction following 
BSO treatment.  The findings presented in this thesis show that OGG1 activity is 
modulated post-transcriptionally in response to increased ROS and provide a possible 
mechanism behind impaired Cys326-hOGG1 repair in oxidising conditions, further 
supporting the role of Cys326-hOGG1 in the process of carcinogenesis.   
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Chapter 1 - 
Introduction  
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1.1 Reactive species and oxidative stress  
 1.1.1 Overview 
Reactive oxygen species (ROS) are oxygen species which exist in a more reactive state 
than molecular oxygen.  The production of low levels of ROS and reactive nitrogen 
species (RNS) is necessary for essential cellular processes including gene regulation, cell 
mediated immunity, cell differentiation, post translational processing of proteins and 
cellular signalling (Adler V. et al. 1999; Dröge W. 2002).  The requirement for radical 
species has necessitated adaptive responses for their detoxification and a delicate cellular 
balance exists termed redox homeostasis.  However, an interference of the balance 
between oxidative and reductive species by either increased ROS/RNS generation or 
decreased ROS/RNS removal can result in cellular oxidative/nitrosative stress and 
cellular components can become damaged (Kohen R. and Nyska A. 2002).   
 1.1.2 Types of reactive species 
There are a variety of commonly occurring ROS and RNS (summarised in Table 1.1).  
The superoxide radical (O2•-), a primary ROS, is formed via the one-electron reduction 
of molecular oxygen and can exist at low pH as hydroperoxyl (HO2•) which penetrates 
biological membranes more easily than O2•- (Kohen R. and Nyska A. 2002).  Although 
relatively unreactive, O2•- is capable of dis-mutating to form hydrogen peroxide (H2O2) 
[Equation 1] (Fridovich I. 1978).  Hydrogen peroxide is stable and uncharged which 
allows it to easily diffuse across membranes (Paulsen C.E. and Carroll K.S. 2009).  
Although not a radical species, H2O2 can directly damage cellular components and can 
react via the Fenton [Equation 2] or the Haber-Weiss reaction [Equation 3] to create 
3 
 
hydroxyl radicals (HO•) and singlet molecular oxygen (1O2) (Kohen R. and Nyska A. 
2002).  
O2
•-
 + O2
•- 
+ 2H
+
              O2 + H2O2 [Equation 1] 
H2O2 + Fe
2+
/Cu
+
             OH
-
 + 
•
OH + Fe
3+
/Cu
2+
 [Equation 2] 
H2O2 + O2
•-
            
1
O2 + OH
-
 + 
•
OH [Equation 3]     
The half-life of hydroxyl radicals is short, typically ~10
-9
 seconds, which renders them 
highly reactive, unable to be eliminated by enzymic reactions and able to perpetuate a 
cascade of ROS production (Genestra M. 2007).  Hydroxyl radicals have a high affinity 
for and react readily with many cellular molecules.  Nitric oxide, produced by vascular 
endothelial cells and activated macrophages, reacts with O2
•- 
to produce the peroxynitrite 
radical (ONOO
-
) which is similar in reactivity to the hydroxyl radical and hence can 
damage many cellular constituents (Beckman J.S. et al. 1990). 
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Table ‎1.1: Summary of ROS and RNS. 
Reactive Species Examples of Formation Properties 
Superoxide O2
·-
 
One 
electron 
reduction 
state of 
O2 
In autoxidation reactions 
and by the electron 
transport chain 
Unreactive but can release 
Fe
2+ 
from iron-sulphur 
proteins and ferritin 
Nitric oxide NO
·
 
Gaseous 
free 
radical 
Via nitric oxide synthase 
which catalyses 
biosynthesis of NO
 
from 
L-arginine 
Reacts with transition metals, 
alters protein activity by S-
nitrosylation, reacts with O2
·-
 
to form peroxynitrite 
Hydroxyl 
radical 
HO
·
 
Three-
electron 
reduction 
state of 
O2 
By Fenton reaction, 
ionising radiation and 
decomposition of 
peroxynitrite 
Short in vivo half-life, highly 
reactive, will attack most 
cellular components and 
damage all macromolecules 
Hydrogen 
peroxide 
H2O2 
Two-
electron 
reduction 
state of 
O2 
By dismutation of O2
·-
 or 
direct reduction of O2 
One of the most powerful 
oxidisers known 
Organic 
hydroperoxide 
ROOH Oxidant 
By radical reactions with 
cellular components such 
as lipids and nucleobases 
Interacts with cellular 
membrane components, 
oxidises plasma membrane 
sulfhydryl groups and disturbs 
transporters 
Hypochlorite HOCl Oxidant 
From H2O2 by 
myeloperoxidase 
Lipid soluble and highly 
reactive, readily oxidises 
protein constituents 
Alkoxy 
radical 
Peroxy radical 
RO
· 
ROO
·
 
Oxygen 
centred 
organic 
radicals 
In the presence of 
oxygen by radical 
addition to double bonds 
or hydrogen abstraction 
Lipid forms participate in 
lipid peroxidation reactions 
Peroxynitrite ONOO
-
 
An 
oxidant 
and 
nitrating 
agent 
By a rapid reaction 
between O2
·- 
and NO
·
 
Lipid soluble and highly 
reactive, can damage a wide 
array of molecules in cells 
Singlet 
oxygen 
1
O2 
The 
lowest 
excited 
state of 
O2 
During photosynthesis 
and via decomposition of 
hydrogen peroxide 
Reacts with many organic 
compounds, can induce lipid 
peroxidation 
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1.1.3 Sources of ROS and RNS 
  1.1.3.1 Endogenous sources 
The consumption of oxygen in metabolic reactions takes place in several cellular 
locations by various enzymes and redox-reactive components and results in the release of 
ROS.  Under certain physiological conditions mitochondria can be a major source of 
ROS, particularly in tissues such as the heart and brain.  Aerobic respiration involves the 
transfer of electrons from NADH to oxygen and complexes I and III can release O2
•-
 as a 
toxic by-product (Ježek P. and Hlavatá L. 2005; Murphy M.P. 2009).   
As well as producing ROS, in certain tissues including liver (Giulivi C. et al. 1998) and 
brain (Lacza Z. et al. 2001), mitochondria have a nitric oxide synthase and can generate 
nitric oxide (Haynes V. et al. 2004).  Nitric oxide synthase catalyses the oxidation of one 
of the terminal guanidonitrogen atoms of L-arginine and the nitric oxide generated can be 
converted to other RNS including peroxynitrite, the nitrosonium cation (NO
+
) or the 
nitroxyl anion (NO
-
) (Palmer R.M.J. et al. 1988; Stamler J.S. et al. 1992).   
Many oxidase enzymes including the xanthine oxidase, peroxisomal oxidases and 
endoplasmic reticular oxidases release ROS.  The xanthine oxidoreductase catalyses the 
hydroxylation of hypoxanthine to xanthine, and xanthine to urate.  The reduction of 
molecular oxygen by this enzyme yields both superoxide and hydrogen peroxide 
(Harrison R. 2002; McNally J.S. et al. 2005).  Hydrogen peroxide is also produced by 
peroxisomal oxidases as they transfer hydrogen to oxygen during metabolic processes 
such as the beta oxidation of fatty acids (Schrader M. and Fahimi H.D. 2006).   
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The oxidation of many endogenous and xenobiotic substances is catalysed by the 
cytochrome P450 family of monooxygenases (CYPs) which are part of a membrane 
bound multi-enzyme system present mainly in the endoplasmic reticulum.  There are two 
mechanisms by which CYPs form the reactive intermediates H2O2 and O2
•-
 and these are 
dependent on both the CYP enzyme and its substrate.  The first mechanism is via O2 
reduction during the CYP catalytic cycle and the second is via the escape of an electron 
from flavins in the NADPH:P450 reductase enzyme (Ježek P. and Hlavatá L. 2005).  
Under certain conditions CYP metabolism can account for a high level of cellular ROS 
production.  For example, CYP2E1, responsible for ethanol detoxification, is a potent 
radical producer as it is poorly coupled with the NADPH-cytochrome P450 reductase 
(Caro A.A. and Cederbaum A.I. 2004).  Hence, in the liver, ethanol mediated induction 
of CYP2E1 can enable this to be a source of ROS either comparable to, or exceeding that 
of the mitochondria (Ježek P. and Hlavatá L. 2005).  
Although often considered a toxic by-product, some cellular systems have evolved to 
produce ROS.  The first identified example of a component with the primary role of ROS 
generation was the phagocyte NADPH oxidase system which produces reactive species 
responsible for mediating an immune response and killing pathogens.  Found in many 
cell types, NADPH oxidases are a family of transmembrane proteins that transport 
electrons across biological membranes, catalysing the production of superoxide by taking 
reducing equivalents from the hexose monophosphate shunt and transferring them to 
molecular oxygen.  Physiological functions of NADPH oxidase family members include 
cell signalling, cell differentiation, regulation of gene expression as well as host defence 
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(Bedard K. and Krause K.H. 2007).  A detailed discussion of the physiological functions 
of ROS is beyond the scope of this thesis but is well reviewed by Valko et al. (2007). 
  1.1.3.2 Exogenous sources 
There are a variety of exogenous sources linked with ROS production which include UV 
light, ionising radiation, metals, and polycyclic aromatic hydrocarbons (PAHs).  
Exposure to such compounds may be via cigarette smoke, environmental pollution, toxic 
food ingredients or sunlight (Limón-Pacheco J. and Gonsebatt M.E. 2009).  During 
metabolic processes PAHs, such as benzo(a)pyrene, form quinone derivatives.  These 
can be enzymatically reduced to semiquinones which donate their extra electron to 
oxygen resulting in superoxide formation as well as regeneration of the original quinone.  
This process, termed redox cycling, leads to PAH-induced ROS generation within cells 
(Kim K.B. and Lee B.M. 1997).  Exposure to UVA or UVB light induces the formation 
of reactive species including superoxide, singlet oxygen and lipid peroxide radicals 
(Black H.S. 1987; Peak M.J. and Peak J.G. 1989).  Ionising radiation cleaves water and 
predominantly generates the hydroxyl radical (Wallace S.S. 1998).  The ability of metals 
to gain and lose electrons means they can directly or indirectly generate ROS and at high 
doses, a variety of metals including cadmium (Ikediobi C.O. et al. 2004), copper 
(Pourahmad J. and O'Brien P. J. 2000), chromium (Bagchi D. et al. 1995) and lead 
(Bokara K.K. et al. 2008) have been shown to induce oxidative stress conditions.  An 
overload of iron can also result in increased radical generation and oxidative stress 
(Papanikolaou G. and Pantopoulos K. 2005).   
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1.1.4 Cellular targets of ROS 
As a detailed discussion of RNS is beyond the scope of this thesis, the focus from this 
point forward will be on ROS.  Reactive species can react with many cellular 
components including lipids, carbohydrates, proteins, mitochondrial and nuclear DNA.  
When ROS react with membrane lipids, a hydrogen atom can be abstracted from carbon 
atoms in the polyunsaturated fatty acid tail.  The resulting reaction is termed lipid 
peroxidation (Figure 1.1) which leads to loss of membrane integrity and compromised 
cellular function, as well as the production of reactive end products; malondialdehyde 
(MDA) or 4-hydroxynonenal (4-HNE) (Brown G.C. and Borutaite V. 2004; Marnett L.J. 
1999).  
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Figure ‎1.1: Lipid Peroxidation. 
Initiation of lipid peroxidation occurs when the 
•
OH radical abstracts a hydrogen atom from a 
polyunsaturated fatty acid, resulting in the generation of a lipid radical.  Lipid radicals can react 
further with oxygen or a second fatty acid to generate lipid hydroperoxides and lipid peroxide 
radicals which can react further, or fragment to produce the reactive end products MDA and 4-
HNE.  Termination of lipid peroxidation occurs when radical species combine to generate non-
reactive products (adapted from Niesink R.J.M. et al. 1996). 
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The reaction of ROS with proteins can result in the irreversible oxidation of amino acid 
side chains and the cleavage of polypeptide chains (Stadtman E.R. 1992).  The reversible 
interaction between ROS and thiol groups present in proteins is necessary for signal 
transduction, resulting in either activation or inactivation of proteins including tyrosine 
kinases and transcription factors (Kamata H. and Hirata H. 1999).  The thiol side chains 
of cysteine residues are susceptible to oxidation by H2O2.  Their reactivity depends both 
on their accessibility to oxidants and the pKa of the thiol group which determines whether 
it exists as the thiolate ion or in the thiol form.  The pKa of a thiol group is typically 
around 8.5 but can be reduced in the presence of polar or positively charged amino acids 
to as low as 3.5, allowing thiolate ion formation at physiological pH (Salsbury Jr. F.R. et 
al. 2008).  The reaction with H2O2 yields a sulphenic acid (SOH) which can undergo 
several possible further reactions (Figure 1.2); disulphide formation with glutathione, 
disulphide formation with another cysteine, sulphenamide formation by attack of the 
amide nitrogen of a neighbouring residue or sulphinic and irreversible sulphonic acid 
formation by further reaction with H2O2.  The thiols can be regenerated by reduction by 
the glutathione reductase or thioredoxin reductase systems (Paulsen C.E. and Carroll 
K.S. 2009).   
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Figure ‎1.2: Reactions of sulphenic acid. 
Reaction of protein thiolates with H2O2 results in formation of sulphenic acid which can either 
react with a second cysteine to yield a disulphide, form a disulphide with reduced glutathione or 
react with the amide nitrogen of the neighbouring protein to form a sulphenamide.  In the 
presence of H2O2 the sulphenic acid can generate sulphinic and sulphonic acid (adapted from 
Paulsen C.E. and Carroll K.S. 2009).  
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The interactions between ROS and nuclear DNA are discussed in detail in section 1.3.  
Nuclear DNA is protected by both histones and DNA repair enzymes.  In contrast, 
mitochondrial DNA lacks protective histones and furthermore is in close proximity to the 
electron transport chain rendering it vulnerable to oxidative stress (Ames B. et al. 2003).  
Mitochondrial DNA damage mediated by ROS has been linked with various cancers 
(Horton T.M. et al. 1996; Tamura G. et al. 1999) and ageing (Sastre J. et al. 2000).  The 
mitochondrial theory of ageing (Harman D. 1956) proposes that as mitochondrial DNA is 
damaged by ROS and accumulates mutations, the oxidative phosphorylation activity is 
reduced resulting in enhanced ROS production and increased damage.  This cycle of 
oxidative stress and mitochondrial DNA damage causes the accumulation of mutations 
resulting in mitochondrial dysfunction and cell death (Alexeyev M.F. et al. 2004).   
 1.1.5 Antioxidant defences 
As reactive species can damage cellular macromolecules, a variety of antioxidant 
defences exist.  Antioxidant enzymes include superoxide dismutase (SOD), which 
catalyses the conversion of superoxide ions to hydrogen peroxide, catalase and 
glutathione peroxidase which catalyse the conversion of hydrogen peroxide to oxygen 
and water, and peroxiredoxins which reduce peroxides directly, as well as in the presence 
of thioredoxins (Ma Q. 2009).  Induction of these enzymes is regulated at the 
transcriptional level by the antioxidant-response element (ARE) (Rushmore T.H. and 
Pickett C.B. 1990), which responds to a variety of reactive compounds in order to 
maintain cellular redox homeostasis.  Many transcription factors including Nrf, Jun, Fos 
Ah (aromatic hydrocarbon) receptor and the oestrogen receptor bind to the ARE 
(Dhakshinamoorthy S. et al. 2000) but it is Nrf2 (nuclear factor E2-related factor 2) 
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which is the primary mediator of gene transcription, controlling both the inducible and 
constitutive gene expression mediated by the ARE (Nguyen T. et al. 2009).   
Non enzymatic antioxidants include amino acids, dietary components including beta 
carotene, ascorbate, alpha-tocopherol and glutathione.  Glutathione (Figure 1.3A) is a 
tripeptide with a variety of important cellular functions (Figure 1.3B), in particular to 
help regulate and maintain redox homeostasis.  In its reduced form (GSH), glutathione 
conjugates and detoxifies reactive metabolites and xenobiotics and is able to deactivate 
ROS.  Conjugation reactions can be spontaneous or catalysed by glutathione S-
transferase enzymes, with the conjugates converted by a series of further reactions to 
mercapturic acids (Meister A. and Anderson M.E. 1983).  Redox-sensitive thiol groups 
are modulated by GSH either by direct interaction or via glutaredoxins, whose reduction 
by GSH allows them to reduce thiol groups.  The oxidation of thiol groups is also 
prevented during oxidative stress by the formation of glutathione-protein mixed 
disulphides (Kalinina E.V. et al. 2008).    
As the most abundant intracellular thiol, GSH is maintained in its reduced state by the 
NADPH-dependent glutathione disulphide reductase (GSSG reductase).  High (0.2 – 10 
mM) intracellular concentrations of GSH are maintained by constitutive de novo 
synthesis via a two-step pathway catalysed by the rate limiting enzyme glutamate-
cysteine ligase (GCL) and glutathione synthetase (GS) (Figure 1.4) (Griffith O.W. and 
Meister A. 1979).   
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Figure ‎1.3: (A) The structure of GSH.  (B) The metabolism and important cellular functions 
of GSH.   
Glutathione is involved in several important intracellular functions including conjugation of 
reactive species, participation as a coenzyme, and amino acid transport.  It is also involved in 
metabolism and the maintenance of thiol moieties of proteins and low molecular weight 
compounds (adapted from figure 2: Anderson M.E. 1998). 
A 
 
B 
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L-γ-Glutamyl-L-cysteine
L-Cysteine
L-Glutamate
ATP ADP + Pi
GlutamateCysteine 
Ligase
Glutathione
Glycine
ATP ADP + Pi
GSH Synthetase
Figure ‎1.4: De novo GSH synthesis. 
GSH is synthesised intracellularly from L-cysteine, L-glutamate and glycine.  Synthesis proceeds 
via a two-step pathway catalysed by GCL and GSH synthetase.   Inhibition of GCL by BSO (see 
section 1.2) results in depletion of intracellular GSH levels (adapted from Balendiran G.K. et al. 
2004). 
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1.2 Buthionine Sulphoximine (BSO) 
L-buthionine-S-sulphoximine (BSO) is a synthetic amino acid which depletes cellular 
GSH.  It does this by inhibiting GCL, the enzyme which catalyses the reaction of L-
glutamate with MgATP to form the enzyme bound intermediate γ-glutamylphosphate, 
which subsequently reacts with L-cysteine (see Figure 1.4).  The phosphorylation of BSO 
is catalysed by GCL as BSO has a structure similar to that of the GCL cysteine adduct 
(Griffith O.W. et al. 1979).  Phosphorylated BSO product binds the GCL active site 
tightly but non-covalently and inhibits the reaction with L-cysteine until the product 
dissociates.  The inhibition of GCL by BSO occurs at low concentrations and is rapid, 
specific and potent (Griffith O.W. 1982).   
Synthesis and catabolism of GSH occurs via the γ-glutamyl cycle which involves a series 
of enzymatic and membrane transport steps (Meister A. and Anderson M.E. 1983).  The 
synthesis of GSH occurs intracellularly however the breakdown of GSH, involving the 
transfer of the γ-glutamyl moiety to acceptors including amino acids and water, is 
catalysed by γ-glutamyl transpeptidase which is on the external surface of the cell 
membrane.  GSH is therefore transported across cell membranes by members of the 
multidrug resistance-associated protein (MRP/CFTR or ABCC) family of ATP-binding 
cassette (ABC) proteins and members of the organic anion transporting polypeptide 
(OATP) family of transporters (Ballatori N. et al. 2005).  Most GSH is exported from 
cells, therefore administration of BSO and the consequent inhibition of GSH synthesis 
results in GSH depletion (Anderson M.E. 1998).  In wild type and mOgg1
-/-
 null mouse 
embryonic fibroblast (MEF) cells BSO has been shown to deplete GSH from the 
cytoplasm in a concentration dependent manner, and deplete GSH from the nucleus and 
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mitochondria at concentrations ≥100 μM (Green R.M. et al. 2006).  Green et al. (2006) 
additionally showed that significant depletion of cytoplasmic GSH, achieved at BSO 
concentrations ≥100 μM, also resulted in a significant increase in ROS formation, levels 
of lipid peroxidation and formation of oxidative DNA modifications.  The use of BSO 
thus serves as an important experimental tool for depletion of GSH and subsequent 
induction of oxidative stress conditions within cells.  
1.3 DNA damage 
Antioxidants have limited capacity and can become overwhelmed giving rise to cellular 
oxidative stress.  The accumulation of oxidative damage has been shown to contribute to 
the process of normal cellular ageing (Gruber J. et al. 2008) and various degenerative 
diseases including cancer (Matés J.M. et al. 2008), Alzheimer‟s disease (Lovell M.A. and 
Markesbery W.R. 2007), Parkinson‟s disease (Chinta S.J. and Anderson J.K. 2008) and 
cardiovascular disease (Ames B.N. et al. 1993). 
Reactive oxygen species are genotoxic and able to induce a range of DNA lesions 
including abasic sites, DNA strand breaks, and base oxidations which, if replicated, can 
lead to apoptosis or mutation (Demple B. and Harrison L. 1994).  The major reactions of 
the hydroxyl radical with DNA are additions to the π bonds of DNA bases or hydrogen 
abstractions from the deoxyribose sugar units (Breen A.P. and Murphy J.A. 1995).  
Hydrogen abstraction is possible from all carbon atoms of the sugar although the most 
common is C4 as its C-H bond is weakest and most sterically exposed in B-DNA (Pardo 
L. et al. 1991).  Following hydrogen abstraction, in the absence of repair, the sugar-
phosphate backbone is cleaved generating a single strand break (SSB) which can be 
mutagenic but often easily repaired due to the alternate intact DNA strand.  However, 
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hydroxyl radical induced breaks generated near to each other on both strands generate a 
double strand break (DSB) which, if unrepaired, is much more likely to cause cell death 
due to the permanent damage to genetic information (Breen A.P. and Murphy J.A. 1995).   
The reaction of hydroxyl radicals with DNA bases is favoured over deoxyribose sugar 
units and primarily occurs at C5 and C6 of the pyrimidines (von Sonntag C. 1987) and at 
C4 and C8 of the purines (Steenken S. 1989).  Due to its low oxidation potential guanine 
is the most easily and most commonly oxidised base (Steenken S. and Jovanovic S.V. 
1997) and the two most abundant products formed are 2,6-diamino-4-hydroxy-5-
formamidopyrimidine (fapyG) and 7,8-dihydro-8-oxodeoxyguanine (8-oxo dG).  
Subsequent oxidation results in the formation of spiroiminodihydantoin and 
guanidinohydantoin (Figure 1.5) (Cadet J. et al. 2008): 
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Figure ‎1.5: Oxidised forms of guanine. 
  The two most abundant products formed following oxidation of guanine are fapyG and 8-oxo 
dG (Figure 1.5A) with subsequent oxidation resulting in the formation of spiroiminodiydantoin 
and guanidinohydantoin (Figure 1.5B) (adapted from Malayappan B. et al. 2007). 
A 
B 
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1.3.1 8-oxo dG  
First discovered in 1984 (Kasai H. and Nishimura S. 1984), 8-oxo dG is a pre-mutagenic 
lesion initially thought capable of mispairing with any base (Kuchino Y. et al. 1987).  
However, experiments with Escherichia Coli (E. coli) (Wood M.L. et al. 1990), in vitro 
and in vivo studies (Cheng K.C. et al. 1992; Moriya M. et al. 1991; Shibutani S. et al. 
1991) and studies in mammalian systems (Klein J.C. et al. 1992) subsequently found that 
8-oxo dG causes predominantly G:CT:A transversions; among the most predominant 
somatic mutations in lung, breast, ovarian, gastric and colorectal cancers (Greenman C. 
et al. 2007) and frequent in the mutational spectrum of the tumour suppressor gene p53 
(Hollstein M. et al. 1996). 
This can be explained by the conformation adopted by 8-oxo dG around the N-glycosidic 
bond.  At physiological pH, 8-oxo dG exists in the keto form and in the normal anti 
conformation around the N-glycosidic bond 8-oxo dG forms a conventional Watson-
Crick pair with cytosine (Figure 1.6A) (Wang D. et al. 1998).  However, in the syn 
conformation it forms a Hoogsteen mispair with adenine (Figure 1.6B) (Bjørås M. et al. 
2002).  The capability for 8-oxo dG to cause G:CT:A transversions is therefore 
attributed to its ability to form this base pair.  It has also been found that 8-oxo dG can 
mispair with guanine (Figure 1.6C) (Thiviyanathan V. et al. 2003), introducing the 
possibility that 8-oxo dG also has the ability to induce GC transversions. 
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Figure ‎1.6: The conformation adopted by 8-oxo dG around the N-glycosidic bond.  
 8-oxo dG in the anti conformation around the N-glycosidic bond forming a stable Watson-Crick 
pair with cytosine (A).  8-oxo dG in the syn conformation around the N-glycosidic bond forming 
a stable Hoogsteen mispair with adenine (B).  8-oxo dG in the syn conformation around the N-
glycosidic bond forming a mispair with guanine (C). (Figure 2: Klungland A. and Bjelland S. 
2007). 
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 1.3.2 8-oxo dG and disease 
In normal tissues it is estimated that the steady-state rate of formation of 8-oxo dG 
lesions is approximately 10
3
 per cell per day (van Loon B. et al. 2010).  Although 
described as weakly mutagenic, with mutation frequencies of 2.5 – 4.8% in mammalian 
cells (Moriya M. 1993), the ability of 8-oxo dG to cause mutation combined with its 
abundance means it is considered to play an important role in carcinogenesis in vivo 
(Cooke M.S. et al. 2006; Floyd R.A. 1990).  The process of carcinogenesis is complex 
and involves multiple stages at which oxidative stress can play a role (Guyton K.Z. and 
Kensler T.W. 1993).  One of the crucial events is the mutation of DNA resulting in the 
activation of proto-oncogenes such as H-ras and/or inactivation of tumour suppressor 
genes such as p53.  Numerous studies, reviewed by Evans et al. (2004), show increased 
levels of 8-oxo dG in tumour tissue (Gackowski D. et al. 2002; Inoue M. et al. 1998; 
Matsui A. et al. 2000; Romano G. et al. 2000; Sentürker S. et al. 1997) and urine from 
cancer patients (Erhola M. et al. 1997; Tagesson C. et al. 1995; Yamamoto T. et al. 
1996).  However, it is important to note that it is currently unclear whether this increase 
is causative of, or an effect of tumours.  
As well as causing DNA mutations 8-oxo dG lesions can result in epigenetic alterations 
which modulate gene expression and may also contribute to carcinogenesis.  Methylation 
patterns of adjacent cytosine residues can be altered by 8-oxo dG which may inhibit the 
initial binding of methylation binding proteins (Valinluck V. et al. 2004).  This interferes 
with subsequent steps in the chromatin condensation cascade resulting in potentially 
heritable epigenetic alterations.  Binding of transcription factors can also be modulated 
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by the presence of 8-oxo dG in promoter elements resulting in alterations in gene 
expression (Ghosh R. and Mitchell D.L. 1999; Ramon O. et al. 1999).   
The involvement of 8-oxo dG has also been implicated in non-cancerous pathological 
conditions including Parkinson's disease (Alam Z.I. et al. 1997; Zhang K. et al. 1999), 
Alzheimer's disease (Lovell M.A. et al. 1999; Mecocci P. et al. 1998), Huntington's 
disease (Browne S.E. et al. 1997), multiple sclerosis (Vladimirova O. et al. 1998) and 
atherosclerosis (Martinet W. et al. 2001). 
1.4 DNA damage repair 
Throughout the lifetime of a cell nuclear DNA is subject to many different types of 
damage with the potential to cause cell death or mutagenesis.  In order to reduce the 
occurrence of such events several mechanisms exist for repair including simple direct 
repair of the damaged base, for example dealkylation, and more complicated 
recombination repair or excision repair systems.  Base excision repair (BER), nucleotide 
excision repair (NER), and mismatch repair (MMR) are all involved in the repair of 
damage to a single DNA strand and are able to use the undamaged strand as a repair 
template.  In contrast, the repair of DSB, where both DNA strands are damaged, is 
complicated by the inavailability of a complementary strand and as a result has the 
potential to be error prone.  Although less well characterised, mitochondrial DNA repair 
pathways also exist.  Mitochondrial DNA is particularly susceptible to oxidative lesions 
hence mitochondria possess proficient BER (de Souza-Pinto N.C. et al. 2008).  
Mitochondria also possess MMR activity which is distinctive from nuclear MMR, as 
well as recombination repair for DSB (reviewed by Liu P. and Demple B. 2010). 
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This thesis focuses on oxidative DNA damage therefore the major DNA repair pathways 
will be briefly reviewed prior to a more in depth discussion of oxidative damage repair, 
with emphasis on nuclear DNA repair. 
 1.4.1 DNA double strand break repair 
Endogenous factors including metabolites and ROS as well as exogenous factors such as 
ionising radiation and xenobiotics have the potential to induce DSB (Weterings E. and 
Chen D.J. 2008).  They can also arise during DNA replication, as a replication fork 
passing through a template containing a SSB leads to conversion of this into a DSB on a 
sister chromatid.  Additionally, DSB are generated during DNA replication and as 
intermediates during other essential cellular processes including meiosis and the 
assembly of mature immunoglobulin and T-cell receptor genes (van Gent D.C. et al. 
2001).  Cleavage of both DNA strands in close proximity causes the DNA molecule to 
break apart leading to chromosome breaks.  The chromosome fragments produced can 
then be unequally distributed to daughter cells or translocated to other parts of the 
genome.  The deleterious effects of such translocation events include cell death, or the 
inactivation of tumour suppressor genes or activation of oncogenes for example 
Philadelphia-chromosome translocation and chronic myeloid leukaemia (Borgaonkar 
D.S. 1973) hence DSB are potentially carcinogenic (Weterings E. and Chen D.J. 2008). 
There are two major pathways involved in mammalian repair of DSB: homologous 
recombination (HR) (Figure 1.7) and non-homologous end joining (NHEJ) (Figure 1.8).  
Error-free HR begins with the processing of DNA ends mediated by the 
Mre11/Rad50/Nbs1 (MRN) complex creating single-strand overhangs.  Rad51, Rad52 
and replication protein A (RPA) associate with these overhands, search for the 
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homologous duplex DNA and generate a joint molecule between the damaged and 
undamaged strands.  The template guides DNA synthesis and resolution of the two 
strands to complete DSB repair (Weterings E. and Chen D.J. 2008).  The mechanism of 
NHEJ involves the processing and joining of broken non-compatible DNA ends, without 
the use of a template.  Consequently more error-prone, NHEJ begins with the recognition 
of the DSB by the Ku70/80, DNA-PKcs complex which brings the ends of the broken 
DNA molecule together.  Non-compatible ends are then processed prior to end-to-end 
ligation by the DNA ligase IV-XRCC4 complex (Phillips E.R. and McKinnon P.J. 2007; 
Weterings E. and Chen D.J. 2008). 
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Figure ‎1.7: Homologous recombination. 
HR begins with the nucleolytic processing of DNA ends mediated by the Mre11/Rad50/Nbs1 
(MRN) complex creating single-strand overhands.  Rad51, Rad52 and replication protein A 
(RPA) associate with these overhangs, search for the homologous duplex DNA and generate a 
joint molecule between the damaged and undamaged strands.  The template guides DNA 
synthesis and resolution of the two strands which completes DSB repair (Weterings E. and Chen 
D.J. 2008).   
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Figure ‎1.8: Non-homologous end joining. 
NHEJ begins with the recognition of the DSB by the Ku70/80, DNA-PKcs complex which brings 
the ends of the broken DNA molecule together.  Non-compatible ends are then processed prior to 
end-to-end ligation by the DNA ligase IV-XRCC4 complex (Weterings E. and Chen D.J. 2008).  
 
28 
 
 1.4.2 Mismatch repair  
The mismatch repair (MMR) system is responsible for the repair of DNA mismatches 
arising through spontaneous and induced base deamination, oxidation and methylation, 
as well as through replication errors (Modrich P. and Lahue R. 1996; Umar A. and 
Kunkel T.A. 1996).  The DNA lesion that initiates the MMR machinery is recognised by 
either the MutSα complex (MSH2 and MSH6) or the MutSβ complex (MSH2 and 
MSH3), depending on its form.  Following complex binding, MMR discriminates 
between the parental and newly synthesised DNA strand by an unclear mechanism that is 
thought to involve either the 'molecular switch model' or the 'hydrolysis-driven 
translocation model' reviewed by Christmann M. et al. (2003).  Following strand 
discrimination a complex between MutSα and MutLα is formed which results in excision 
of the DNA strand containing the mispaired base by exonuclease I and resynthesis by 
Polδ (Figure 1.9). 
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Figure ‎1.9: Mismatch repair. 
Recognition of the DNA lesion by the MutSα complex (MSH2 and MSH6) leads to strand 
discrimination, resulting in the formation of a complex composed of MutSα and MutLα.  
Excision is then performed by ExoI and repair synthesis completed by polymerase δ and DNA 
ligase I (Figure 2, Christmann M. et al. 2003). 
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 1.4.3 Excision repair 
The process of excision repair was discovered in 1964 when two independent groups 
observed that following UV light exposure, bacteria such as E.coli excise small pieces of 
DNA from their genome (Boyce R.P. and Howard-Flanders P. 1964; Setlow R.B. and 
Carrier W.L. 1964).  The distinction between NER and BER was made following the 
discovery by Lindahl (1974) that uracil is excised from DNA as a free base, in contrast to 
pyrimidine dimers which are excised as small oligonucleotide fragments. 
 1.4.4 Nucleotide excision repair 
The NER pathway is often considered the most versatile and flexible known DNA repair 
pathway due to its ability to deal with a wide range of structurally unrelated DNA lesions 
and bulky DNA adducts such as PAHs (Costa R.M.A. et al. 2003).  Lesions that distort 
the DNA helix, including UV light-induced cyclobutane pyrimidine dimers and 6-4 
photoproducts, if unrepaired, interfere with base pairing and block DNA duplication and 
transcription.  These lesions are repaired either by a mechanism which acts only on DNA 
lesions in transcribed strands and is coupled to active transcription; transcription 
coupled-NER (TC-NER), or by a mechanism that is able to repair DNA lesions 
throughout the genome; global genome-NER (GG-NER) (Fousteri M. and Mullenders 
L.H.F. 2008).   
The damage recognition mechanisms of TC-NER and GG-NER are distinct but 
subsequent steps require identical core factors as the two pathways converge.  Initiation 
of TC-NER begins following the generation of DNA lesions which block the elongating 
RNA polymerase II complex (RNAPIIo), which triggers the recruitment of TC-NER 
specific factors and NER proteins (Fousteri M. and Mullenders L.H.F. 2008).  In 
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contrast, GG-NER begins with recognition of the DNA lesion by the UV-DDB and XPC-
RAD23B protein complexes which recognise the distortion and have a binding affinity to 
damaged DNA (Shuck S.C. et al. 2008).  Following recognition, TFIIH, XPA and RPA 
open the helix and verify the lesion prior to dual incision of the damaged strand by 
ERCC1-XPF and XPG endonucleases.  A single strand gap is created which is filled by 
DNA polymerase δ, PCNA and RFC and then sealed by DNA ligase III-XRCC1 in non-
dividing cells, or by DNA ligase III-XRCC1 plus DNA polymerase ε and DNA ligase I 
in dividing cells (Figure 1.10) (Fousteri M and Mullenders L.H.F. 2008).  A detailed 
discussion of NER is beyond the scope of this thesis but is reviewed by Hoeijmakers J.H. 
(2001). 
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Figure ‎1.10: Nucleotide excision repair. 
TC-NER begins with the binding of XPC-hHR23B and UV-DDB.  GG-NER begins with the 
blockage of RNAPIIo.  The two pathways then converge and TFIIH, XPA and RPA open the 
helix, prior to dual incision of the damaged strand by ERCC1-XPF and XPG endonucleases.  
DNA polymerase δ, PCNA and RFC fill the single strand gap prior to gap sealing by 
XRCC1/DNA ligase III or XRCC1/DNA ligase III plus DNA polymerase ε and DNA ligase I 
(adapted from figure 1, Fousteri M. and Mullenders L.H.F. 2008). 
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 1.4.5 Base excision repair  
Oxidative base lesions including 8-oxo dG and FapyG are repaired by the BER pathway.  
This highly conserved, versatile pathway is also responsible for the repair of products 
arising from spontaneous hydrolytic deamination e.g. uracil from deamination of 
cytosine (Krokan H.E. et al. 2002), alkylation e.g. 3-methyladenine (Sedgwick B. et al. 
2007) and hydrolysis of the N-glycosidic bond producing an abasic site.  Such 
modifications would lead to mispairs which could result in impaired genetic stability, 
hence their successful repair is necessary to maintain genomic integrity. 
A lesion specific glycosylase (Table 1.2) initiates BER by excising the altered base, BER 
is then completed by either short-patch BER or long-patch BER; replacement of one, or 
two to thirteen bases respectively (Almeida K.H. and Sobol R.W. 2007).  Following 
glycosylase excision of the damaged base an apurinic/apyridimic (AP) site is created 
within the DNA backbone.  This is recognised and cleaved either by an AP-
endonuclease, generating a 3′OH and a 5′-deoxyribose phosphate (dRP), or by the 
intrinsic AP-lyase activity of bi-functional DNA glycosylases.  The latter generates 3′ 
blocking phosphoribose or phosphate termini together with 5′ phosphates which are 
subsequently cleaved by the 3′ phosphodiesterase activity of APE1.  The resulting dRP is 
released by the intrinsic 5′-dRPase activity of β-polymerase (short-patch BER) or the 5′-
flap endonuclease Fen1 (long-patch BER).  The nucleotide gap is filled by β-polymerase 
and finally sealed by either DNA ligase I or a complex of DNA ligase III and XRCC1 
(Figure 1.11) (Boiteux S. and Guillet M. 2004; Hazra T.K. et al. 2007). 
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Table ‎1.2: DNA glycosylases in human cell nuclei. 
(Adapted from Table 1: Lindahl T. and Wood R.D. 1999 and Table 1: Hegde M.L. et al. 2008). 
Enzyme Altered base removal from DNA 
UNG U and 5-hydroxyuracil 
TDG U or T opposite G, ethenocytosine 
hSMUG1 U (preferentially from single-stranded DNA) 
MBD4 U or T opposite G at CpG sequences 
hOGG1 8-oxoG opposite C, formamido-pyrimidine 
MYH A opposite 8-oxoG 
hNTH1 
Thymine glycol, cytosine glycol, dihydrouracil, formamido-
pyrimidine 
MPG 3-MeA, ethenoadenine, hypoxanthine 
NEIL1 Fapy-A, 5-hydroxyuracil, thymine glycol 
NEIL2 Hydantoin, 5-hydroxyuracil 
NEIL3 FapyA, FapyG, 5-hydroxyuracil 
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Figure ‎1.11: Monofunctional Base Excision Repair. 
Initiation of BER involves recognition and glycosylase-mediated excision of the altered base, 
which generates an AP site in the DNA backbone.  This is cleaved either by the intrinsic lyase 
activity of the glycosylase or by APE1 and then processed by either polymerase β, prior to 
religation by the XRCC1/DNA ligase III complex (short patch pathway), or PCNA, polymerase δ, 
polymerase β and Fen1 prior to religation by DNA ligase I (long patch pathway) (Scheme 1: 
Evans M.D. et al. 2004). 
36 
 
Glycosylase enzymes are highly conserved, do not require cofactors, and have broad 
substrate specificities, although most have a preference for either purine or pyrimidine 
derivatives.  Their initial recognition of the deformed DNA helix results in their binding 
to the minor groove and subsequently flipping the lesion base out of the DNA major 
groove (Hegde M.L. et al. 2008).  A number of base-specific DNA glycosylases have 
been identified in mammals including 8-oxodeoxyguanine DNA glycosylase 1 (OGG1), 
the endonuclease III homolog NTH1, and the E.coli Nth-like NEILs (NEIL1, NEIL2 and 
NEIL3).  Base lesions are excised by OGG1 and NTH1 only from double-stranded DNA 
whereas the NEILs prefer single-stranded DNA and are thought to be involved in repair 
of oxidised bases during transcription and DNA replication (Dou H. et al. 2003).  
Specific to pyrimidines, NTH1 recognises a wide range of oxidised pyrimidine 
derivatives including thymine glycol, 5-hydroxycytosine, dihydrouracil, urea and the 
ring-opened structure of 1, N
6
-ethenoadenine (Speina E. et al. 2001).  Similarly, the 
NEILs prefer oxidised pyrimidines, NEIL1 has high affinity for ring-opened purines and 
thymine glycol whereas NEIL2 prefers cytosine-derived lesions including 5-
hydroxyuracil and 5-hydroxycytosine.  No glycosylase activity has been detected for 
NEIL3 (Hazra T.K. et al. 2007).  The NEILs are also able to recognise and remove 
spiroiminodihydantoin and guanidinohydantoin (Hailer M.K. et al. 2005).  
1.5 Base excision repair and the role of OGG1 
In E.coli. defence against the mutagenic effects of 8-oxo dG is via an enzymatic pathway 
called the “guanine oxide (GO) system” (Figure 1.12).  This includes an 8-oxodeoxyG-
DNA glycosylase; formamidopyrimidine DNA glycosylase (Fpg/MutM), a mismatch-
specific adenine-DNA glycosylase; MutY, and an 8-oxodGTPase; MutT (Zharkov D.O. 
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and Rosenquist T.A. 2002).  An analogous BER system exists in mammalian cells, 
involving MTH1 (human MutT orthologue), MutYH (human MutY homologue) and the 
human Fpg functional analogue OGG1 with both N-glycosylase and β-lyase activities.  
In vitro, the OGG1 enzyme recognises oxoG:C pairs and catalyses both the removal of 8-
oxo dG and cleavage of the DNA backbone (Bruner S.D. et al 2000).   Although capable 
of bifunctional activity, recent evidence suggests that the AP lyase activity of human 
OGG1 is not essential and that the enzyme may operate as a monofunctional glycosylase 
in vivo (Dalhus B. et al. 2011).   
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Figure ‎1.12: The E.coli “GO‎system”.   
o
GTP/GMP = 8-oxo-dGTP/GMP.  An 8-oxo dGTPase, MutT, is responsible for removing 
oxidatively damaged GTP from the nucleotide pool, thereby preventing its incorporation into 
nascent DNA.  A DNA glycosylase, MutM, excises oxidised guanine from 8-oxoG:C pairs and a 
second DNA glycosylase, MutY, excises any adenine residues that have been misincorporated 
opposite 8-oxo dG (Adapted from Figure 1: Sampson J.R. et al. 2005). 
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The human OGG1 (hOGG1) gene, isolated by several groups in 1997 (Arai K. et al. 
1997; Aburatani H. et al. 1997; Lu R. et al. 1997; Rosenquist T.A. et al. 1997)  has been 
mapped to chromosome 3p26.2 (Arai K. et al. 1997) and found to undergo alternative 
splicing (Aburatani H. et al. 1997).  Two main forms of messenger RNAs are expressed 
with open reading frames which code for proteins of 345 and 424 amino acids; the 
39kDa α-hOGG1 and 47kDa β-hOGG1 respectively.  The first 316 amino acids are 
identical and contain a mitochondrial targeting sequence however the carboxy-terminal 
ends differ extensively, with that of α-hOGG1 containing a nuclear localisation sequence 
absent in β-hOGG1 (Boiteux S. and Radicella J.P. 2000).  This PAKRRK sequence at 
position 333 in the C-terminus of α-hOGG1 targets it to the nucleus (Takao M. et al. 
1998) and suppresses the mitochondrial targeting sequence which targets β-hOGG1 to 
the mitochondria (Nishioka K. et al. 1999).  It was hypothesised that β-hOGG1 was 
responsible for mitochondrial BER however it has more recently been shown to lack 
glycoslyase activity (Hashiguchi K. et al. 2004), so it is thought instead that α-hOGG1 is 
responsible for mitochondrial DNA repair.  Although interesting, β-hOGG1 is not the 
subject of investigation in this project which instead concentrates solely on α-hOGG1, 
which from this point forward will be referred to simply as hOGG1. 
The structural features of hOGG1 include a helix-hairpin-helix followed by a Gly/Pro 
rich loop and a conserved aspartic acid (HhH-GDP motif) which is common to repair 
proteins with DNA glycosylase/AP-lyase activities.  When DNA bound, hOGG1 is 
strongly bound to the DNA backbone of the 8-oxo dG containing strand but is not in 
contact with the backbone of the complementary strand.  The 8-oxo dG residue extrudes 
from the helix and is inserted deeply into an extrahelical active-site cleft on the enzyme 
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(Bruner S.D. et al. 2000).  The catalytic mechanism of the DNA glycosylase activity of 
hOGG1 involves an attack on C-1′ of the 8-oxo dG-containing nucleotide by the ε-NH2 
group of Lys249, with Asp268 playing a catalytic role, eliminating the 8-oxo dG base.  
The hOGG1 protein then forms a covalent enzyme-DNA intermediate which undergoes 
rearrangements and forms a ring-opened Schiff base resulting in scission of the sugar-
phosphate backbone on the 3′-side of the AP site (Figure 1.13A). 
In order to effectively initiate DNA repair hOGG1 must specifically excise 8-oxo dG but 
not guanine, and must only remove 8-oxo dG when bound to cytosine, not adenine.  The 
structure of DNA bound hOGG1 compared with the structure of free hOGG1 revealed 
that conformational changes take place to allow recognition of 8-oxo dG:C to be coupled 
with catalysis.  Asp268 and Asn149 are hydrogen bonded to the protonated N
ε 
of the 
catalytic Lys249 in the free enzyme.  These hydrogen bonds serve as independent 
„trigger-locks‟ with one linked to recognition of cytosine and the other to recognition of 
8-oxo dG.  The removal of both of these bonds is necessary in order to „prime‟ the 
catalytic lysine for nucleophilic attack of the N-glycosidic bond (Bjørås M. et al. 2002). 
As previously stated, recent evidence suggests that OGG1 operates as a monofunctional 
glycosylase in vivo and the mechanism suggested for this process involves the reaction 
proceeding through an oxocarbenium ion which is stabilised by Asp268.  This 
oxocarbenium ion subsequently reacts with a water nucleophile to form an AP site which 
is incised by an AP endonuclease (Dalhus B. et al. 2011; Figure 1.13B). 
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Figure ‎1.13: Reaction mechanisms of OGG1.   
A: The acknowledged bifunctional mechanism of hOGG1 where Lys249 forms a covalent Schiff 
base intermediate and Asp268 activates Lys249.  Hydrolysis with water results in beta-
elimination and 3‟ strand incision.  
B: Putative monofunctional mechanism of hOGG1 where the reaction proceeds via formation of 
an oxocarbenium ion charge-stabilised by Asp268.  Subsequent reaction with a water nucleophile 
forms an AP site which is incised by AP endonuclease (Dalhus B. et al. 2011, Figure 1). 
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1.5.1 hOGG1 localisation, post-translational modification and 
 protein interactions 
It has been demonstrated that during S-phase of the cell cycle hOGG1 is localised within 
the nucleoli, and that this nuclear localisation is linked to transcription (Luna L. et al. 
2005).  During interphase wild-type α-hOGG1 has been shown to be associated with 
soluble chromatin and the nuclear matrix, and during mitosis with condensed chromatin 
(Dantzer F. et al. 2002).   
Dantzer et al. (2002) performed western blot analysis of HeLa cells expressing enhanced 
green fluorescence protein (EGFP)-hOGG1 fusion protein fractions using an anti-
phosphoserine antibody to examine hOGG1 phosphorylation in vivo.  This showed that 
hOGG1 associated with the nuclear matrix is unphosphorylated but hOGG1 associated 
with chromatin is phosphorylated on a serine residue.  Immunoprecipitation experiments 
revealed that in vitro, nuclear matrix-associated hOGG1 is phosphorylated by protein 
kinase C (PKC) and that chromatin-associated hOGG1 interacts with PKC but is not 
phosphorylated by it.  No alteration in enzymatic function occurred following 
phosphorylation leading to the suggestion that the phosphorylation event may be 
involved in protein re-localisation rather than modulation of enzymatic function (Dantzer 
F. et al. 2002).  
The first evidence that a post-translational modification of OGG1 could affect its activity 
was provided by Hu et al. (2005) who found that in vitro and in vivo OGG1 interacts 
with and is phosphorylated by Cdk4 and c-Abl kinases.  The serine/threonine 
phosphorylation by Cdk4 was shown to stimulate 8-oxo dG incision and the authors 
suggest that this is due to phosphorylation mediated enhancement of the coupling 
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between the base release and strand cleavage steps.  In contrast, tyrosine phosphorylation 
by c-Abl did not affect 8-oxo dG incision activity and its potential regulatory role 
remains to be determined (Hu J. et al. 2005).   
As well as being phosphorylated OGG1 has also been shown to be acetylated by 
p300/CBP both in vitro and in vivo (Bhakat K.K. et al. 2006).  The p300 and closely 
related CBP proteins are transcriptional co-activators with intrinsic histone 
acetylasetransferase activity which acetylate lysine residues in histones and a variety of 
transcription factors (Bannister A.J. and Kouzarides T 1996; Eckner R. et al. 1994; 
Goodman R.H. and Smolik S. 2000; Ogryzko V.V. et al. 1996).  They have been shown 
to play a role in DNA replication and BER as they acetylate Fen1 and interact with 
proliferating cell nuclear antigen (PCNA) to stimulate Fen1 (Hasan S. et al. 2001; Hasan 
S. et al. 2001.2).  Bhakat et al. (2006) show that acetylation of OGG1, predominantly at 
Lys338 and Lys341, increases its repair activity.  They propose that this is due to the 
weakening of the interaction of OGG1 with the AP product; the rate limiting dissociation 
step in 8-oxo dG excision, resulting in OGG1 displacement by APE1.  In agreement with 
this proposal, it has been shown that APE1 enhances OGG1 activity (Hill J.W. et al. 
2001; Vidal A.E. et al. 2001.1) and that this is partly by active displacement of the 
protein from the nascent AP site (Sidorenko V.S. et al. 2007; Sidorenko V.S. et al. 2008).  
By a mechanism similar to that of APE1, NEIL1 has also been shown to stimulate OGG1 
turnover and enhance its activity (Mokkapati S.K. et al. 2004).  It is suggested that in 
some human cells NEIL1 serves as a backup to APE1 for stimulation of 8-oxo dG repair.  
OGG1 also interacts with p53, and in vitro p53 enhances 8-oxo dG excision by 
increasing OGG1 and APE1 activity (Achanta G. and Huang P. 2004).  
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The process of BER is highly coordinated and involves multiple interactions between the 
proteins of the pathway.  One of the proteins which plays a central role in the 
coordination of BER is XRCC1 which interacts with all enzymes involved in BER 
downstream of the DNA glycosylase (Caldecott K.W. et al. 1994; Caldecott K.W. et al. 
1996; Kubota Y. et al. 1996; Vidal A.E. et al. 2001.2) and serves as a scaffold to 
stimulate or stabilise the components.  It has been shown to physically interact with and 
enhance the base excision activity of hOGG1 by stimulating the formation of the hOGG1 
Schiff-base DNA intermediate (Marsin S. et al. 2003).  The homologous recombination 
protein RAD52 has also been shown to physically interact with OGG1 (de Souza-Pinto 
N.C. et al. 2009).  This interaction leads to stimulation of OGG1 incision activity, by 
increasing turnover, but to inhibition of RAD52 activity suggesting cooperation between 
the two proteins to repair oxidative damage.  Interaction and cooperation between DNA 
repair proteins results in tight regulation of BER and could enhance cellular resistance to 
oxidative stress.  
Proteins involved in other cellular pathways may also play a role in BER.  One example 
of this is the human ribosomal protein S3 (hS3) which, as well as being a ribosomal 
subunit and involved in protein translation, has high binding affinity for 8-oxo dG 
(Hegde V. et al. 2004.1).  Although hS3 shares 80% sequence homology with drosophila 
S3 (dS3) which has the ability to remove 8-oxo dG (Yacoub A. et al. 1996), hS3 has no 
glycosylase activity hence its function has been the subject of investigation.  It was 
shown to interact with hOGG1 and APE1 and increase the activity of OGG1, but only 
when the purified proteins were mixed prior to exposure to DNA (Hegde V. et al. 
2004.2).  Further analysis showed that incubation of OGG1 with a hS3 mutant that 
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cannot bind 8-oxo dG resulted in OGG1 activity stimulation whereas incubation with 
wild-type hS3 resulted in OGG1 activity inhibition (Hegde V. et al. 2006).  In support of 
the finding that hS3 can create an obstacle to OGG1 BER, a decrease in hS3 expression 
was shown to result in the increased survival of human embryonic kidney (HEK293) 
cells exposed to DNA damaging agents (Hegde V. et al. 2007).  Following exposure to 
DNA damaging agents hS3 was found to translocate from the cytoplasm to the nucleus 
and co-localise with foci of nuclear 8-oxo dG DNA lesions in vitro (Yadavilli S. et al. 
2007) and in vivo (Hegde V. et al. 2009).  The significance of these findings and their 
relationship with OGG1 and other components of BER remain to be elucidated, but this 
serves as an example of cross-talk between BER proteins and proteins involved in 
alternate cellular pathways. 
1.6 hOGG1 polymorphisms  
The chromosomal location of the hOGG1 gene is frequently subject to monoallelic 
deletion and loss of heterozygosity in various cancers (Audebert M. et al. 2000; Lu R. et 
al. 1997).  Compared with wild-type mice mOgg1
-/-
 null (KO) mice have greater levels of 
8-oxo dG, show increased G:CT:A transversion mutations in their DNA, and are 
predisposed to lung adenocarcinoma and adenoma (Klungland A. et al. 1999; Minowa O. 
et al. 2000; Sakumi K. et al. 2003).   OGG1 is therefore a candidate tumour suppressor 
gene, resulting in interest in identifying mutations in the hOGG1 gene and investigating 
their effects on levels and activity of the protein (Kohno T. et al. 1998).   
Although several polymorphisms of the hOGG1 gene have been identified, the single 
nucleotide polymorphism (SNP) at codon 326 has received most attention because it is 
relatively common, and evidence suggests it is a possible genetic factor for increased 
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cancer risk (Yamane A. et al. 2004).  This missense polymorphism, present at an allele 
frequency of 0.33 – 0.45 in Asian populations and 0.22 – 0.27 in Caucasian populations, 
occurs due to a CG substitution at position 1245 in exon 7 and results in the exchange 
of a redox-sensitive cysteine for a serine in codon 326 (Weiss J.M. et al. 2005).  
As large numbers of individuals possess this polymorphic variant, there is considerable 
justification for the numerous studies investigating both its links with cancers and its 
activity, to determine to what effect such individuals may be predisposed to certain 
cancers.  The approaches used to evaluate the effect of the Ser326Cys (S326C) 
polymorphism have involved functional and epidemiologic studies, measuring the repair 
ability of Cys326-hOGG1 and the association between Cys326-hOGG1 and the risk of 
cancer respectively (Weiss J.M. et al. 2005). 
 1.6.1 Ser326Cys and cancer  
Individuals homozygous for the S326C hOGG1 allele have been shown to have an 
increased risk of cancers including nasopharyngeal, oesophageal, gallbladder and lung 
(Cho E.Y. et al. 2003; Kohno T. et al. 2006; Le Marchand L.L. et al. 2002; Park J. et al. 
2004; Srivastava A. et al. 2009; Sugimura H. et al. 1999; Xing D.Y. et al. 2001) but to 
have no increased risk of breast, prostate or biliary tract cancers (Agalliu I. et al. 2010; 
Cai Q. et al. 2006; Choi J.Y. et al. 2003; Huang W.Y. et al. 2008; Sterpone S. et al. 
2010; Vogel U. et al. 2003).  Surprisingly, a recent meta-analysis of all available studies 
revealed that the S326C hOGG1 allele may play a protective role in the carcinogenesis of 
breast cancer in European women (Yuan W. et al. 2010).  No association between colon 
cancer susceptibility and the S326C polymorphism was observed (Kim J.I. et al. 2003), 
even though the theoretical basis for such a link appeared strong as there is a clear role 
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for defects in DNA mismatch repair in colon carcinogenesis (de Wind N. el al. 1999).  
Although Kim et al. (2003) found no overall association between S326C and colon 
carcinogenesis, when external factors were evaluated they saw an increased risk 
associated with the CC genotype among smokers and those who ate more meat.  As both 
exposures are known to increase DNA damage, this suggests that any functional deficit 
only becomes significant in stressed cells and only when two polymorphic alleles are 
present.      
In support of this, no association between orolaryngeal or head and neck squamous cell 
carcinoma cancer risk and hOGG1 genotype was observed in individuals who abstained 
from drinking and smoking (Elahi A. et al. 2002; Zhang Z. et al. 2004).  However, 
increased risk of orolaryngeal cancer was observed for CC homozygous individuals who 
smoked or drank alcohol (Elahi A. et al. 2002) and an association between the CC 
genotype and head and neck squamous cell carcinoma was observed in heavy cigarette 
smokers (Hashimoto T. et al. 2006).  Interestingly, when factors including alcohol and 
meat consumption were evaluated an association between the S326C allele and increased 
risk of stomach cancer was observed (Takezaki T. et al. 2002).  Furthermore, the risk of 
progression of Helicobacter pylori-induced gastric cancer, associated with oxygen free 
radical formation, was increased in CC homozygotes and this risk was significantly 
elevated in smokers (Li W.Q. et al. 2009).  This evidence suggests that any defect of the 
Cys326-hOGG1 protein becomes more apparent in oxidising conditions.  
Although the evidence for an association between S326C and increased cancer risk is 
conflicting, cancer is a complex disease and individual SNPs are too simple to be reliable 
predictors of cancer (Paz-Elizur T. et al. 2008).  Current evidence supports the theory 
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that the impact of the S326C polymorphism is enhanced under conditions of oxidative 
stress.  It is important however to consider that DNA repair genes do not act in isolation 
and that although the impact of a single SNP in a single repair gene such as OGG1 may 
not result in a clear association with carcinogenesis (Vineis P. et al. 2009), genetic 
variants in multiple repair pathways may have an additive effect in cancer risk (Klinchid 
J. et al. 2009; Sterpone S. et al. 2010).  It is also important to consider the ethnic origins 
of the population studied when interpreting epidemiological data.  This has been 
highlighted by a meta-analysis of published studies evaluating the association between 
S326C and lung cancer which found no association between SC or CC and susceptibility 
to lung cancer when analysing all subjects, but when analysed by ethnicity a significant 
association was observed in Asian but not Caucasian subjects (Li H. et al. 2008).  As 
well as proposing the possibility of such an observation reflecting environmental 
exposures, the authors hypothesise that Asians may have a higher susceptibility to lung 
cancer due to having a higher frequency of the variant Cys326 allele.   
 1.6.2 Ser326Cys and hOGG1 functional activity 
A range of functional assays have been used to assess the ability of polymorphic OGG1 
protein to repair 8-oxo dG lesions.  Indirect repair capacity has been assessed by 
measuring levels of 8-oxo dG in cultured cells, leukocytes, tumorous and non-tumorous 
tissues using high pressure liquid chromatography with electrochemical detection 
(HPLC-ECD) or flow cytometry, or by 8-oxo dG cleavage and lyase assays (Blons H. et 
al. 1999; Bravard A. et al. 2009; Chen S.K. et al. 2003; Kondo S. et al. 2000; Yamane A. 
et al. 2004).  Direct repair capacity has been assessed using bacterial complementation 
assays (Kohno T. et al. 1998) and gas chromatography/isotope-dilution mass 
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spectrometry (GC/IDMS) quantification of 8-oxo dG following γ-irradiaton exposure and 
subsequent incubation with purified wild-type and polymorphic OGG1 proteins 
(Audebert M. et al 2000; Dherin C. et al. 1999). 
The bacterial complementation assay involves transfection of mutant rifampicin resistant 
(Rif
R
) E.coli strains, which are defective in the repair of 8-oxo dG and therefore have an 
extremely high G:CT:A mutation rate, with plasmids that code for Ser326-hOGG1 and 
Cys326-hOGG1 protein products.  Rifampicin resistance is then used as a marker for 
mutagenesis (Kohno T. et al. 1998).  Using this approach Kohno et al. (1998) observed a 
significantly reduced repair activity of Cys326-hOGG1 compared with wild type, 
however other studies using the same approach found no reduction in repair capacity 
(Blons H. et al. 1999; Dherin C. et al. 1999), although the use of cleavage assays by 
Dherin et al. (1999) gave Kcat/Km values for excision that were 1.6-fold lower for the 
GST-Cys326-α-hOGG1 protein.  Using an in vivo version of the complementation 
system Yamane et al. (2004) compared the mutation suppressive ability between Ser326-
OGG1 and Cys326-OGG1 under experimental conditions representing severe oxidative 
stress.  They found that mutations caused by 8-oxo dG were more efficiently suppressed 
in Ser326-OGG1 transduced cells than in Cys326-OGG1 transduced cells.  In agreement, 
Zielinska et al. (2011) observed a reduced repair rate of laser induced DNA damage by 
Cys326-hOGG1 compared with Ser326-hOGG1 in EGFP-OGG1-transfected cells. 
Chen et al. (2003) obtained blood samples from healthy adult volunteers and using a 
cleavage assay, found a significant decrease in hOGG1 activity in those with the CC 
genotype and a minor decrease in those with the SC genotype.  Bravard et al. (2009) also 
found, using homozygous Ser326- (SS) or Cys326-hOGG1 (CC) lymphoblastoid cell 
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lines, a two-fold lower basal glycosylase activity of CC cell extracts compared with SS 
cell extracts.  Interestingly, significantly higher 8-oxo dG levels were detected by Tarng 
et al. (2001) in chronic haemodialysis patients with the CC genotype compared with 
those with the CS or SS genotype.  This was not seen in healthy controls suggesting that 
any differences in repair ability between Ser326-hOGG1 and Cys326-hOGG1 only 
become apparent under conditions of stress.  In contrast, no significant differences were 
observed using cleavage assays, measurement of 8-oxo dG levels or lyase assays by other 
groups (Hardie L.J. et al. 2000; Janssen K. et al. 2001; Kondo S. et al. 2000; Li D. et al. 
2002; Park Y.J. et al. 2001; Shinmura K. et al. 1998). 
The conventional comet assay and a modified version which uses fpg to specifically 
detect oxidised purines are recognised techniques for use in whole cells for the detection 
of DNA strand breaks and oxidative damage respectively (Figure 1.14) (Ostling O. and 
Johanson K.J. 1984; Duthie S.J. et al. 1996).  
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Figure ‎1.14: An overview of the conventional comet assay.   
The FPG-modified comet assay involves all conventional steps plus treatment with FPG enzyme 
(green arrow).   
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Both versions have been used to assess wild-type and variant hOGG1 repair capacity in 
whole cells under conditions of oxidative stress (Lee A. et al. 2005; Smart D.J. et al. 
2006).  Lee et al. (2005) assessed the levels of DNA strand breaks in whole blood cells 
from healthy adult volunteers and found that treatment with sodium dichromate resulted 
in a significant increase in FPG-dependent oxidative DNA damage in CC individuals 
compared with SC and SS individuals.  When divided on the basis of genotype, CC 
individuals also had a higher oxidative DNA damage: plasma antioxidant capacity ratio 
than SC or SS individuals.  The difference in DNA damage was not observed without 
treatment suggesting that the Cys326-hOGG1 protein is deficient in repair ability only 
under conditions of cellular oxidative stress.   
In support of this, Smart et al. (2006) found that the Cys326-hOGG1 variant had a 
significantly reduced repair capacity compared with Ser326-hOGG1 after treatment of 
mOGG1
 -/-
 and mOGG1
+/+
 MEF with the known 8-oxo dG inducing agents Ro19-8022 (+ 
light), sodium dichromate and potassium bromate.  This reduced repair ability was 
observed at early time points, however longer periods allowed recovery of repair ability.  
The authors hypothesise that the substitution at position 326 results in either the loss of a 
regulatory serine phosphorylation site or the gain of a redox-sensitive cysteine residue, 
and that either or both of these events may be responsible for the reduced repair ability.       
 1.6.3 Ser326Cys and hOGG1 localisation 
Luna et al. (2005) investigated the differences between wild-type and S326C mutant 
hOGG1 protein and found that the polymorphism affects association with the nuclear 
matrix and chromatin, localisation to the nucleoli during S-phase, and co-localisation to 
the condensed chromosomes during mitosis.  As the S326C residue lies close to the 
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nuclear localisation signal (NLS) and within a predicted potential phosphorylation site, 
Luna et al. (2005) mimicked a hOGG1 protein phosphorylated at position 326 and 
demonstrated that S326C mutation-affected processes are mediated through 
phosphorylation of serine-326.  They found that EGFP-hOGG1-Cys
326
 and EGFP-
hOGG1-Ala
326
 proteins were excluded from the nucleoli, indicating that the presence of 
the serine residue is important for accurate hOGG1 localisation.  Luna et al. (2005) 
suggest that phosphorylation of serine-326 is required for interaction with a protein 
during S-phase which will translocate hOGG1 to the nucleolus and to the condensed 
chromosomes during mitosis.  They further suggest that the phosphorylation mediated 
subcellular localisation could explain any difference in mutational suppressive ability 
between the wild-type and S326C hOGG1 proteins.   
 1.6.4 Ser326Cys and hOGG1 dimer formation  
The mechanistic basis underlying the observed reduced repair ability of Cys326-hOGG1 
is currently unknown and as no crystal structures exist for OGG1 that include amino 
acids C-terminal to residue 325, no information can be gained from structural data.  The 
loss of the Ser326 residue, a phosphorylation site important for the localisation of 
hOGG1, or the introduction of the redox-sensitive cysteine residue are two potential 
mechanisms, with recent evidence favouring the latter.  
Evidence for redox state modulation of hOGG1 was presented by Bravard et al. (2006) 
who demonstrated that hOGG1 activity could be reversibly modulated by cadmium and 
inhibited using the cysteine-modifying agent N-ethylmaleimide or the thiol oxidant 
diamide.  Bravard and colleagues then investigated the oxidation status effects on 
Ser326- and Cys326-hOGG1 in lymphoblastoid cell lines and observed reduced activity 
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of Cys326-hOGG1, which was recovered with the addition of reducing agents (Bravard 
et al. 2009).  Incubation of cells with the cysteine oxidising agent diamide resulted in 
Cys326-hOGG1 cells showing only 20% of the activity of the untreated cells compared 
with 60% for the Ser326-hOGG1 cells.   
A study using the electrophoretic mobility shift assay (EMSA) to investigate the DNA 
damage binding affinities of wild type and S326C mutant purified hOGG1 for 8-
oxoguanine and abasic sites found that high molecular weight shifts consistent with a 
hOGG1 dimer were formed with Cys326-hOGG1 but not Ser326-hOGG1 (Hill J.W. and 
Evans M.K. 2006).  Using an anti-FLAG western blot, Hill and Evans (2006) also 
observed this dimer in nuclear extracts from cells expressing both wild type and Cys326-
hOGG1 following incubation with a chemical cross-linker.  These findings suggest that 
Cys326-hOGG1 both exists as a dimer in solution and binds DNA as a dimer, and that 
Ser326-hOGG1 has the ability to form a dimer in the presence of cross-linker.  In support 
of this, further analysis of the oxidation state of cysteine residues by Bravard et al. 
(2009) revealed that Cys326 can be easily involved in disulphide bond formation.  Cross-
linking experiments using GFP-hOGG1 and FLAG-hOGG1 fusion proteins expressed in 
HeLa cells showed that inactivation of Ser326-hOGG1 was associated with the oxidation 
of one cysteine residue whereas inactivation of Cys326-hOGG1 was associated with the 
oxidation of two.  The authors conclude that this is likely to be the result of the formation 
of a disulphide bond and show that incubation with a reagent that specifically cross-links 
cysteines in close proximity resulted in an intramolecular cross-link such as that found 
with oxidative treatment. 
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The substitution of serine with cysteine at position 326 introduces a further redox active 
thiol group in addition to those of the eight other cysteine residues present in the  hOGG1 
protein.  Thiol groups contain a labile proton which renders them subject to reversible 
oxidation to sulphenic acid in order to play a role in normal cellular redox regulation 
pathways.  However, in the presence of oxidative stress and absence of GSH these thiol 
groups are susceptible to react readily with oxygen or other oxidants to produce 
sulphenic acid, sulphinic acid and irreversible sulfonic acid species.  Sulphenic acid is 
relatively reactive and able to disulphide bond quickly with a nearby thiol (Biswas S. et 
al. 2006).  The cys326 residue is present in a highly positively charged sequence 
environment (ADLRQ[ser326cys]RHAQ) and replaces the serine residue in a short 
disordered peptide segment at the C terminus of the hOGG1 protein (Bruner S.D. et al. 
2000).  Using C-terminally truncated hOGG1 proteins Hill and Evans (2006) found that 
the residues C-terminal to cys326 play roles in both the reduced activity and dimerisation 
of S326C hOGG1 and also showed that cys326 alone is sufficient to cause dimerisation 
and catalytic inhibition (Hill J.W. and Evans M.K. 2006).  
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1.7 Aims and objectives 
The current study aimed to investigate the response of OGG1 to BSO-induced oxidative 
stress and further explore the hypothesis that a functional difference becomes more 
apparent between wild-type and variant hOGG1 under oxidative conditions. 
Specifically: 
 To investigate the effect of oxidative stress on OGG1 activity, gene and protein 
expression. 
 To improve previous in vitro study models and generate mOGG1-/- MEF cells that 
stably express Ser326- and Cys326-hOGG1, then use these to investigate human 
OGG1 activity and gene expression following exposure to oxidative stress 
conditions. 
 To investigate the mechanism underlying functional differences by studying 
Ser326- and Cys326-hOGG1 localisation and ability to form oligomeric 
complexes, and by assessing Ser326- and Cys326-hOGG1 retention within the 
insoluble nuclear fraction following oxidative stress. 
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Chapter 2 – Materials 
and Methods 
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2.1 Chemicals 
All chemicals were obtained from Sigma-Aldrich (UK) unless otherwise statedMaterials 
and Methods 
2.2 Cell culture 
All cell culture work was conducted in sterile conditions in a class II tissue culture hood 
(Aura B4, Bio Air, Italy).  All solutions used were obtained sterile or autoclaved as 
necessary before use. 
 2.2.1 Cell maintenance – mouse embryonic fibroblasts  
Wild-type (WT) and mOgg1
-/-
 null (KO) mouse embryonic fibroblasts (MEFs) were a 
generous gift from T.Lindahl (Cancer Research U.K., Clare Hall Laboratories, South 
Mimms, Hertfordshire EN6 3LD, U.K.).  Cells were cultured at 37°C in a humidified 
chamber (5% CO2, 95% air; MCO-15AC, Sanyo, Japan) in 75cm
2
 cell culture flasks 
(Greiner Bio-one, U.K.) containing Dulbecco‟s modified Eagle‟s medium (DMEM) 
supplemented with foetal bovine serum (10% v/v) (FBS), L-glutamine (2 mM), penicillin 
(100 U/ml) and streptomycin (100 µg/ml).  Cells were seeded at approximately 1 × 10
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cells per flask and passaged using a standard trypsin-EDTA (0.25%:0.02%) protocol 
when fully confluent. 
 2.2.2 Cell Cryopreservation 
Resuspended trypsinised cells (10 ml) were transferred to sterile 15 ml centrifuge tubes 
(Falcon) and subjected to centrifugation at 1000 × g (Rotofix 32, Hettich Zentrifugen, 
Germany) at room temperature for 10 minutes.  DMEM was removed and cells were 
resuspended in FBS (1 ml) containing cryoprotectant (10% v/v sterile dimethyl 
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sulphoxide DMSO).  The suspension was transferred to 1 ml cryovials (Nalgene, U.S.A.) 
and stored at -80°C for 24 hours before transfer to liquid nitrogen. 
2.3 Oxidative treatment 
Cells seeded in 6, 12 or 24 well tissue culture plates (Greiner Bio-one, U.K.) were grown 
to confluence overnight.  DMEM was removed and cells washed with phosphate 
buffered saline (PBS) (1 ml) prior to the addition of fresh DMEM containing L-
buthionine-S-sulfoximine (BSO), or diamide at the appropriate concentrations.  Cells 
were incubated at 37°C for 30 minutes (diamide) or 24 hours (BSO) as oxidative DNA 
modifications are formed following 24 hour BSO treatment (Green R.M. et al. 2006).  
2.4 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium 
bromide (MTT) reduction assay 
The water soluble dye MTT is able to cross cell membranes and is reduced principally by 
mitochondrial succinate dehydrogenase yielding a blue insoluble formazan product.  This 
product, when dissolved with DMSO, forms a purple solution allowing quantification of 
cell viability by measuring the absorbance of the solution between 500 and 570 nm 
(Hussain et al 1993).  The greater the absorbance reading, the greater the viable cell 
population. 
2.4.1 Assay procedure 
Cells were cultured in supplemented cell culture medium in 96 well cell culture plates 
(Greiner Bio-one, U.K.), grown to confluence and treated as described in 2.3.  Cells were 
washed with PBS (200 µl) and fresh medium was added (200 µl) along with 3-(4,5-
Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) (0.5 mg/ml).  
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Following incubation at 37°C for 2 hours in a humidified chamber the medium was 
removed and DMSO was added (200 µl) to solubilise the blue formazan product.  The 
plates were rocked gently for 2 hours at room temperature in the dark.  The absorbance 
was determined at 570 nm using a Bio-Tek FL600 plate reader (Bio-Tek Instruments Inc. 
U.S.A.) against a DMSO blank.   
2.5 Assay for the measurement of reactive oxygen species 
This assay, based upon that described by Carini et al. (2000), uses the compound 2‟,7‟-
dichlorodihydrofluoroscein-diacetate (H2DCF-DA) which is readily taken up by cells in 
culture and hydrolysed by intracellular esterases to yield 2‟,7‟-
dichlorodihydrofluoroscein (H2DCF).  H2DCF is non-fluorescent but can be oxidised by 
intracellular reactive oxygen species (ROS) to yield the fluorophore DCF (Gomes A. et 
al. 2005; Bartosz G. 2006). 
2.5.1 Assay procedure 
Cells were seeded in 12 well tissue culture plates, grown to confluence and treated with 
BSO as described in section 2.3.  Following treatment, DMEM was removed and cells 
were washed with PBS (1 ml).  Fresh DMEM was added (3 ml) containing 10 µM 
H2DCF-DA (Invitrogen U.K.) and cells were incubated for 45 minutes at 37°C prior to 
fluorescence analysis by flow cytometry (BD FACS Calibur) (emission wavelength 517 
– 527 nm) as described previously (Hayden R.E. et al. 2009).  Weasel software (Walter 
and Eliza hall institute of medical research, Australia) was used to generate histograms of 
the data and blank adjusted median values were used to compare fluorescence intensities.   
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2.6 Assay for the measurement of total reduced glutathione 
Total reduced cellular glutathione (GSH) was measured using a fluorescence-based 
technique originally described by Cohn and Lyle (1966).  This technique has been 
modified by Hissin and Hilf (1976) and Senft et al. (2000) and optimised for use in MEF 
cells by Green R.M. et al. (2006).  The derivatising agent used in this assay; o-
phthalaldehyde (OPA), is non-fluorescent until it reacts as a heterobifunctional reagent 
with a primary amine in the presence of a thiol, cyanide or sulphite and generates a 
fluorescent isoindole.  GSH supplies both the amine and thiol moieties and therefore 
reacts with OPA (Senft A.P. 2000). 
2.6.1 Buffers 
Phosphate-EDTA assay buffer: NaH2PO4 (100 mM) and Na2EDTA (5 mM), adjusted 
to pH 8 
Cell lysis buffer: 0.1% Triton X-100 in phosphate-EDTA assay buffer 
2.6.2 Sample preparation 
Following treatment as described in section 2.3, DMEM was removed from confluent 
cells seeded in 6 well culture plates and cells were washed using PBS (1 ml).  After 
removal of PBS, cells were scraped into 450 µl ice cold cell lysis buffer, transferred to 
1.5 ml microcentrifuge tubes and an aliquot (2 µl) was taken and used for protein 
quantification as described in section 2.11.3.  Ice cold 50% trichloroacetic acid (TCA) 
(50 μl) was added to each tube and GSH-containing protein-free supernatants were 
prepared by centrifugation of the samples at 15000 × g for 5 minutes at 4 °C.   
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2.6.3 Assay procedure 
From the supernatants prepared, 100 µl was taken and added to 3 ml polystyrene 
fluorescence cuvettes containing 1.8 ml phosphate–EDTA assay buffer.   A GSH 
standard curve was constructed by adding the required amount (0 – 20 µl, 0 – 2 µg) of a 
freshly prepared GSH stock (0.1 mg/ml in phosphate–EDTA assay buffer) to a cuvette 
containing 1.8 ml phosphate-EDTA assay buffer and 100 µl 5% TCA (w/v in phosphate-
EDTA assay buffer).  To each cuvette 100 µl OPA (1 mg/ml in methanol) was added.  
Cuvettes were left in the dark for 15 minutes on a rocking platform before fluorescence 
was read using a fluorimeter (Perkin Elmer LS 50B) with λexcitation = 340 nm (slit width 
2.5 nm) and λemission = 420 nm (slit width 4.0 nm).  Using the standard curve total sample 
GSH was determined and normalised to protein as described in section 2.11.4. 
2.7 Cloning 
For the generation of hOGG1-expressing KO MEF cells, hOGG1 cDNA was cloned into 
mammalian expression vectors and used to transfect KO MEF cells.  For the generation 
of yellow fluorescent protein (YFP)-hOGG1 bimolecular fluorescence complementation 
(BiFC) constructs YFP-hOGG1 cDNA was cloned into mammalian expression vectors 
and used for KO MEF cell transfection. 
BiFC is a method for the visualisation of protein – protein interactions in live cells, as 
described in further detail in section 5.1.  BiFC involves the reconstitution of the 
fluorescence of yellow fluorescent protein (YFP) by the association of two non-
fluorescent YFP half molecules fused to proteins of interest, such as hOGG1 (Figure 
2.1).      
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Figure ‎2.1: Principle of the BiFC assay. 
The YFP-N and YFP-C fragments are fused to putative interaction partners.  Upon interaction of 
these partners the non-fluorescent YFP halves will complement resulting in fluorescence. 
 
2.7.1 hOGG1-expressing MEF cell vector preparation  
pcDNA3© plasmids containing wild-type (Ser326-) and polymorphic (Cys326-) hOGG1 
cDNA were a generous gift from J.Yokota (National Cancer Centre, Tokyo, Japan).  
These vectors had been previously sub-cloned in our laboratory into a 
pcDNA3.1/Hygro©(+) mammalian expression vector (Invitrogen, U.S.A.) (see appendix, 
pages 218-219).  Following DNA isolation from frozen bacterial stocks, this was used for 
transient hOGG1 transfection of KO MEF cells. 
The pcDNA3.1/Hygro©(+) plasmids had, in our laboratory, been previously used to sub-
clone hOGG1 variant cDNA into a pIREShyg3 mammalian expression vector (B.D. 
Clontech, U.S.A.) (see appendix, page 220).  Following DNA isolation from frozen 
bacterial stocks, this was used for stable hOGG1 transfection of KO MEF cells.    
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 2.7.2 BiFC-construct vector preparation  
pBluescript II KS(-) plasmids (see appendix, page 222) containing either the N- or C-
terminus of yellow fluorescent protein, YFP-N and YFP-C respectively, were a generous 
gift from S. Brogna, (University of Birmingham, B15 2TT).  Plasmid identities were 
confirmed by sequencing as described in section 2.7.6.  Ser326- and Cys326-hOGG1 
cDNA was amplified from pcDNA3© plasmids by polymerase chain reaction (PCR) (as 
described in section 2.10.4) using primers with BamHI sites, then cloned into pBluescript 
II vectors.   
(Forward primer: 5‟-GAGAGGATCCATGCCTGCCCGCGCGCTTCTG-3‟ Reverse 
primer: 5‟-GGCAGGATCCTTACTAGCCTTCCGGCCCTTTG-3‟ see table 2.1 for 
conditions)  
Next YFP-N and YFP-C-hOGG1 cDNA was subcloned first into a pEGFP-N1 
mammalian expression vector (B.D. Clontech) (see appendix, page 221) then into a 
pcDNA3.1/Hygro©(+) mammalian expression vector (Invitrogen, U.S.A.) to generate: 
YFP-N-Ser326-hOGG1, YFP-C-Ser326-hOGG1, YFP-N-Cys326-hOGG1 and YFP-C-
Cys326-hOGG1 constructs (Figure 2.2).  To enable detection of background fluorescence 
arising from non-hOGG1 mediated YFP fragment association, controls were also 
generated without hOGG1: YFP-N and YFP-C. 
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This cloning strategy was undertaken as the work was initially intended to be done using 
a drosophila expression vector, with compatible NotI and KpnI restriction sites, for use in 
drosophila cells.  As there were no compatible restriction sites which would allow direct 
cloning from the pBluescriptII SK/KS(-) plasmid into the mammalian pcDNA3.1 hygro 
Figure ‎2.2: Outline of cloning strategy for BiFC-construct vector preparation. 
hOGG1 cDNA was amplified by PCR and cloned into pBluescriptII SK/KS(-) vectors, then 
subcloned into a pEGFP-N1 mammalian expression vector, then further subcloned into a 
pcDNA3.1/Hygro(+) mammalian expression vector which was used for all experiments.   
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(+) expression vector, the approach detailed above was chosen.  A more direct approach 
would be to use PCR to transfer the YFP-hOGG1 constructs.  
2.7.2.1 Restriction digestion  
1) pBluescript II KS(-) plasmids (5 µg) and Ser326- and Cys326-hOGG1 BamHI 
PCR products were combined with BamHI (5 units), 100X bovine serum albumin 
(BSA) (0.1 μl), NEBBuffer 3 (2 μl) (New England Biolabs, Hertfordshire, U.K.) 
and sterile water to 30 μl. Reactions were incubated for 16 hours at 37°C prior to 
gel purification, as described in section 2.10.7. 
2) pBluescript II KS(-) plasmids (5 µg) containing Ser326- and Cys326-hOGG1 
inserts and pEGFP-N1 plasmids (5 µg) were combined with KpnI (5 units), NotI 
(5 units), BamHI-buffer (2 µl) (Fermentas, U.K.) and sterile water to 20 µl.  
Reactions were incubated for 2 hours at 37°C prior to gel purification, as 
described in section 2.10.7.   
3) pEGFP-N1 plasmids (5 µg) containing Ser326- and Cys326-hOGG1 inserts and 
pcDNA3.1/Hygro© (+) plasmids (5 µg) were combined with NotI (5 units), XhoI 
(5 units), 100X BSA (0.1 µl), NEBBuffer 3 (2 µl) (New England Biolabs, 
Hertfordshire, U.K.) and sterile water to 20 µl.  Reactions were incubated for 2 
hours at 37°C prior to gel purification, as described in section 2.10.7. 
2.7.2.2 DNA ligation 
1) Gel purified BamHI-digested pBluescript II KS(-) plasmids (15 µl) were 
incubated with calf intestinal alkaline phosphatase (10 units) and NEBBuffer 3 
(1.5 µl) (New England Biolabs, Hertfordshire, U.K.)  for 1 hour at 37°C  prior to 
ligation with gel purified BamHI-digested Ser326- and Cys326-hOGG1 using T4 
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DNA ligase (New England Biolabs, Hertfordshire, UK).  Digested pBluescript II 
KS(-) plasmids (50 ng), digested hOGG1 (50 ng), T4 DNA ligase (800 units), 
10X ligation buffer (3 µl) were combined with sterile water to 30 μl and 
incubated at 12°C for 16 hours.   
2) Gel purified KpnI-NotI-digested pEGFP-N1 plasmids (15 µl) were incubated with 
calf intestinal alkaline phosphatase (10 units) and NEBBuffer 3 (1.5 µl) (New 
England Biolabs, Hertfordshire, U.K.) for 1 hour at 37°C prior to ligation with gel 
purified KpnI-NotI-digested hOGG1-containing pBluescript II KS(-) plasmids as 
described above.   
3) Gel purified NotI-XhoI-digested pcDNA3.1/Hygro© (+) plasmids (15 µl) were 
incubated with calf intestinal alkaline phosphatase (10 units) and NEBBuffer 3 
(1.5 µl) (New England Biolabs, Hertfordshire, U.K.) for 1 hour at 37°C prior to 
ligation with gel purified NotI-XhoI-digested hOGG1-containing pEGFP-N1 
plasmids as described above.   
2.7.3 Bacterial transformation 
High efficiency JM109 competent E.coli cells (>10
8
 cfu/μg) (Promega, U.K.) were 
defrosted on ice.  Ligated DNA (5 μl) was added to the cells and the suspension was 
mixed by gently flicking the tube.  After incubating on ice for 30 minutes the cell 
suspension was incubated at 42°C for exactly 30 seconds before returning to ice for 2 
minutes.  Room temperature SOC medium (900 μl) was added and cells were incubated 
with shaking (225 rpm) at 37°C for 1 hour.  Cells (10 μl) were spread onto Luria-Bertani 
(LB)-agar plates containing ampicillin (100 μg/ml) or kanamycin (30 µg/ml) which were 
inverted and incubated at 37°C for 16 hours.  Colonies were selected at random using a 
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sterile pipette tip and used to inoculate 3 ml LB-broth containing ampicillin (100 μg/ml) 
or kanamycin (30 µg/ml).  Bacterial cultures were shaken (225 rpm) at 37°C for 16 hours 
prior to insert screening by PCR, as described in section 2.10.4, using M13 primers or 
hOGG1 primers where appropriate (see table 2.1 for conditions and primer sequences) 
with an additional 10 minute initial denaturation step to lyse the bacteria. 
2.7.4 Plasmid DNA mini-preparation 
An aliquot of the appropriate stock of high efficiency JM109 competent E.coli cells 
transformed with the ligated expression vectors was added to LB-broth (15 ml) 
containing ampicillin (100 µg/ml) or kanamycin (30 µg/ml) using a sterile pipette tip.  
Bacterial cultures were shaken (225 rpm) at 37°C for 16 – 48 hours.  Plasmid DNA was 
isolated from bacterial cultures using a QIAprep® spin miniprep kit (Qiagen) as per 
manufacturer‟s instructions.  Briefly, bacterial cells were pelleted by centrifugation at 
6000 × g for 10 minutes and resuspended in buffer P1 (500 µl), followed by vortexing.  
The cell suspension was transferred to a 1.5 ml microcentrifuge tube and buffer P2 (250 
µl) added.  Tubes were gently mixed and buffer N3 (350 µl) was added, followed by 
further gentle mixing.  The tubes were centrifuged (8000 × g, 10 minutes) to remove 
precipitated bacterial cell debris.  The supernatant was decanted and transferred to a 
QIAprep column with collecting tube.  The column was centrifuged (8000 × g, 60 
seconds).  A second wash step was carried out using buffer PE (750 µl) and the column 
was subjected again to centrifugation at 8000 × g for 60 seconds.  The flow through was 
discarded and the residual buffer removed by centrifugation at 8000 × g for 60 seconds.  
The column was transferred to a new 1.5 ml microcentrifuge tube and incubated with 
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buffer EB (100 µl) for 1 minute at room temperature, followed by centrifugation for 60 
seconds at 8000 × g.  Eluted plasmid DNA was stored at -20°C. 
2.7.5 DNA quantification 
Eluted plasmid DNA concentration expressed in micrograms per microlitre was 
determined using UV spectroscopy (UVIKON Spectrophotometer 922, Konton 
Instruments, U.K.) by measuring absorbance at 260 nm. 
2.7.6 DNA sequencing 
DNA was sequenced by The Genomics Laboratory, School of Biosciences, University of 
Birmingham, Edgbaston, Birmingham, B15 2TT, U.K. 
2.8 Stable cell line generation  
2.8.1 Linearisation of hOGG1 pIREShyg3 
Vector linearisation prevents episomal replication and permits stable genomic 
integration.  Linearisation of Ser326- and Cys326- pIREShyg3 expression vectors was 
achieved by restriction endonuclease digestion.  Ser326- or Cys326-hOGG1 pIREShyg3 
(15 µg) was incubated with 20 units of SspI restriction endonuclease (New England 
Biolabs, Hertfordshire, U.K.), 10X enzyme buffer (5 µl), 100X BSA (0.1 µl) and sterile 
water (to 50 µl) for 16 hours at 37°C prior to gel purification as described in section 
2.10.7. 
2.8.2 Selection of transfected cells; kill curve generation  
KO MEF cells were seeded at 35 000 cells per well and cultured in 12-well cell culture 
plates (15 mm diameter, Greiner, Bio-one, U.K.).  Hygromycin B, an aminocyclitol 
70 
 
compound that inhibits protein synthesis, was added to complete DMEM at final 
concentrations of 0, 25, 100, 200 and 250 µg/ml.  Cells cultured with hygromycin B were 
trypsinised at 0, 24, 48, 72 and 120 hours and counted using a haemocytometer.  These 
data were used to construct a KO MEF cell kill curve in order to determine the optimal 
concentration of hygromycin for selection and maintenance of stably-transfected clones.  
2.8.3 Transient transfection of KO MEF cells 
Cells were plated at 60% confluency in 60 mm cell culture dishes and incubated at 37°C 
for 4 hours to allow attachment, and growth to approximately 75% confluency.  For each 
60 mm cell culture dish TurboFect™ transfection reagent (Fermentas, U.K.) (10 µl) and 
Ser326- or Cys326-hOGG1 pcDNA3.1/Hygro©(+) (6 µg) were added to 500 µl serum-
free DMEM in a sterile 1.5 ml microcentrifuge tube.  Gentle pipetting was used to mix 
and the mixture incubated at room temperature for 20 minutes.  The entire volume of 
DNA/TurboFect™/serum-free DMEM mixture was subsequently added drop-wise to 
cells and the dish was gently tilted several times to distribute evenly.  Dishes were 
incubated for 24 hours prior to pro-oxidant treatment and/or harvesting. 
2.8.4 Stable transfection of KO MEF cells 
Cells were transfected as described in section 2.8.3 with either Ser326- or Cys326- 
pIREShyg3 (or empty vector as control) (6 µg) and incubated for 48 hours.  Cells were 
washed with 5 ml PBS and fresh DMEM was added prior to a further 24 hour incubation 
to allow growth to confluence.   
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2.8.5 Selection and maintenance of stable cell lines 
Confluent Ser326-, Cys326- or empty- pIREShyg3-transfected KO MEF cells were 
trypsinised and reseeded in 60 mm cell culture dishes (5 per transfection) prior to the 
addition of complete DMEM containing hygromycin B antibiotic (200 µg/ml).  Cells 
were cultured for 14 days to allow growth.  Healthy colonies (36 per transfection) were 
selected by trypsinisation and reseeded into 12 well cell culture plates and grown to 
confluence prior to reseeding into 6 well culture plates and finally 75 cm
2
 cell culture 
flasks.  All clones which grew to confluence were initially assessed for hOGG1 activity 
using the molecular beacon assay (as described in section 2.9).  Total RNA/cDNA, 
genomic DNA and nuclear protein extract (as described in sections 2.10 and 2.11) were 
subsequently isolated from successful candidates to allow stable cell line 
characterisation.  
2.9 Molecular beacon incision assay 
The use of molecular beacon incision assays to allow measurement of DNA glycosylase 
activity in live cells has been previously described (Maksimenko et al. 2004) and further 
developed and optimised in our laboratory for the specific analysis of OGG1 activity 
(Mirbahai L. et al. 2010; Priestley C.C. et al. 2010).  The molecular beacon (Figure 
2.3A) is an oligonucleotide with a 5‟-fluorophore (fluorescein isothiocyanate; FITC) and 
a 3‟-quencher (4-dimethylaminophenylazobenzoic acid; DAB).  The stem-loop 
conformation adopted due to the self-complementary regions brings the FITC 
fluorophore in close proximity with the DAB quencher which quenches the fluorescence 
by fluorescence resonance energy transfer (FRET).  The oligonucleotide synthesised by 
Alta Biosciences (University of Birmingham, U.K.) contains an 8-oxo dG lesion which 
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pairs with a dC residue providing a lesion recognition site for OGG1.  Once transfected 
into cells, the molecular beacon can be cleaved by OGG1, leading to separation of the 
fluorophore and quencher resulting in fluorescence (Figure 2.4).  A positive control 
beacon was also synthesised (Figure 2.3B) and transfected into cells to assess and control 
for transfection efficiency. 
 
  
Figure ‎2.3 Molecular beacons. 
(A): 8-oxo dG-containing molecular beacon.  (B): Positive control molecular beacon. 
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2.9.1 Transfection with molecular beacons 
The molecular beacon was dissolved in sterile H2O to a final concentration of 10 
pmol/µl, heated to 95°C for 3 minutes then allowed to anneal by cooling at room 
temperature for 3 hours.  MEF cells were plated in 12 well cell culture dishes, allowed to 
grow to 75% confluence and either treated as described in section 2.3 or left as untreated 
controls.  Per well, TurboFect™ transfection reagent (Fermentas, U.K.) (2 µl) was 
combined with beacon (140 pmol) and 67 µl serum free DMEM in a sterile 1.5 ml 
microcentrifuge tube.  Gentle pipetting was used to mix and the mixture was incubated at 
room temperature for 20 minutes.  The entire volume of beacon/TurboFect™/serum-free 
DMEM mixture was subsequently added drop-wise to cells and the dishes gently tilted 
several times to distribute evenly.  Dishes were incubated at 37°C in a humidified 
chamber. 
2.9.2 Flow cytometry analysis of FITC-derived fluorescence in 
MEF cells 
Following treatment and transfection with molecular beacon DMEM was removed and 
cells were washed with PBS.  Trypsin (500 µl) was used to detach cells which were 
centrifuged (1000 × g, 4 minutes, room temperature) and the resulting pellet resuspended 
in PBS (200 µl) and FACS fixative (200 µl) (1% (v/v) formaldehyde, 2% (v/v) FBS in 
PBS) with repeat pipetting to ensure a single cell suspension.  Samples (10 000 live cells) 
were analysed using a BD FACScalibur™ flow cytometer (Becton Dickinson).  
CellQuestPro™ software and Weasel software (Walter and Eliza hall institute of medical 
research, Australia) were used to generate histograms of data, with an M-gate set at 10
1
 
on the FL1 (FITC) channel (Figure 2.5).  This M-gate was applied to all of the data and 
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the percentage of positive events was compared (Figure 2.5).  As controls, a mock-
transfected population was analysed and BSO treated population without molecular 
beacon was also analysed. 
 
 
Figure ‎2.4: Measurement of OGG1 activity using 8-oxo dG-containing molecular beacon. 
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Figure ‎2.5: Flow cytometry analysis of molecular beacon fluorescent events. 
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2.10 Nucleic acid purification and amplification 
2.10.1 Isolation of total RNA from cultured cells 
Total cellular RNA was isolated from cells as described by Chomczynski P. and Sacchi 
N. (1987) using an EZ-RNA kit (Geneflow, Staffordshire, U.K.) as per manufacturer‟s 
instructions.  Briefly, cells grown to confluence in a 6 well culture plate (~5 × 10
6
 cells) 
were washed with PBS prior to the addition of 500 µl guanidine thiocyanate detergent.  
The cell lysate was transferred to a 1.5 ml microcentrifuge tube and incubated at room 
temperature for 5 minutes.  Phenol:chloroform extraction solution (500 µl) was added 
and following mixing by vortexing (15 seconds) left at room temperature for 10 minutes 
prior to centrifugation (12000 × g, 15 minutes, 4°C).  The aqueous (RNA containing) 
phase (500 µl) was transferred to a fresh 1.5 ml microcentrifuge tube, isopropanol (500 
µl) was added and the sample incubated for 16 hours at -20°C.  Following centrifugation 
(12000 × g, 8 minutes, 4°C) and removal of the supernatant, the pellet was washed with 1 
ml 75% ethanol and left to air dry (5 minutes) prior to resuspension in 20 µl DEPC-
treated dH2O.  RNA was quantified by spectrophotometry using a Nanodrop ND1000 
and stored at -80°C.  DNA contamination was removed using a DNA-free treatment kit 
as per manufacturer‟s instructions (Ambion, Austin, U.S.A.).  
2.10.2 Isolation of genomic DNA from cultured cells 
Cells grown to confluence in a 6 well plate (~5 × 10
6 
cells) were subjected to 
trypsinisation, centrifugation (1000 × g, 3 minutes) and resuspended in PBS (200 µl).  
Genomic DNA was isolated using the QIAamp® DNA Mini Kit as per manufacturer‟s 
instructions.  Briefly, 20 µl Qiagen protease was added to the cell suspension and mixed 
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thoroughly.  RNase A (4 µl, 100 ml/ml) was added, mixed, and the suspension was 
incubated for 2 minutes at room temperature.  Buffer AL (200 µl) was added and mixed 
by pulse-vortexing prior to incubation at 56°C for 10 minutes to lyse cells.  Ethanol 
(100%, 200 µl) was added and after mixing the sample was pipetted on to a QIAamp spin 
column and centrifuged (6000 × g, 1 minute).  The column was transferred to a fresh 
collection tube and buffer AW1 (500 µl) was added prior to centrifugation (6000 × g, 1 
minute).  The column was transferred to a fresh collection tube and buffer AW2 (500 µl) 
was added prior to centrifugation (20000 × g, 3 minutes).  Residual buffer AW2 was 
removed by a further centrifugation step in a new collection tube (8000 × g, 1 minute).  
The column was placed in a sterile 1.5 ml microcentrifuge tube and incubated with 50 µl 
buffer AE for 1 minute prior to centrifugation (6000 × g, 1 minute) to elute DNA.  DNA 
was stored at -20°C. 
2.10.3 First-strand cDNA synthesis from total RNA 
Total RNA isolated as described in section 2.10.1 was used for first-strand cDNA 
synthesis using a SuperScript II Reverse Transcriptase kit as per manufacturer‟s 
instructions (Invitrogen, Paisley, U.K.).  Briefly, RNA (1 µg) was combined with 1 µl 
random hexamers (50 ng) (Bioline, U.K.) and made up to a final volume of 15 µl with 
dH2O prior to heating to 65°C for 5 minutes.  0.1 M DTT (2 µl), first strand buffer (5 µl), 
superscript II reverse transcriptase (0.5 µl), 25 mM dNTP mix (Bioline, U.K.) (0.4 µl) 
and dH2O (2.1 µl) were added and first-strand cDNA synthesis completed by incubating 
at 25°C for 10 minutes and 42°C for 90 minutes followed by 70°C for 15 minutes.  
cDNA was quantified by spectrophotometry using a Nanodrop ND1000 and stored at -
20°C.   
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2.10.4 Polymerase chain reaction (PCR) 
cDNA was amplified by PCR using sequence specific primers synthesised by Alta 
Bioscience, Birmingham, U.K. (see table 2.1 for conditions and primer sequences).  In a 
200 µl microcentrifuge tube 0.625 units Taq DNA polymerase (Fermentas, U.K.), 
forward primer (10 pmol), reverse primer (10 pmol), 25 mM dNTPs (Bioline, U.K.) (0.2 
µl), 10X Taq buffer (2.5 µl) and dH2O up to a final volume of 25 µl were combined.  
PCR reaction mixtures were denatured at 95°C for 5 minutes then subjected to 
denaturation, annealing and extension steps in a PCR machine (Eppendorf Mastercycler 
Gradient).  The PCR programme consisted of 34 cycles of denaturation at 95°C for 1 
minute, annealing for 1 minute (at the required annealing temperature) and extension at 
72°C for 1 minute, followed by a final extension step at 72°C for 5 minutes.  The 
resulting products were analysed by DNA gel electrophoresis as described in section 
2.10.6.   
2.10.5 Quantitation of gene expression by real time PCR 
Real time PCR with cDNA prepared as described in section 2.10.3 was performed using 
a Sensimix dT SYBR Green kit (Quantace, Finchley, U.K.) and the relevant sequence 
specific primers.  Per well, cDNA (200 ng) was combined with Sensimix (13 µl), dH2O 
(8 µl), SYBR Green (0.5 µl) and primers (0.2 pmol/µl) and made up to a final volume of 
25 µl.  Real time PCR was performed with all samples (n=3) in duplicate, using an 
Ambiprism 7000 sequence detection system with products amplified and detected, 
following a dissociation protocol, using a program of 35 cycles of 95°C for 30 seconds 
and 61.1°C for 30 seconds. 
 
79 
 
Sequence identity of PCR products was confirmed by sequencing (The Genomics 
Laboratory, University of Birmingham, U.K.).  The melt curves for all samples were 
analysed and Ct values were recorded for each gene in the linear phase of amplification.  
Differences in sample Ct values (n=3) were assessed using a one-way ANOVA (SPSS 
v16).  PCR reaction efficiencies were assessed using the LinRegPCR software 
(Ramakers et al 2003).  Where differences in Ct values were significant, sample Ct values 
were normalised to β-actin mRNA levels, which were not affected by treatment, and fold 
change was calculated by the 2
-ΔΔC
T method of relative quantification (Livak K.J. and 
Schmittgen T.D. 2001).   
2.10.6 Nucleic acid gel electrophoresis 
Powdered agarose (1.2 g) was dissolved by heating in 50 ml 1X TBE buffer (89 mM Tris 
base, 89 mM boric acid and 2 mM Na2EDTA, adjusted to pH 8) containing ethidium 
bromide (0.5 µg/ml).  The gel was cast, allowed to solidify at room temperature and 
immersed in 1X TBE buffer containing ethidium bromide (0.5 µg/ml).  Nucleic acid 
samples were combined with 1 µl 6X gel loading dye (New England Biolabs, 
Hertfordshire, U.K.) and loaded into the sample wells.  A DNA molecular weight marker 
(New England Biolabs, Hertfordshire, U.K.) was also loaded.  Samples were subjected to 
electrophoresis at 80 V for 40 minutes and the gel visualised by UV transillumination. 
2.10.7 Gel purification of DNA 
Electrophoresis at 80 V for 40 minutes (1.2% w/v 1X TBE agarose gel containing 0.5 
µg/ml ethidium bromide) was used to separate DNA fragments.  Gels were visualised on 
a UV transilluminator and the appropriate band was excised.  A QIAquick® gel 
extraction kit (Qiagen, U.K.) was used to extract DNA from the gel, according to the 
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manufacturer‟s instructions.  Briefly, three volumes of buffer QG were added per volume 
of gel and the gel was dissolved by heating at 50°C for 10 minutes with regular 
vortexing.  One gel volume of isopropanol was added and the sample mixed prior to 
loading onto a QIAquick spin column.  Centrifugation (8000 × g, 1 minute) was followed 
by the addition of 500 µl buffer QG to remove traces of agarose and an additional 
centrifugation step (8000 × g, 1 minute).  After discarding flow-through the column was 
washed with buffer PE (750 µl) followed by centrifugation (8000 × g, 1 minute).  
Residual buffer PE was removed by an additional centrifugation step (8000 × g, 1 
minute).  The column was transferred to a sterile 1.5 ml microcentrifuge tube and 
incubated with buffer EB (30 µl) for 2 minutes prior to DNA elution by centrifugation 
(8000 × g, 1 minute).  DNA was stored at -20°C.   
2.11 Isolation of protein extract from cultured cells 
2.11.1 Isolation of nuclear protein extract 
2.11.1.1 Buffers 
Lysis buffer A: NP-40 (0.6% v/v), NaCl (150 mM), Tris-HCl pH 8.0 (10 mM), 
Na2EDTA (1 mM) and mammalian protease cocktail inhibitor (10 µl/ml). 
Lysis buffer B: Glycerol (25% v/v), NaCl (420 mM), Tris-HCl pH 8.0 (20 mM), 
Na2EDTA (0.2 mM), MgCl (1.5 mM), mammalian protease cocktail inhibitor (10 µl/ml) 
and DTT (0.5 mM). 
Dialysis buffer: Glycerol (20% v/v), KCl (0.1 mM), Tris-HCl pH 8.0 (20 mM), 
Na2EDTA (0.2 mM) and DTT (0.5 mM). 
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2.11.1.2 Assay procedure  
Following treatment as described in section 2.3, the growth medium was removed and 
cells washed in cold PBS (1 ml).  Lysis buffer A was added (500 µl) and vigorous 
scraping was used to detach and resuspend cells.  The cell suspension was transferred to 
a sterile 1.5 ml microcentrifuge tube and incubated at 4°C for 20 minutes prior to 
centrifugation (Hawk 15/05 refrigerated bench-top centrifuge, Sanyo, Japan) at 3000 × g, 
at 4°C, for 5 minutes.  Following aspiration of the supernatant the pellet was resuspended 
in lysis buffer B (50 µl) and cells were incubated at 4°C for 30 minutes with regular 
gentle vortexing.  The supernatant was subjected to centrifugation at 15 000 × g for 20 
minutes at 4°C and then aspirated and transferred into the lumen of sterile dialysis 
tubing.  The supernatant was dialysed at 4°C against 1000 volumes of dialysis buffer for 
16 hours, with stirring.  The nuclear protein extract was transferred to a sterile 1.5 ml 
microcentrifuge tube and used immediately in the oligonucleotide incision assay or 
stored at -80°C. 
2.11.2 Isolation of whole protein extract 
2.11.2.1 Buffers 
RIPA buffer: Tris-HCl pH 7.6 (25 mM), NaCl (150 mM), NP-40 (1% v/v), sodium 
deoxycholate (1%), sodium dodecyle sulphate (SDS) (0.1% w/v) and mammalian 
protease cocktail inhibitor (10 µl/ml). 
2.11.2.2 Assay procedure 
Following treatment as described in section 2.3, the growth medium was removed and 
cells washed in cold PBS (1 ml).  Trypsin (500 µl) was used to detach cells which were 
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then subjected to centrifugation (1000 × g; 4 minutes, room temp).  Cell pellets (~ 5 × 
10
6
 cells) were incubated with RIPA buffer on ice for 20 minutes with regular vortexing.  
Cell debris was pelleted by centrifugation at 14 000 × g for 15 minutes at 4°C.  The 
supernatant was transferred to a sterile 1.5 ml microcentrifuge tube and used immediately 
or stored at -80°C. 
2.11.3 Isolation of soluble and insoluble nuclear protein 
Cytoskeleton (CSK) buffer: NaCl (100 mM), sucrose (300 mM), PIPES (10 mM) pH 
6.8, MgCl2 (3 mM), 0.5% Triton X-100 and mammalian protease cocktail inhibitor (10 
µl/ml). 
Following treatment as described in section 2.3, the growth medium was removed and 
cells washed in cold PBS (1 ml).  Cells were incubated with CSK buffer (300 µl) for 5 
min on ice which was then removed and retained as the soluble protein-containing (S1) 
fraction.  Next, cells were scraped into RIPA buffer (150 µl) and incubated on ice with 
regular vortexing for 20 minutes.  Cell debris was pelleted by centrifugation at 14 000 × 
g for 15 minutes at 4°C.  The supernatant was transferred to a sterile 1.5 ml 
microcentrifuge tube and retained as the insoluble protein-containing (P1) fraction.  
Fractions were used immediately or stored at -80°C. 
2.11.4 Bradford assay 
Protein concentrations were determined using the Bradford method (Bradford M. M. 
1976) using BSA (1 – 10 µg) as a standard. 
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2.12 Oligonucleotide incision assay (Figure 2.6) 
2.12.1 Buffers 
1.8X REC buffer: Tris-HCl pH 7.5 (18 mM), KCl (180 mM), Na2EDTA (18 mM) and 
BSA (0.18 mg/ml). 
Formamide loading buffer: Na2EDTA (0.5 mM), SDS (2.5% w/v), xylene cyanol (XC) 
/ bromophenol blue (BPB) (46.5 µl) made up to 1 ml with formamide. 
2.12.2 Labelling of probe 
A single-stranded oligonucleotide (24 mer) containing a single 8-oxo dG residue (8) at 
position 10 (5‟-GAACTAGTG8ATCCCCCGGGCTGC-3‟) (Trevigen, U.S.A.) (10 
pmol) was combined with 2.5 µl of 10X T4 polynucleotide kinase (T4 PNK) buffer 
(Promega, U.S.A.) and dH2O up to a final volume of 25 µl.  The oligonucleotide was 
end-labelled with 
32
phosphorus (
32
P) via incubation with T4 PNK (Promega) (7.5 units) 
(1.5 µl) and 225 µCi of γ-32P-ATP (Perkin Elmer, U.S.A.) (5 µl) for 10 minutes at 37°C.  
The addition of 0.5 M Na2EDTA (2 µl) followed by heating to 78°C for 60 seconds 
terminated the end-labelling reaction. 
Annealing of the labelled oligonucleotide to a complimentary oligonucleotide (3‟-
CTTGATCACCTAGGGGGCCCGACG-5‟) (24 mer Trevigen, U.S.A.) was achieved via 
the addition of a 1.5 fold excess of complimentary oligonucleotide.  The mixture was 
heated to 95°C for 10 minutes and allowed to cool slowly to room temperature.  The 
resulting 
32
P-labelled double-stranded oligonucleotide was purified using the QIAquick® 
nucleotide removal kit (Qiagen, U.K.).   
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2.12.3 Sample preparation and visualisation 
Nuclear protein extract, extracted as described in section 2.11.1 (5 µg) was added to a 
sterile 1.5 ml microcentrifuge tube and combined with 1.8X REC buffer (5.5 µl) and the 
32
P-labelled double-stranded 8-oxo dG oligonucleotide (3.5 µl) in a final volume of 20 
µl.  Following vortexing the reaction mixture was incubated at 37°C for 1 hour.  
Formamide loading buffer (10 µl) was added and the sample was denatured by heating to 
95°C for 5 minutes, then cooling on ice for 3 minutes.  The entire sample was loaded 
onto a polyacrylamide gel (20% acrylamide, 8 M urea, 1X TBE) and electrophoresed at 
300V for 120 minutes.  After electrophoresis the gel was placed onto blotting paper and 
wrapped in SaranWrap™.  Exposure of the gel to radiation sensitive film (Amersham, 
U.K.) for 3.5 hours at -80°C was followed by development using an X-ograph machine 
(AGFA Curix60). 
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Figure ‎2.6: Oligonucleotide incision assay.  
Adapted from Smart (2006) Activity of OGG1 in the repair of pro-oxidant-induced 8-oxo-2′-
deoxyguanosine 2002-2006 PhD Thesis, University of Birmingham 
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2.13 Western blotting  
2.13.1 Buffers 
1X TBS: Tris base (0.1 M) and NaCl (0.15 M), adjusted to pH 8.0. 
1X TBS-0.05% Tween 20: Tris base (0.1 M), NaCl (0.15 M) and Tween 20 (0.05%), 
adjusted to pH 8.0. 
SDS-PAGE running buffer: Tris base (25 mM), glycine (192 mM), and SDS (0.1% 
w/v). 
Transfer buffer: Tris base (20 mM), glycine (150 mM) and methanol (20% v/v). 
Blocking buffer: Low-fat powdered milk (Marvel, U.K.) (5%) in 1X TBS-0.05% Tween 
20 
2.13.2 Gels 
12.5% Resolving gel: Acrylamide:bisacrylamide 30% solution (12.5%), Tris-HCl pH 
8.8 (375 mM), SDS (0.1% w/v).  Immediately prior to casting N,N,N,N-
tetramethylethylenediamine (TEMED) (15 μl per 10 ml) and 10% w/v ammonium 
persulphate (APS) (150 μl per 10 ml) were added. 
4% Stacking gel: Acrylamide:bisacrylamide 30% solution (4%), Tris-HCl pH 6.8 (125 
mM), SDS (0.1% w/v).  Immediately prior to casting N,N,N,N-
tetramethylethylenediamine (TEMED) (15 μl per 10 ml) and 10% w/v ammonium 
persulphate (APS) (150 μl per 10 ml) were added. 
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2.13.3 Assay procedure 
Nuclear protein extracts (15 μg for hOGG1, 70 µg for rOGG1) or whole cell extracts (20 
µg) were mixed with Laemmli 2X loading buffer and heated at 95°C for 5 minutes.  
Samples were resolved on a 12.5% SDS-polyacrylamide gel at 120V for 90 minutes then 
transferred to a nitrocellulose membrane (Amersham Biosciences) using a mini trans-blot 
electrophoretic transfer cell (Bio-Rad) at 100V for 120 minutes at 4°C.  Blocking was 
achieved by incubating the nitrocellulose membrane with blocking buffer for 16 hours at 
4°C on a rocking platform (Stuart Scientific STR9, U.K.).  The nitrocellulose membrane 
was then incubated with either (hOGG1 blotting): mouse anti-hOGG1 polyclonal IgG 
primary antibody (1 μg/ml, clone 7E2, Assay Designs Inc., U.S.A.), (rOGG1 blotting): 
goat anti-Ogg1 polyclonal IgG primary antibody (0.3 µg/ml, Abcam, Cambridge, U.K.) 
or (EGFP blotting): rabbit polyclonal anti-GFP primary antibody (1:2000 dilution, 
Abcam, Cambridge, U.K.) in blocking buffer for 1 hour on a rocking platform at room 
temperature.  1X TBS-0.05% Tween 20 solution was used to wash the membrane (3 × 10 
minutes), which was subsequently incubated with a horseradish peroxidase (HRP)-
conjugated (hOGG1 blotting): anti-mouse secondary antibody (1:750 dilution, DAKO, 
U.K.), (rOGG1 blotting): anti-goat secondary antibody (1:10000 dilution, DAKO, U.K.) 
or (EGFP blotting): anti-rabbit secondary antibody (1:5000 dilution, DAKO, U.K.) in 
blocking buffer at room temperature for 1 hour.  1X TBS-0.05% Tween 20 solution was 
used to wash again (2 × 10 minutes), followed by a final wash in 1X TBS (1 × 10 
minutes).  The membrane was incubated with SuperSignal West Pico chemiluminescent 
detection reagent (Thermo Fisher Scientific, U.K.), prepared as per manufacturer‟s 
instructions.  Protein bands were visualised via exposure to ECL hyperfilm (Amersham 
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Biosciences) and development in an X-ograph machine (AGFA Curix60).  Where 
appropriate, the intensity of each band was quantified by densitometry (ImageJ) and 
normalised to a beta actin loading control. 
2.14 Confocal microscopy 
Cells were grown on coverslips and counterstained by incubation with 0.5 µg/ml 
Hoechst-34580 (Invitrogen, U.K.) for 20 minutes at 37°C.  All images were collected 
using live cells, except when cells were incubated with CSK buffer (as described in 
section 2.11.3) prior to fixation with 4 % para-formaldehyde, pH 7.4, for 20 minutes at 
room temperature.    
Image acquisition was performed with a Leica TCS SP2 confocal microscope (Leica 
Microsystems), using a 63x oil immersion objective NA 1.32.  Fluorochromes were 
excited using an argon laser at 488 nm for FITC, EGFP and YFP and 405 nm for 
Hoechst.  Images were collected sequentially then merged using Adobe Photoshop CS5 
(Adobe Systems Inc.).  
2.15 Statistical analysis of data  
All statistical analysis was performed using SPSS version 16 software.  Data which was 
normally distributed (as assessed by Shapiro-Wilk test) and displayed homogeneity of 
variance (as assessed by Levene‟s test) was analysed by one-way ANOVA followed by a 
2-tailed or paired Student‟s t-test.  Data which was not normally distributed or did not 
display homogeneity of variance was analysed by Kruskal-Wallis test or Mann-Whitney 
U test.  
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Table ‎2.1: PCR primers and conditions 
 Name Primer Sequence 
Predicted Annealing 
Temperature 
Primer pair PCR conditions 
mOGG1 F 5'-GTAACTACGGCTGGCATCC-3' 55.5 95°C (5 min), 95°C (1 min), 61°C (1 min), 
72°C (5 min) mOGG1 R 5'-AGGCTTGGTTGGCGAAGG-3' 60.9 
Hygromycin F 5'-GATGTAGGAGGGCGTGGATA-3' 57.4 95°C (5 min), 95°C (1 min), 60°C (1 min), 
72°C (5 min) Hygromycin R 5'-GATGTTGGCGACCTCGTATT-3' 57.5 
mBeta actin F 5'-AGCCATGTACGTAGCCATCC-3' 57.6 95°C (5 min), 95°C (1 min), 61°C (1 min), 
72°C (5 min) mBeta actin R 5'-CTCTCAGCTGTGGTGGTGAA-3' 56.3 
BamHI F 5‟-GAGAGGATCCATGCCTGCCCGCGCGCTTCTG-3‟ 86.5 98°C (30 s), 98°C (30 s), 65°C (30 s), 72°C 
(30 s)* BamHI R 5‟-GGCAGGATCCTTACTAGCCTTCCGGCCCTTTG-3‟  79.7 
M13 F 5'-GTAAAACGACGGCCAGT-3 50.8 95°C (5 min), 95°C (1 min), 55°C (1 min), 
72°C (5 min) M13 R 5'-AACAGCTATGACCATG-3' 38.5 
hOGG1 F 5' -GAGGTGGAGGCTCATCTCAG-3' 56.7 95°C (5 min), 95°C (1 min), 61°C (1 min), 
72°C (5 min) hOGG1 R 5' -AGGGTGCCAGCTGTAGTCAC-3' 57.4 
hOGG1 F 5' -GAGGTGGAGGCTCATCTCAG-3' 56.7 95°C (5 min), 95°C (1 min), 63°C (1 min), 
72°C (5 min) Hygromycin R 5'-GATGTTGGCGACCTCGTATT-3' 57.5 
* Instead of Fermentas Taq DNA polymerase, Phusion ® High Fidelity DNA polymerase was used 
All with a final extension step at 72°C for 
10 min 
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Chapter 3 – Response 
of mouse and rat 
OGG1 to oxidative 
stress 
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3.1 Introduction 
Normal cellular processes generate approximately 10
3
 8-oxo dG lesions per cell per day 
(Lindahl T. and Barnes D.E. 2000) which are repaired primarily by the OGG1 BER 
protein.  As 8-oxo dG can exist in the syn conformation in DNA and mimic thymine it 
can mispair with adenine during DNA replication and lead to G:CT:A transversion 
mutations (Wang D. et al. 1998).  An increase in ROS results in cellular oxidative stress.  
Reduction of OGG1 activity under such conditions could result in reduced DNA repair 
capacity and sensitivity to oxidative DNA damage.  The response of the OGG1 protein to 
oxidative stress conditions has therefore been the subject of investigation with gene 
expression, protein levels and activity measured following exposure to a variety of 
compounds implicated in ROS production including cadmium, sodium dichromate and 
potassium bromate. 
Many studies report compound-specific induction or inhibition of OGG1 activity 
associated with altered mRNA expression.  The response of mouse OGG1 (Zharkov D.O 
and Rosenquist T.A. 2002), rat OGG1 (Potts R.J. et al. 2003) and human OGG1 (Bravard 
2006; Youn C.K. et al. 2005) to cadmium was a reduction in glycosylase activity 
associated with decreased levels of protein and mRNA expression.  Reduced hOGG1 
activity associated with decreased levels of protein and mRNA expression was also 
observed in human A549 lung carcinoma cells following treatment with sodium 
dichromate (Hodges N.J. and Chipman J.K. 2002).  In contrast, an increase in rOGG1 
activity, associated with an increase in mRNA expression, was observed following 
exposure of male Sprague-Dawley rats to aniline (Ma H. et al. 2008).   
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The increase in rOGG1 activity observed in neuronal cells treated with synthetic nitrogen 
compounds previously shown to have elevated ROS scavenging activity, was not linked 
with an increase in mRNA expression (Silva J.P. et al. 2009).  Furthermore, we observed 
an increase in mOGG1 activity following treatment of mouse embryonic fibroblast 
(MEF) cells with potassium bromate which was not associated with any change in 
mRNA levels (Mirbahai L. et al. 2010).  Such non-transcriptional regulation of OGG1 
activity suggests that in these cells any observed ROS-mediated alteration in OGG1 
activity is a result of protein or mRNA stabilisation, alteration in localisation, post-
translational modification and/or protein interactions.  In support of this, treatment of 
MEF cells with glucose oxidase, which induces cellular oxidative stress by generation of 
O2
•-
, resulted in a transient increase in OGG1 acetylation and OGG1 activity, with no 
change at the polypeptide level (Bhakat K.K. et al. 2006).   
The work presented in this chapter aimed to build on previous data showing induction of 
mOGG1 activity following treatment of MEF cells with potassium bromate (Mirbahai L. 
et al. 2010) and used the glutathione synthesis inhibitor BSO to assess the effect of ROS 
on OGG1 activity, mRNA expression and protein levels.  The response of mOGG1 was 
investigated using wild-type MEF cells however OGG1 protein could not be detected in 
these cells with any commercially available antibody.  Rat OGG1 shows extensive 
homology with the human and mouse protein (Prieto Alamo M.J. et al. 1998; For 
sequence alignment see appendix, page 223) and was easily detected in rat hepatoma 
(MH1C1) cells by western blotting hence MH1C1 cells were employed to investigate 
potential BSO-mediated OGG1 protein level alteration. 
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3.2 Results 
3.2.1 Cell viability following BSO treatment  
To investigate BSO mediated cytotoxcity, MEF and MH1C1 cells were cultured in 96 
well cell culture plates and treated for 24 h with BSO (0, 1, 10, 100, 1000 µM) prior to 
analysis by the MTT reduction assay, as described in section 2.4.  No significant 
difference in absorbance was observed between untreated and BSO treated cells (P > 
0.05 as determined by one-way ANOVA) indicating that 24 h treatment with up to 1000 
µM BSO does not affect the viability of these cells (Figure 3.1). 
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Figure ‎3.1: Viability of MEF and MH1C1 cells after 24 h BSO treatment as assessed using 
the MTT reduction assay.  
 Data are displayed as percentage of untreated control ±SEM from 3 independent experiments.  
No statistically significant change in MTT reduction was observed, as determined by one-way 
ANOVA.  
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3.2.2 Total cellular reduced glutathione following BSO 
treatment  
Treatment with BSO for 24 h at concentrations ≥ 1 µM has been shown to deplete 
cytoplasmic GSH in KO and WT MEF cells, with nuclear depletion occurring following 
treatment with 1000 µM BSO (Green R.M. et al. 2006).  To determine and compare the 
levels of total GSH in MEF and MH1C1 cells after BSO treatment (0, 1, 10, 100, 1000 
µM, 24 h), cells were treated and total GSH measured as described in section 2.6. 
Statistically significant depletion of total GSH occurred following treatment with ≥ 1 µM 
BSO in KO MEF cells.  In WT MEF and MH1C1 cells statistically significant depletion 
of total GSH occurred following treatment with ≥ 10 µM BSO.  No significant difference 
in total GSH was observed between KO and WT MEF cells following treatment with any 
concentration (P > 0.05 as determined by one-way ANOVA), however MH1C1 cells had 
significantly more total GSH than KO MEF cells following treatment with 1, 10 and 100 
µM BSO and significantly more total GSH than WT MEF cells following treatment with 
1 and 10 µM BSO (Figure 3.2). 
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Figure ‎3.2: Total GSH in MEF and MH1C1 cells after 24 h BSO treatment.   
Data are displayed as percentage of untreated control (nm GSH/mg protein KO MEF: 18.54 ± 
1.32, WT MEF: 20.94 ± 3.13, MH1C1: 25.6 ± 1.32) and as nm GSH/mg protein ±SEM from 3 
independent experiments.  **,***: Significantly different from control (**P < 0.01 ***P < 
0.001), #: significantly different from WT MEF (##P < 0.01), ⌂: significantly different from KO 
MEF (
⌂
P < 0.05 
⌂⌂
P < 0.01) as determined by 2-tailed Student‟s t-test. 
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3.2.3 Intracellular ROS following BSO treatment 
Using the fluorescent dye dichlorofluorescein, intracellular ROS have been shown to be 
induced in KO and WT MEF cells with 24 h BSO treatment at concentrations ≥ 100 µM 
(Green R.M. et al. 2006).  The current study modified the technique used by Green et al. 
and employed the use of flow cytometry to measure intracellular ROS levels, as 
described in section 2.5. 
Fluorescence was statistically significantly increased in a concentration dependent 
manner compared with control in all cells following treatment with ≥ 10 µM BSO.  There 
was no statistically significant difference in response between WT and KO MEF cells, 
however fluorescence was significantly lower in MH1C1 cells than KO MEF following 
treatment with 10, 100 and 1000 µM BSO.  Fluorescence was significantly lower in 
MH1C1 cells than WT MEF cells without treatment and following treatment with all 
concentrations of BSO (Figures 3.3 and 3.4). 
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Figure ‎3.3: ROS levels as assessed by DCF fluorescence in MEF and MH1C1 cells after 24 h 
BSO treatment. 
Individual replicates are displayed (n=4). 
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Figure ‎3.4: ROS levels in MEF and MH1C1 cells after 24 h BSO treatment. 
Data are displayed as median fluorescence intensity as percentage of untreated control (KO MEF: 
4.33 ± 0.88, WT MEF: 3.94 ± 0.52, MH1C1: 1.87 ± 0.32) and as median fluorescence intensity 
±SEM from 4 independent experiments. *: Significantly different from control (*P < 0.05), #: 
significantly different from WT MEF (#P < 0.05), ⌂: significantly different from KO MEF (⌂P < 
0.05) as determined by Mann-Whitney U test. 
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3.2.4 Mouse OGG1 activity following BSO treatment 
To determine the effect of increased cellular ROS on mOGG1 activity WT MEF cells 
were treated with BSO (0, 1, 5, 10, 50, 100 and 1000 µM, 24 h) then transfected with an 
8-oxo dG-containing molecular beacon prior to fluorescence analysis by flow cytometry 
as described in section 2.9.  Data are displayed as the number of positive events (as 
described in section 2.9.2) as a percentage of untreated control.  A statistically significant 
concentration dependent increase in fluorescence was observed following treatment with 
BSO at concentrations ≥ 5 µM (Figure 3.5). 
Transfection of WT MEF cells with a positive control molecular beacon after BSO 
treatment (0, 1, 5, 10, 50, 100, 1000 µM, 24 h) allowed the assessment of transfection 
efficiency.  No statistically significant difference in fluorescence was observed at any 
BSO concentration (P > 0.05 as determined by one-way ANOVA) (Bottom panel, figure 
3.5), confirming that BSO treatment did not affect transfection efficiency of cells. 
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[BSO] µM Number of positive control beacon events (WT MEF) ± SEM 
0 33.91±6.78 
1 25.63±3.55 
5 22.31±2.96 
10 23.58±2.92 
50 23.46±4.05 
100 24.57±5.73 
1000 26.61±1.99 
 
Figure ‎3.5: mOGG1 activity, as assessed by beacon fluorescence following 24 h BSO 
treatment.   
Data are displayed as the number of positive events as percentage of untreated control 
(3.32±0.53), ±SEM from 3 independent experiments.  *,**,***: Significantly different from 
control (*P < 0.05 **P < 0.01 ***P < 0.001) as determined by 2-tailed Student‟s t-test. 
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3.2.5 Mouse OGG1 activity controls 
To confirm the specificity of the beacon, KO MEF cells were transfected with 8-oxo dG-
containing molecular beacon.  Fluorescence levels were significantly lower than in WT 
MEF cells (P < 0.05 as determined by 2-tailed Student‟s t-test) (Tables 3.1 and 3.2) and 
not affected by BSO treatment. 
To confirm that the fluorescence was a result of BSO-induced OGG1 activity and not 
BSO alone, KO MEF cells were transfected with 8-oxo dG-containing molecular beacon.  
No increase in fluorescence was observed with BSO treatment (P > 0.05 as determined 
by 2-tailed Student‟s t-test) (Table 3.1).  To determine whether differences in transfection 
efficiency could account for the reduced fluorescence in KO MEF cells compared with 
WT MEF cells, KO MEF cells were treated with BSO (0, 10, 1000 µM, 24 h) then 
transfected with positive control molecular beacon.  No statistically significant difference 
in fluorescence was observed at any BSO concentration investigated (P > 0.05 as 
determined by one-way ANOVA) (Table 3.2).  
Table ‎3.1: Beacon cutting activity in MEF cells following BSO treatment 
[BSO] 
µM 
Number of positive events (KO 
MEF) ± SEM 
Number of positive events (WT 
MEF) ± SEM 
0 0.52±0.13 1.07±0.11 
100 0.68±0.29 2.34±0.31 
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Table ‎3.2: Positive control beacon events in KO MEF cells 
[BSO] µM Number of positive events (KO MEF) ± SEM 
0 53.48±4.12 
10 49.48±0.80 
1000 53.50±1.35 
 
3.2.6 Mouse OGG1 mRNA expression following BSO treatment 
To assess whether levels of OGG1 mRNA changed following treatment with BSO, RNA 
was extracted from WT MEF cells then used to synthesise cDNA.  Levels of OGG1 
mRNA were measured using real time PCR as described in section 2.10.  To determine 
time-dependent changes in OGG1 expression during the 24 h BSO treatment period RNA 
was extracted from control and BSO treated (1000 µM) WT MEF cells 0, 6, 12, 18 and 
24 h post treatment.  Analysis by real time PCR revealed that there was no significant 
difference in Ct values between any control and treated samples (P > 0.05 as determined 
by one-way ANOVA) however there was a significant change in Ct values in control 
samples between 0 and 24 h.  Therefore Ct values were normalised to a beta-actin 
loading control and expressed as fold change relative to untreated control (t=0).  There 
was a time dependent increase in OGG1 mRNA levels which became statistically 
significant after 24 h in untreated samples.  There was no difference between  control and 
treated samples at any time point investigated (Figure 3.6).   
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Figure ‎3.6: mOGG1 mRNA levels following BSO treatment.   
WT
 
MEF cells were treated with BSO (1000 µM) then OGG1 mRNA levels were measured at 
various times post treatment (0, 6, 12, 18, 24 h) by real time PCR (n = 3, performed in duplicate), 
normalised to a beta-actin control and expressed as fold change relative to untreated control at 
time 0 ±S.E.M.  No significant difference between treated and untreated samples was observed.  
A significant increase in OGG1 mRNA levels was observed at 24 h.  *: Significantly different 
from control at time 0 (*P < 0.05) as determined by 2-tailed Student‟s t-test. 
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 3.2.7 OGG1 protein levels following BSO treatment 
To determine the effect of BSO treatment on OGG1 protein levels several commercial 
antibodies specific to mouse OGG1 were tried, however OGG1 could not be detected in 
MEF cells.  Mouse and rat OGG1 proteins show significant sequence homology and the 
rOGG1 protein was detectable in MH1C1 cells.  For this reason, MH1C1 cells were used 
to investigate OGG1 protein levels following BSO treatment (24 h, 0, 1, 10, 100, 1000 
µM) prior to nuclear protein extraction as described in section 2.11.1.  OGG1 protein 
levels were determined by western blot as described in section 2.13 and normalised to a 
beta-actin loading control.  A representative blot is shown (Figure 3.7A).  Densitometry 
analysis was performed using ImageJ.  Absorbance units (AU) after correction for beta-
actin loading controls are plotted, with values displayed as percentage of untreated 
control. A significant increase in OGG1 protein levels was observed compared with 
control following 1 and 10 µM BSO treatment (P > 0.05 as determined by paired 
Student‟s t-test) (Figure 3.7B), but not following treatment with 100 and 1000 µM. 
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Figure ‎3.7: rOGG1 protein levels following 24 h BSO treatment.  
Western blot analysis of BSO treated MH1C1 cells.  Signals were quantified using ImageJ, with 
values normalised to a beta-actin loading control.  Data are displayed as percentage of untreated 
control ±SEM from 4 independent experiments.  *: Significantly different from control (*P < 
0.05) as determined by paired Student‟s t-test. 
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3.2.8 Rat OGG1 activity following BSO treatment  
To determine the effect of reactive oxygen species on rOGG1 activity MH1C1 cells were 
treated with BSO (0, 1, 10, 100 and 1000 µM, 24 h) then transfected with an 8-oxo dG-
containing molecular beacon prior to analysis by flow cytometry as described in section 
2.9.  Data are displayed as the number of positive events, as described in section 2.9.2.  
No statistically significant difference in fluorescence was observed following treatment 
with any concentration of BSO (P > 0.05 as determined by one way ANOVA) (Figure 
3.8). 
Transfection of MH1C1 cells with a positive control molecular beacon after BSO 
treatment (0, 1, 10, 100, 1000 µM, 24 h) allowed the assessment of transfection 
efficiency.  No statistically significant difference in fluorescence was observed following 
treatment with BSO at any concentration (P > 0.05 as determined by one way ANOVA) 
(Bottom panel, figure 3.8). 
The activities of mOGG1 and rOGG1 in MEF and MH1C1 cells following BSO 
treatment were compared, with data displayed as the number of positive events, as 
described in section 2.9.2.  A statistically significant difference between fluorescence in 
WT MEF and MH1C1 cells was observed in untreated and low dose (1 µM) BSO treated 
cells (Figure 3.9).  
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[BSO] µM Number of positive control beacon events ±SEM 
0 62.90±5.95 
1 62.94±1.38 
10 63.08±5.54 
100 65.22±2.64 
1000 56.80±1.65 
 
Figure ‎3.8: rOGG1 glycosylase activity, as assessed by beacon fluorescence following 24 h 
BSO treatment. 
Data are displayed as the number of positive events as percentage of untreated control 
(12.49±2.50), ±SEM from 4 independent experiments.  
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Figure ‎3.9: mOGG1 and rOGG1 glycosylase activity, as assessed by beacon fluorescence 
following 24 h BSO treatment. 
Data are displayed as the number of positive events ±SEM from 3 (mOGG1) or 4 (rOGG1) 
independent experiments.  *: Significantly different between cell types (*P < 0.05) as determined 
by 2-tailed Student‟s t-test.  
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3.3 Discussion 
Intracellular ROS, which can oxidise DNA, are increased in a variety of pathological 
conditions including cancer, Alzheimer‟s disease and diabetes (Halliwell B. 2007; Reddy 
V.P. et al. 2009).  An understanding of the mechanism of regulation of OGG1 activity 
following induction of oxidative stress is important as OGG1 is the only enzyme able to 
eliminate the potentially mutagenic 8-oxo dG lesion from genomic DNA.  Previous 
studies have shown both OGG1 activity inhibition (Bravard A. et al. 2006; Hodges N.J. 
and Chipman J.K. 2002; Potts R.J. et al. 2003; Youn C.K. et al. 2005; Zharkov D.O and 
Rosenquist T.A. 2002) and induction (Ma H. et al. 2008; Mirbahai L. et al. 2010; Silva 
J.P. et al. 2009) following exposure to pro-oxidant compounds and the response appears 
to be cell and compound specific.  In order to further investigate the response of OGG1 
to cellular oxidative stress this study used the glutathione synthesis inhibitor BSO to 
induce oxidative stress conditions and investigate OGG1 activity, mRNA expression and 
protein levels.   
Treatment of MEF and MH1C1 cells with BSO depleted glutathione and increased ROS 
in a concentration dependent manner with no effect on cell viability at the concentrations 
investigated.  The highest BSO concentration used was selected based on its ability to 
deplete nuclear GSH in MEF cells (Green R.M. et al. 2006) however its effect on nuclear 
GSH in MH1C1 cells was not investigated.  BSO treatment resulted in concentration 
dependent induction of ROS and mOGG1 activity.  An increase in mOGG1 activity 
following an increase in ROS is easily rationalised as a response to the requirement of 
the cell to repair oxidatively damaged DNA, as an inability to rapidly repair 8-oxo dG 
lesions could result in the accumulation of G:CT:A transversion mutations.   
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Interestingly, the activity increase in MEF cells was not a result of any change in mRNA 
levels because although OGG1 mRNA levels increased in culture over time, possibly as a 
result of stress in culture, this was not affected by BSO.  This is in agreement with 
previous work in our laboratory using the same cells treated with potassium bromate 
(Mirbahai L. et al. 2010) and several other studies which demonstrate that the activity of 
OGG1 is modulated post-transcriptionally (Bhakat K.K. et al. 2006; Conlon K.A. et al. 
2003; Silva J.P. et al. 2009).   
It is possible that this activity increase could be due in part to an increased level of 
protein, however despite extensive testing no commercial mouse OGG1 antibody was 
found that could consistently detect mOGG1 in this cell line.  As rat OGG1 shows 
extensive homology to mouse OGG1 and the rat OGG1 protein was very easily detected, 
this hypothesis was instead tested using MH1C1 cells to measure rat OGG1 protein 
levels following treatment with BSO.  Interestingly, rOGG1 protein levels were 
significantly increased following treatment with low concentrations of BSO and appeared 
increased, although not statistically significantly, following treatment with very high 
concentrations of BSO.  There was no significant change in rOGG1 activity following 
BSO treatment although, as with the protein levels, activity appeared greater following 
treatment with very low concentrations and very high concentrations of BSO.  
Oxidative stress conditions are induced by BSO by depletion of GSH, which serves to 
deactivate ROS either by direct interaction or by the indirect activity of GSH 
peroxidases, to levels low enough to result in increased ROS.  Both WT MEF cells and 
MH1C1 cells had similar levels of GSH prior to BSO treatment however higher BSO 
concentrations were required to deplete GSH in MH1C1 cells.  All mammalian cells are 
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able to synthesise GSH but the major site of synthesis is the liver (Morand C. et al. 1997) 
and in hepatocytes, which export GSH, concentrations can reach 10 mM (Forman H.J. et 
al. 2009).  It is therefore possible that in MH1C1 cells, which are derived from rat liver 
hepatomas, there is increased GCL therefore greater inhibition of GCL is required for 
GSH depletion, hence the requirement for increased concentrations of BSO.   
Basal levels of ROS were lower in MH1C1 cells and were increased by BSO treatment to 
a lesser extent than in WT MEF cells, in agreement with the reduced decrease in GSH.  It 
has been demonstrated that levels of oxidised purines show a positive linear correlation 
with levels of ROS and a negative linear correlation with levels of GSH (Green R.M. et 
al. 2006).  It is therefore likely that fewer oxidised guanine residues were generated 
following BSO treatment in MH1C1 cells hence the requirement for OGG1-mediated 
repair was lower compared with MEF cells.  A direct comparison between mOGG1 
activity in WT MEF cells and rOGG1 activity in MH1C1 cells revealed that the basal 
rOGG1 activity was roughly four times greater than that of mOGG1 and comparable to 
the activity observed following 1000 µM BSO treatment in WT MEF cells.  This 
suggests that the lack of induction of rOGG1 activity following increased ROS in these 
cells could be explained by the basal activity levels being great enough to repair any 
oxidatively damaged DNA arising as a result of modestly increased ROS.  It is possible 
that increased concentrations of BSO or prolonged BSO exposure may further increase 
ROS and may result in an alteration of rOGG1 repair activity.   
An improvement to our study would be the use of a mOGG1 antibody to detect mOGG1 
protein following BSO treatment however we failed to find a suitable commercially 
available antibody and due to time and financial restrictions were unable to generate our 
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own.  An increase in mOGG1 protein levels in MEF cells has however been previously 
shown following 2 hours of nutrient deprivation (Conlon K.A. et al. 2003).  In agreement 
with our data, Conlon et al. (2003) note that the short time frame of their experiment 
suggests that the newly appearing mOGG1 is not the result of transcription.  A study 
showing increased rOGG1 protein expression in photoreceptor synaptic terminals 
following bright light treatment in rats (Cortina M.S. et al. 2005) provides further 
evidence of oxidative stress induced modification of rOGG1 protein levels.  However the 
low concentration BSO-initiated increase followed by high concentration decrease we 
observed in rOGG1 protein levels is difficult to interpret.  There is evidence that low 
levels of oxidative stress induces cellular proliferation  (Burden R. H. 1995), for example 
by activation of epidermal growth factor receptor (EGFR), and that rOGG1 mRNA 
expression is increased in foetal tissue during periods of rapid cellular proliferation (Riis 
B. et al. 2002).   
The assessment of OGG1 cutting activity using the molecular beacon provides a 
measurement of overall cellular OGG1 activity.  In contrast, this study measured nuclear 
rOGG1 protein levels.  It is possible that nuclear rOGG1 protein levels increased in 
response to low levels of ROS but at higher BSO concentrations rOGG1 protein was 
relocated to the mitochondria.  Mitochondrial DNA, which lacks protective histones and 
other DNA associated proteins are susceptible to ROS-induced damage and it is thought 
that OGG1 may represent the only 8-oxo dG repair pathway in mitochondria (de Souza-
Pinto N.C. et al. 2001).  Studies have shown that targeting OGG1 to mitochondria 
protects against this oxidative damage by enhancing mitochondrial DNA repair (Dobson 
A.W. et al. 2002; LeDoux S.P. et al. 2007; Rachek L.I. et al. 2002).  There is some 
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evidence to support BER enzyme relocalisation in response to oxidative stress.  For 
example, APE1, the major hydrolytic AP endonuclease responsible for cleavage of AP 
sites in mammalian cells, has been shown to re-localise from the nucleus to the 
mitochondria in the B-lymphocyte Raji cell line in response to oxidative stress induced 
by H2O2 (Frossi B. et al. 2002).   
The response of OGG1 to oxidative stress conditions appears to be damage and cell 
specific (as noted recently by van Loon B. et al. 2010) and this study provides further 
evidence to support this.  The data support evidence that the activity of OGG1 can be 
modulated in response to increased cellular ROS.  Interestingly, the absence of any 
change in rOGG1 activity in MH1C1 cells, where ROS levels were lower, further 
supports this.  It would be interesting to investigate the ROS response in a non-tumour 
rOGG1 expressing cell, as the contrasting MH1C1 and MEF responses could be related 
to the tumorous origin of the MH1C1 cells which may have altered DNA repair capacity 
and a greater tolerance for oxidative DNA damage. 
The effect of oxidative stress induced by BSO on human OGG1 is of paramount interest 
as reduction of OGG1 activity under conditions of oxidative stress would result in 
reduced DNA repair capacity and sensitivity to chemically-induced oxidative DNA 
damage.  The data presented here demonstrate that the activity of mouse OGG1 in MEF 
cells is modified post-transcriptionally following induction of oxidative stress by BSO.  
This justifies the use of transgenic cell lines expressing human OGG1 under the control 
of the cytomegalovirus (CMV) promoter (Chapter 4) to investigate the effect of ROS on 
human OGG1 and investigate any difference in response between the wild-type Ser326- 
and variant Cys326-hOGG1 proteins (Chapter 5).   
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Chapter 4 – 
Development of 
hOGG1 stably 
expressing cells to 
study Ser326- and 
Cys326-hOGG1 repair 
activity 
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4.1 Introduction 
There is evidence that the Cys326-hOGG1 protein variant has a reduced repair ability 
compared with the wild-type Ser326-hOGG1, particularly under conditions of oxidative 
stress, as described in detail in section 1.6.2.  To investigate such repair differences a 
variety of techniques have been employed including the use of the comet assay, bacterial 
complementation assays, cleavage assays, gel shift assays and more recently laser 
directed damage using multi-photon microscopy (Zielinska A.E. et al. 2011).  Extensive 
use has been made of purified hOGG1 proteins and this has yielded both detailed 
structural information revealing the mechanistic basis for recognition and catalytic 
excision of 8-oxo dG, and important repair activity information (Bruner S.D. et al. 2000; 
Hill J.W. and Evans M.K. 2006).  Human blood and tissue samples from individuals 
expressing either Ser326- or Cys326-hOGG1 have also been used to investigate activity 
differences in vivo and to establish cell lines (Bravard A. et al. 2009; Chen S.K. et al. 
2003; Kondo S. et al. 2000; Lee A.J. et al. 2005).   
Cultured mammalian cells provide a powerful tool for relatively large scale, inexpensive 
and fast investigations into DNA-repair activity of proteins and are advantageous to 
bacterial overexpression systems and studying purified protein as proteins are maintained 
in their cellular environment.  This is particularly useful when observing the effect of 
oxidising cellular conditions.  The overexpression of hOGG1 has been achieved by 
transient and stable transfection in a variety of cultured cells including AS52 and AA8 
Chinese hamster ovary cells (Dahle J. et al. 2008; Hollenbach S. et al. 1999), HeLa cells 
(Bravard A. et al. 2009), human fibroblast GM00637 cells (Jeong H.G. et al. 2004) and 
mouse embryonic fibroblast cells (Oka S. et al. 2008).   
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Homozygous Ogg1
-/- 
null mice have been generated by replacing approximately 4.6 kilo 
bases (kb) of genomic DNA, including the helix-hairpin-helix required for catalytic 
activity, with a targeting construct containing the neomycin (neo) resistance gene 
(Klungland A. et al. 1999).  These knock-out mice are viable and have allowed the 
derivation of mOgg1
-/-
 embryonic fibroblast (KO MEF) cells which have been used to 
investigate the consequences of OGG1 deficiency and the role of OGG1 in 8-oxodG 
repair and prevention of mutagenesis (Klungland A. et al. 1999; Osterod M. et al. 2001).   
Transiently transfected KO MEF provide an excellent model for the in vitro study of 
wild-type and mutant hOGG1 as they allow overexpression of hOGG1 proteins whilst 
eliminating background OGG1 activity levels.  In our laboratory transiently transfected 
KO MEF cells have been successfully used to assess differences between Ser326- and 
Cys326-hOGG1 using the comet assay (Smart D. et al. 2006).  Whilst useful, the process 
of transfection is variable and, as discussed further in section 4.3, limits the techniques 
that can be used to investigate activity.  To extend our research into differences between 
wild-type and Cys326-hOGG1 this study generated KO MEF cells stably expressing 
Ser326- and Cys326-hOGG1.   
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4.2 Results 
4.2.1 Hygromycin B selection optimisation 
Hygromycin B resistance is conferred by the hygromycin B phosphotransferase (hph) 
gene encoded by the pIREShyg3 mammalian expression vector.  In order to optimise 
colony selection conditions a KO MEF cell kill curve was constructed following 
treatment with hygromycin B (0, 25, 100, 200, 250 µg/ml) at 0 h, 24 h, 48 h, 72 h and 
120 h (Figure 4.1).  The results showed that 200 µg/ml Hygromycin B (120 h) was 100% 
lethal to non-transfected cells and this concentration was therefore used for selection of 
OGG1 expressing clones.  
 
 
 
Figure ‎4.1: Hygromycin B kill curve. 
 KO MEF cells were cultured in 12 well plates then treated with hygromycin B (0, 25, 100, 200, 
250 µg/ml).  Live cells were counted at 0, 24, 48, 72 and 120 h post treatment.  Data are 
displayed as numbers of live cells at each time point.   
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4.2.2 Initial hOGG1 activity screen 
To generate stable transgenic cell lines KO MEF cells were transfected with Ser326- and 
Cys326-hOGG1 pIREShyg3 mammalian expression vectors and empty expression vector 
as a control, as described in section 2.8.  After selection in hygromycin B (200 μg/ml, 
120 h) colonies were picked and expanded then putative Ser326- and Cys326-hOGG1 
MEF cell clones were assessed for OGG1 activity by transfection with an 8-oxo dG-
containing molecular beacon prior to fluorescence analysis 48 h later by flow cytometry, 
as described in section 2.9.  Cleaved beacon fluorescence, expressed as the percentage of 
fluorescent events greater than 10
1
 on the FITC channel, was compared with that of 8-
oxo dG-containing molecular beacon-transfected KO MEF cells.  Ser326-hOGG1 
transfected cells (S) and Cys326-hOGG1 transfected cells (C) were analysed separately 
with their own controls (Table 4.1).  
Background (Blank) KO and WT MEF cell fluorescence was measured in the absence of 
transfection reagent and molecular beacon.  To ensure the transfection reagent did not 
fluoresce, fluorescence was measured in KO and WT MEF cells after 48 h transfection 
with Turbofect™ alone, no fluorescence was observed (Table 4.1). 
  
120 
 
Table ‎4.1: OGG1 activity in putative Ser326- and Cys326-hOGG1 MEF cell clones.   
Data are displayed as number of positive events and compared with KO MEF cells (fluorescence 
> than KO MEF cells = red, fluorescence < KO MEF cells = green).  All samples were 
transfected with 8-oxo dG-containing molecular beacon for 48 h. 
Sample Positive events Sample Positive events 
mOGG1
-/-
 Blank 0.53 mOGG1
-/-
 Blank 0.07 
mOGG1
+/+
 Blank 0.57 mOGG1
+/+
 Blank 0.18 
mOGG1
-/-
 + Turbofect™ 0.56 mOGG1-/- + Turbofect™ 0.05 
mOGG1
+/+
 + Turbofect™ 0.62 mOGG1+/+ + Turbofect™ 0.19 
mOGG1
-/-
 1.60 mOGG1
-/-
 1.76 
mOGG1
+/+
  2.86 mOGG1
+/+
 11.35 
S1 4.29 C1 19.57 
S2 6.35 C2 7.21 
S3 5.50 C3 11.45 
S4 1.48 C4 29.12 
S5 8.76 C5 37.26 
S6 11.02 C6 29.18 
S7 1.25 C7 29.49 
S8 2.01 C8 29.66 
S9 5.38 C9 15.62 
S10 1.93 C11 10.34 
S11 1.52 C12 11.97 
S12 2.29 C13 12.72 
S13 0.66 C19 4.48 
S14 4.62 C20 8.99 
S15 3.48 C22 3.62 
S16 3.16 C23 4.01 
S17 10.06 C24 9.68 
S18 3.71 C25 6.62 
S19 8.27 C26 4.39 
S20 1.99 C27 3.44 
S21 6.71 C28 7.95 
S22 3.94 C29 11.23 
S23 3.14 C30 9.88 
S24 9.81 C31 8.61 
S25 5.93 C32 2.99 
S26 2.97 C33 11.8 
S28 5.35 C34 12.03 
S29 2.68 C35 3.39 
S30 4.72 C36 9.31 
S31 2.27 
  S32 1.99 
  S33 2.05 
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4.2.3 Human OGG1 protein expression 
Cell lines which grew well and had high activity based on the 8-oxo dG-molecular 
beacon assay were selected and analysed for protein expression by western blot, as 
described in section 2.13.  Transiently transfected Ser326- and Cys326-hOGG1 MEF 
cells and KO MEF cells were included as controls.  hOGG1 protein was detected in S5, 
C8, C5 and C4 MEF cells, with S5 and C4 having the greatest levels as determined by 
densitometry using ImageJ (Integrated Density, S5:57307, C4:63471, C5:42881, 
C8:60164)   (Figure 4.2).  Based on this finding S5 and C4 MEF cells were selected. 
 
La Ladder 
KO (-ve control) mOGG1 
-/-
 null (KO) cells 
SER (+ve control) Transiently transfected Ser326-hOGG1 KO cells 
CYS (+ve control) Transiently transfected Cys326-hOGG1 KO cells 
S- Putative stable transgenic Ser326-hOGG1 cell line, no. - 
C- Putative stable transgenic Cys326-hOGG1 cell line, no. - 
 
Figure ‎4.2: hOGG1 protein expression in putative Ser326- and Cys326-hOGG1 MEF cells. 
Protein expression was confirmed in S5, C8, C5 and C4 MEF. 
  
La KO CYS C11 C12 C8 C5 C1 C4 C6
38kDa
La KO SER S5 S21 S2 S17 S9 S19 S24
38kDa
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4.2.4 Human OGG1 gene expression 
To further confirm and characterise OGG1 expression RNA was extracted from KO, 
WT, Ser326-hOGG1 (S5), Cys326-hOGG1 (C4) and vector control-transfected MEF 
cells and used to synthesise cDNA to detect hph (hygromycin B) and hOGG1 gene 
expression by PCR, as described in section 2.10.  hph Gene expression was confirmed by 
the amplification of a 579 base pair (bp) product in S5, C4 and vector control-transfected 
MEF cells and absent in KO and WT MEF cells.   hOGG1 gene expression was 
confirmed by the amplification of a 279bp product in S5 and C4 MEF, and absent in KO 
MEF, WT MEF and vector control-transfected MEF cells (Figure 4.3). 
 
 
 
 
Figure ‎4.3: hph and hOGG1 gene expression in Ser326- and Cys326-hOGG1 MEF cells. 
hph mRNA expression is indicated by the presence of a 579bp product in Ser326-hOGG1, 
Cys326-hOGG1 and vector control-transfected MEF.   hOGG1 mRNA expression is indicated by 
the presence of a 279 bp product in Ser326- and Cys326-hOGG1 MEF cells. 
  
123 
 
4.2.5 Quant ification of hOGG1 mRNA expression 
Real-time PCR was used to quantify relative Ser326-hOGG1 and Cys326-hOGG1 
expression in cell lines S5 and C4, as described in section 2.10.  There was no significant 
difference in mRNA expression between the cell lines (Figure 4.4).   
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Figure ‎4.4: Relative Ogg1 mRNA expression in Ser326- and Cys326-hOGG1 MEF cells. 
Ct values are plotted ±SEM.  No significant difference in Ct values was observed (P > 0.05 as 
determined by one-way ANOVA).     
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4.2.6 Quantification of hOGG1 activity  
Similar basal OGG1 activity was required for these cell lines to be a suitable model to 
investigate differences between Ser326- and Cys326-hOGG1.  The relative activities of 
Ser326- and Cys326-hOGG1 were determined by transfecting MEF cells with an 8-oxo 
dG-containing molecular beacon prior to fluorescence analysis by flow cytometry as 
described in section 2.9.  The number of Ser326- and Cys326-hOGG1 positive events (as 
described in section 2.9.2) are expressed as a percentage of mOGG1 positive events. 
Ser326-hOGG1 and Cys326-hOGG1 both exhibited greater activity than mOGG1 but 
there was no statistically significant difference in activity between Ser326- and Cys326-
hOGG1, as determined by 2-tailed Student‟s t-test (Figure 4.5).  This is in agreement 
with the similar levels of expression detected by western blot and confirmed the 
suitability of the cells as a model system for the study of OGG1 repair. 
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Figure ‎4.5: Relative OGG1 activity in Ser326- and Cys326-hOGG1 MEF cells 
Data are displayed as percentage glycoslyase activity relative to mOGG1.  *: Significantly 
different from mOGG1 (P < 0.05) as determined by 2-tailed Student‟s t-test. 
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4.2.6 Genomic incorporation of the OGG1 transgene 
Genomic DNA was extracted from KO, WT, Ser326-hOGG1 (S5), Cys326-hOGG1 (C4) 
and vector control-transfected MEF cells and used to detect hph (hygromycin B) and 
hOGG1 by PCR as described in section 2.10.  hph Genomic DNA incorporation was 
confirmed by the amplification of a 579 bp product in  S5, C4 and vector control-
transfected MEF cells and shown to be absent in KO and WT
 
MEF cells.  hOGG1 
genomic DNA incorporation was confirmed by the amplification of a 279 bp product in 
S5 and C4 MEF cells and shown to be absent in KO, WT and vector control-transfected 
MEF cells (Figure 4.6). 
 
 
 
 
 
 
Figure ‎4.6: hph and hOGG1 Genomic DNA incorporation in Ser326- and Cys326-hOGG1 
MEF cells. 
 hph  Genomic DNA incorporation is indicated by the presence of a 579bp product in Ser326-
hOGG1, Cys326-hOGG1 and vector control-transfected MEF.   hOGG1 Genomic DNA 
incorporation is indicated by the presence of a 279 bp product in Ser326- and Cys326-hOGG1 
MEF cells. 
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4.2.7 Confirmation of hOGG1 genotype by sequencing 
The genotype of the S5 and C4 clones was confirmed by sequencing as described in 
section 2.10.5 (Figure 4.7). 
 
. 
  
Ser326 
Cys326 
Figure ‎4.7: Confirmation of Ser326- and Cys326-hOGG1 sequence identity in Ser326- and 
Cys326-hOGG1 MEF cells. 
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4.2.8 Confirmation of hOGG1 activity  
An oligonucleotide incision assay was used as an established method with an alternative 
measurement end-point to confirm hOGG1 activity in Ser326- and Cys326-hOGG1 MEF 
cells as described in section 2.12, n=1.  Cleavage of the 8-oxo dG-containing 
oligonucleotide was observed in nuclear protein extract from WT, Ser326-hOGG1 (S5) 
and Cys326-hOGG1 (C4) MEF cells.  Cleavage was not observed in nuclear protein 
extract from KO MEF cells.  The oligonucleotide was incubated with lysis buffer B as a 
negative control and with formamidopyrimidine glycosylase (Fpg) (1 unit) as a positive 
control (Figure 4.8).   
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Figure ‎4.8: hOGG1 activity in WT, Ser326- and Cys326-hOGG1 MEF cells. 
Cutting activity was detected in WT, Ser326-hOGG1 (S5) and Cys326-hOGG1 (C4) MEF cells 
(n=1).  No cleavage was detected following incubation with extracts from KO MEF or with lysis 
buffer B.  
 
 
FPG
Lysis
buffer 
B
KO WT S5 C4
Intact 
oligonucleotide
(24mer)
Cleaved 
oligonucleotide
(12mer)
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4.3 Discussion 
Many researchers have used OGG1-overexpressing transgenic cell lines to study the 
OGG1 protein.  These studies have yielded important information about the protein 
including its localisation, post-translational modification and response to oxidative stress 
and DNA damage (Dahle J. et al. 2008; Dantzer F. et al. 2002; Hollenbach S. et al. 1999; 
Jeong H.G. et al. 2004; Luna L. et al. 2005; Oka S. et al. 2008).  The substitution of 
serine 326 for cysteine has been linked with increased risk of various cancers (Cho E.Y. 
et al. 2003; Elahi A. et al. 2002; Kohno T. et al. 2006; Le Marchand L.L. et al. 2002; 
Park J. et al. 2004; Srivastava A. et al. 2009; Sugimura H. et al. 1999; Xing D.Y. et al. 
2001) and transgenic cell lines have been successfully used to focus on possible 
differences in repair abilities between Ser326- and Cys326-hOGG1 (Bravard A. et al. 
2009; Hill J.W. and Evans M.K. 2006; Smart D.J. et al. 2006).   
The efficient removal of 8-oxo dG:C pairs is catalysed by mammalian OGG1 which has 
been shown to be the only DNA glycosylase that efficiently removes 8-oxo dG:C from 
DNA (Klungland A. et al. 1999).  KO MEF cells do not express mOgg1 and as a result 
are unable to undergo OGG1-mediated BER.  They are therefore extremely well suited to 
stably over-express the human OGG1 protein to address the objectives of this study.  
Previously, HeLa cells have commonly been used to overexpress hOGG1 (e.g. Dantzer 
F. et al. 2002; Luna L. et al. 2005) however these express low levels of endogenous 
hOGG1 and are a rapidly dividing cancer cell line.  The MEF cells generated in the 
current study, in contrast to HeLa cells, have no background OGG1 expression and are 
karyotypically normal therefore, even allowing for the accumulation of mutations in 
culture, they offer a significant improvement to previous models. 
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This study used a pIREShyg3 bicistronic expression vector to enable the translation of 
two open reading frames from a single mRNA species.  Translation of hOGG1 and hph, 
which confers resistance to hygromycin B, occurs from the same mRNA molecule 
therefore cells resistant to treatment with hygromycin B should express hOGG1.   An 
additional modification to the IRES sequence results in the attenuation of the efficiency 
of initiation of the hph resistance gene relative to that of hOGG1, resulting in the 
preferential selection of hygromycin B resistant cells with high hOGG1 gene expression.  
Following transfection of KO MEF cells with Ser326-hOGG1-, Cys326-hOGG1- and 
empty pIREShyg3 vector, thirty six hygromycin B resistant clones were selected from 
both Ser326- and Cys326-hOGG1 pIREShyg3 transfected cells and those that grew to 
confluence were assessed for hOGG1 activity.  Seven of those clones with the greatest 
hOGG1 activity were screened for protein expression and of those, the Ser326-hOGG1 
and Cys326-hOGG1 clones with the greatest protein expression were further 
characterised.   
This study successfully generated nuclear and functional Ser326- and Cys326-hOGG1 
expressing KO
 
MEF cells and confirmed hOGG1 genomic incorporation, protein 
expression and activity.  The expression of both genes, under the control of the 
cytomegalovirus (CMV) promoter, was greater than that of mOGG1 and this was 
reflected in the OGG1 glycosylase activity, however there was no significant difference 
in their activities or protein expression therefore they provide a suitable model system for 
investigating relative repair differences between Ser326- and Cys326-hOGG1. 
The generation of these cell lines has also allowed the use of a novel molecular beacon 
assay optimised in our laboratory which, coupled with either flow cytometry or confocal 
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microscopy, allows the specific measurement of OGG1 activity in live cells (Mirbahai L. 
et al. 2010; Priestley C.C. et al. 2010).  This assay, which involves the transfection of an 
8-oxo dG-containing molecular beacon into cultured cells, was previously impractical 
using a transient transfection model as it involved a poorly tolerated double transfection 
(data not shown).  Following the successful generation of these cell lines this technique 
has been employed to investigate Ser326-hOGG1 and Cys326-hOGG1 repair ability 
differences following induction of oxidative stress conditions (Chapter 5).  
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Chapter 5 – Response 
of Ser326- and 
Cys326-hOGG1 to 
oxidative stress 
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5.1 Introduction 
Inflammation and exposure to cigarette smoke, ionising radiation, environmental 
pollution, toxic food ingredients and sunlight can all result in increased cellular ROS and 
increased 8-oxo dG formation (Ma Q. 2009).  Efficient repair of 8-oxo dG by hOGG1 is 
required to prevent errors during DNA replication and elevated frequency of mutation 
and cancer.  Epidemiological evidence suggests that under normoxic conditions risk of 
cancers including nasopharyngeal, oesophageal, gallbladder and lung is increased in 
individuals homozygous for the S326C hOGG1 allele (Cho E.Y. et al. 2003; Kohno T. et 
al. 2006; Le Marchand L.L. et al. 2002; Park J. et al. 2004; Srivastava A. et al. 2009; 
Sugimura H. et al. 1999; Xing D.Y. et al. 2001).  When external factors are evaluated 
such as smoking, alcohol or meat consumption the risk of head and neck squamous cell 
carcinoma, colon, orolaryngeal and stomach cancer is increased in CC homozygotes 
(Elahi A. et al. 2002; Hashimoto T. et al. 2006; Kim J.I. et al. 2003; Lan Q. et al. 2004; 
Li W.Q. et al. 2009; Takezaki T. et al. 2002; Zhang Z. et al. 2004).   
It is accepted that in addition to the separate contributions of genetic differences and 
environmental factors, interactions between the two are important in disease 
development (Hunter D.J. 2005) and epidemiological evidence supports an interaction 
between the Cys326-hOGG1 allele and environmental exposure to ROS resulting in 
increased risk of cancer.  In support of this, whilst evidence for reduced repair activity of 
Cys326-hOGG1 under normoxic conditions is conflicting, with reduced repair observed 
by some (Bravard A. et al. 2009; Kohno T. et al. 1998) but not others (Blons H. et al. 
1999; Dherin C. et al. 1999; Hardie L.J. et al. 2000; Janssen K. et al. 2001; Kondo S. et 
al. 2000; Li D. et al. 2002; Park Y.J. et al. 2001; Shinmura K. et al. 1998), it is becoming 
135 
 
increasingly clear that reduced repair ability of Cys326-hOGG1 becomes more apparent 
under oxidising conditions (Bravard A. et al. 2009; Chen S.K. et al. 2003; Hill J.W. and 
Evans M.K. 2006; Lee A. et al. 2005; Smart D. et al. 2006; Yamane A. et al. 2004).  
The mechanism underlying any difference in repair ability is poorly understood.  It is 
possible that the loss of a potential regulatory serine residue could affect activity as the 
phosphorylation of Ser326 has been shown to be important in hOGG1 localisation, with 
Cys326-hOGG1 excluded from the nucleoli during S-phase (Luna L. et al. 2005).  An 
increasing body of evidence supports the alternative possibility that repair activity could 
be affected by the introduction of a redox-sensitive cysteine residue, as repair defects are 
more marked under oxidising conditions.  Redox state modulation of hOGG1 activity has 
previously been demonstrated, with recovery of decreased Cys326-hOGG1 activity 
following the addition of reducing agents (Bravard A. et al. 2006; Bravard A. et al. 
2009).  The additional cysteine thiol group is susceptible to the formation of sulphenic 
acid under conditions of oxidative stress which can disulphide bond with a nearby thiol 
(Biswas S. et al. 2006).  There is evidence that Cys326 can be easily involved in 
disulphide bond formation (Bravard A. et al. 2009) and purified Cys326-hOGG1 has 
been shown to exist as a dimer that is dependent on residues C-terminal to Cys326 (Hill 
J.W. and Evans M.K. 2006).  
To extend the work of Hill and Evans (2006) and investigate hOGG1 dimer formation in 
live cells, a relatively new fluorescence based technique; bimolecular fluorescence 
complementation (BiFC) was employed in the current study.  This assay is useful for 
investigating protein-protein interactions in living cells (Hu C.D. et al. 2002; Kerppola 
T.K. 2008; Kerppola T.K. 2009) and involves the reconstitution of fluorescence of 
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yellow fluorescent protein (YFP) by the association of two non-fluorescent YFP half 
molecules fused to proteins of interest, such as hOGG1 (Figure 2.1).  The fluorescence 
resulting from this association can be quantified by flow cytometry and visualised by 
confocal microscopy.  Using BiFC to study hOGG1 dimer formation rather than EMSA 
allows investigation of dimer formation in live cells, without the removal of the OGG1 
protein from its native environment.  Additionally, the technique could reveal important 
information about the intracellular localisation of any dimer products.   
In addition to investigation of possible OGG1 dimer formation by BiFC, results are 
presented in this chapter of Ser326- and Cys326-hOGG1 activity, gene expression, 
protein levels and protein localisation following oxidative stress induction by BSO 
treatment using stably expressing cells described in chapter 4.   
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5.2 Results 
5.2.1 Cell viability following BSO treatment  
To investigate BSO mediated cytotoxcity, MEF cells were cultured in 96 well cell culture 
plates and treated for 24 h with BSO (0, 1, 10, 100, 1000 µM) prior to analysis by the 
MTT reduction assay, as described in section 2.4.  No statistically significant difference 
in absorbance was observed between untreated and BSO treated cells (P > 0.05 as 
determined by one-way ANOVA) indicating that 24 h treatment with up to 1000 µM 
BSO does not affect the viability of these cells (Figure 5.1). 
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Figure ‎5.1: Viability of MEF cells after 24 h BSO treatment as assessed using the MTT 
reduction assay. 
Data are displayed as percentage of untreated control ±SEM from 3 independent experiments. 
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5.2.2 Total cellular reduced glutathione following BSO 
treatment  
Treatment with BSO for 24 h at concentrations ≥ 1 µM has been shown to deplete 
cytoplasmic GSH in KO MEF cells, with nuclear depletion occurring following treatment 
with 1000 µM BSO (Green R.M. et al. 2006).  To determine and compare the levels of 
total GSH in Ser326-hOGG1 MEF and Cys326-hOGG1 MEF after BSO treatment (0, 1, 
10, 100, 1000 µM, 24 h), cells were treated then total GSH was measured as described in 
section 2.6. 
Statistically significant depletion of total cellular GSH occurred following treatment with 
≥ 1 µM BSO in KO and Ser326-hOGG1 MEF cells.  In Cys326-hOGG1 MEF cells 
statistically significant depletion of total GSH occurred following treatment with ≥ 10 
µM BSO.  No significant difference in total GSH was observed between any of the MEF 
cell lines following treatment with any concentration of BSO (P > 0.05 as determined by 
one-way ANOVA) (Figure 5.2). 
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Figure ‎5.2: Total GSH in MEF cells after 24 h BSO treatment. 
Data are displayed as percentage of untreated control (nm GSH/mg protein. KO MEF: 18.54 ± 
1.32, Ser326-hOGG1 MEF: 24.77 ± 1.77, Cys326-hOGG1 MEF: 19.88 ± 2.30) ±SEM from 3 
independent experiments.  *,**,***: Significantly different from control (*P < 0.05 **P < 0.01 
***P < 0.001) as determined by 2-tailed Student‟s t-test. 
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5.2.3 Intracellular ROS following BSO treatment 
Using the fluorescent dye dichlorofluorescein, intracellular ROS have been shown to be 
induced in KO MEF cells with 24 h BSO treatment at concentrations ≥ 100 µM (Green 
R.M. et al. 2006).  The current study modified the technique used by Green et al. and 
employed the use of flow cytometry to measure intracellular ROS levels, as described in 
section 2.5. 
Fluorescein fluorescence was statistically significantly increased compared with 
untreated control in all cell lines following treatment with ≥ 10 µM BSO.  There was no 
statistically significant difference in response between any of the cell lines (Figures 5.3 
and 5.4). 
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Figure ‎5.3: ROS levels, as assessed by DCF fluorescence in MEF cells after 24 h BSO 
treatment. 
 Individual replicates are displayed (n = 4). 
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Figure ‎5.4: ROS levels in MEF cells after 24 h BSO treatment. 
Data are displayed as median fluorescence intensity as percentage of untreated control ±SEM 
from 4 independent experiments.  *: Significantly different from control (P < 0.05) as determined 
by Mann-Whitney U test. 
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5.2.4 hOGG1 activity following BSO treatment  
To determine the effect of BSO on Ser326- and Cys326-hOGG1 repair activity, Ser326- 
and Cys326-hOGG1 MEF were treated with BSO (0, 1, 10, 100, 1000 μM, 24 h) then 
transfected with an 8-oxo dG-containing molecular beacon prior to fluorescence analysis 
by flow cytometry as described in section 2.9 and confocal microscopy as described in 
section 2.14.   
Data are expressed as the number of positive events (as described in section 2.9.2) as a 
percentage of time matched untreated control (Figure 5.6A) or as a percentage of 
untreated control (Figure 5.6B and C).  Following treatment with 1000 µM BSO, a peak 
in beacon fluorescence was observed after 12 h in Ser326-hOGG1 MEF cells and after 
24 h in Cys326-hOGG1 MEF cells (Figure 5.5 and 5.6A).  Beacon fluorescence in both 
Ser326- and Cys326-hOGG1 expressing cells increased in a concentration dependent 
manner following BSO treatment (Figure 5.5 and Figure 5.6B and C).   
Beacon fluorescence was visualised using confocal microscopy 12 hours (Figures 5.7 and 
5.8) and 24 hours (Figures 5.9 and 5.10) post BSO treatment.  This confirmed the 
increase in fluorescence and indicated that although there is some faint cytoplasmic 
staining, the majority of the cleaved beacon appeared to be in the nucleus of the cells.   
 
 
 
 
145 
 
 
Figure ‎5.5: Ser326- and Cys326-hOGG1 activity, as assessed by beacon fluorescence 
following BSO treatment. 
Representative histograms are displayed. 
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Figure ‎5.6: Ser326- and Cys326-hOGG1 activity following BSO treatment. 
A: Time-dependent increase in hOGG1 activity, with each bar representing the number of 
positive beacon events of treated cells (1000 µM BSO) as a percentage of time-matched 
untreated cells.  B: Concentration-dependent increase in activity in Ser326-hOGG1 MEF cells 12 
h post BSO treatment.  C: Concentration-dependent increase in activity in Cys326-hOGG1 MEF 
cells 24 h post BSO treatment.  Data are expressed as the number of positive beacon events as a 
percentage of untreated control, ±SEM from 4 independent experiments.  Significantly different 
from untreated control (#P = 0.05 *P < 0.05 **P < 0.01 ***P < 0.001) as determined by 2-tailed 
Student‟s t-test. 
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Figure ‎5.7: Confocal microscopy analysis of cleaved 8-oxo dG-molecular beacon in Ser326-hOGG1 MEF cells 12 hours post BSO treatment 
(1000 µM).  
OGG1 activity was visualised by the FITC fluorescence (green channel) of cleaved beacon.  The nucleus was visualised by Hoechst stain (blue 
channel).  C = control, T = treated.   
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Figure ‎5.8: Confocal microscopy analysis of cleaved 8-oxo dG-molecular beacon in Cys326-hOGG1 MEF cells 12 hours post BSO treatment 
(1000 µM). 
 OGG1 activity was visualised by the FITC fluorescence (green channel) of cleaved beacon.  The nucleus was visualised by Hoechst stain (blue 
channel).  C = control, T = treated.   
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Figure ‎5.9: Confocal microscopy analysis of cleaved 8-oxo dG-molecular beacon in Ser326-hOGG1 MEF cells 24 hours post BSO treatment 
(1000 µM).  
OGG1 activity was visualised by the FITC fluorescence (green channel) of cleaved beacon.  The nucleus was visualised by Hoechst stain (blue 
channel).  C = control, T = treated.   
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Figure ‎5.10: Confocal microscopy analysis of cleaved 8-oxo dG-molecular beacon in Cys326-hOGG1 MEF cells 24 hours post BSO treatment 
(1000 µM). 
OGG1 activity was visualised by the FITC fluorescence (green channel) of cleaved beacon.  The nucleus was visualised by Hoechst stain (blue 
channel).  C = control, T = treated.   
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Transfection of Ser326-hOGG1 and Cys326-hOGG1 MEF cells with a positive control 
molecular beacon after BSO treatment (0, 1, 10, 100, 1000 µM, 24 h) allowed the 
assessment of transfection efficiency.  Using flow cytometry no statistically significant 
difference in fluorescence was observed following treatment with BSO at any 
concentration investigated (P > 0.05 as determined by Kruskal-Wallis test) (Table 5.1).  
Using confocal microscopy, fluorescence was detected 12 hours (Figures 5.11 and 5.12) 
and 24 hours (Figures 5.13 and 5.14) post BSO treatment, with no difference in 
localisation observed between the cell types of following BSO treatment.  Positive 
control beacon fluorescence was present in the nucleus and cytoplasm. 
Table ‎5.1: Ser326- and Cys326-hOGG1 positive control beacon events 
[BSO] 
µM 
Ser326-hOGG1 
MEFs (12 h post 
treatment) 
Cys326-hOGG1 
MEFs (12 h post 
treatment) 
Ser326-hOGG1 
MEFs (24 h post 
treatment) 
Cys326-hOGG1 
MEFs (24 h post 
treatment) 
0 72.03±3.19 74.11±5.10 78.31±8.05 73.63±7.71 
1 71.86±4.47 71.44±6.70 69.51±12.14 71.74±10.27 
10 70.10±2.53 69.73±5.37 69.36±17.27 64.45±16.06 
100 72.90±5.67 70.58±5.67 66.41±18.81 64.72±15.44 
1000 69.37±4.81 67.83±8.62 67.98±16.67 68.89±16.09 
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Figure ‎5.11: Confocal microscopy analysis of positive control beacon in Ser326-hOGG1 MEF cells 12 hours post BSO treatment (1000 µM). 
Positive control molecular beacon fluorescence was visualised by FITC fluorescence (green channel).  The nucleus was visualised by Hoechst stain 
(blue channel).  C = control, T = treated.   
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Figure ‎5.12: Confocal microscopy analysis of positive control beacon in Cys326-hOGG1 MEF cells 12 hours post BSO treatment (1000 µM). 
Positive control molecular beacon fluorescence was visualised by FITC fluorescence (green channel).  The nucleus was visualised by Hoechst stain 
(blue channel).  C = control, T = treated.   
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Figure ‎5.13: Confocal microscopy analysis of positive control beacon in Ser326-hOGG1 MEF cells 24 hours post BSO treatment (1000 µM). 
Positive control molecular beacon fluorescence was visualised by FITC fluorescence (green channel).  The nucleus was visualised by Hoechst stain 
(blue channel).  C = control, T = treated. 
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Figure ‎5.14: Confocal microscopy analysis of positive control beacon in Cys326-hOGG1 MEF cells 24 hours post BSO treatment (1000 µM). 
Positive control molecular beacon fluorescence was visualised by FITC fluorescence (green channel).  The nucleus was visualised by Hoechst stain 
(blue channel).  C = control, T = treated.  
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5.2.5 hOGG1 mRNA expression following BSO treatment 
In this experimental model the CMV promoter controls the expression of ser326- and 
cys326-hOGG1.  It was therefore important to test that BSO treatment had no effect on 
the CMV driven transcription of hOGG1.  Levels of hOGG1 mRNA were measured 
using real time PCR as described in section 2.10.  To determine whether there was any 
change in hOGG1 expression during the 24 h BSO treatment period RNA was extracted 
from control and BSO treated (1000 µM) Ser326- and Cys326-hOGG1 MEF at 0, 6, 12, 
18 and 24 h post treatment.  Analysis by real time PCR revealed that there was no 
significant difference in Ct values between control and treated samples at any time point 
investigated (Figure 5.15) (P > 0.05 as determined by one-way ANOVA). 
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Figure ‎5.15: hOGG1 mRNA levels following BSO treatment. 
Ser326- and Cys326-hOGG1 MEF cells were treated with 1000 µM BSO for 24 h then OGG1 
mRNA levels were assessed by real time PCR (n = 3, performed in duplicate).  Ct values are 
plotted ±SEM.  No significant difference between Ct values was observed with oxidative 
treatment or over time (P > 0.05 as determined by one-way ANOVA). 
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5.2.6 hOGG1 protein levels following BSO treatment 
To determine any effect of BSO treatment on Ser326- and Cys326-hOGG1 protein 
levels, KO MEF cells transfected with EGFP-Ser326- and EGFP-Cys326-hOGG1 were 
treated with BSO for 24 h (1000 µM), washed, then total protein was extracted (as 
described in section 2.11.2) 0 h, 8 h and 24 h after treatment.  hOGG1 protein levels were 
measured by western blot as described in section 2.13 and normalised to a beta-actin 
loading control.  A representative blot is shown (Figure 5.16).  No significant difference 
in levels of hOGG1 protein was observed compared with time-normalised control 
following treatment (P > 0.05 as determined by one-way ANOVA).  
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Figure ‎5.16: hOGG1 protein levels following 24 h BSO treatment (1000 µM). 
Western blot analysis of BSO treated EGFP-Ser326-hOGG1 and EGFP-Cys326-hOGG1 
expressing MEF cells.  Signals were quantified using ImageJ, with values normalised to the beta 
actin loading control.  Each value represents a treated sample as a ratio of time-matched control 
±SEM.  No significant difference in protein levels was observed (P > 0.05 as determined by one-
way ANOVA). 
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 5.2.7 EGFP-Ser326- and EGFP-Cys326-hOGG1 protein 
localisation following BSO treatment 
To investigate intracellular localisation of hOGG1 following BSO treatment KO MEF 
cells transfected with EGFP-Ser326- and EGFP-Cys326-hOGG1 were treated with BSO 
for 24 h (1000 µM) then imaged by confocal microscopy (as described in section 2.14) 0 
h, 12 h and 24 h after treatment.  Diffuse staining of both EGFP-Ser326- and EGFP-
Cys326-hOGG1 was observed throughout the entire nucleus with stronger staining 
observed on regions corresponding to heterochromatin, as indicated by Hoechst staining 
of condensed foci.  No difference in protein localisation was observed between Ser326- 
and Cys326-hOGG1 and no change in protein localisation was observed following BSO 
treatment at any time point investigated (Figure 5.17).  
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Figure ‎5.17: Confocal microscopy analysis of EGFP-Ser326- and EGFP-Cys326-hOGG1 
localisation in BSO treated (1000 µM) KO MEF cells.   
EGFP-tagged proteins were visualised by EGFP fluorescence (green channel).  The nucleus was 
visualised by Hoechst stain (blue channel).  C = control, T = treated.  Top panel: EGFP-Ser326-
hOGG1 transfected KO MEF cells.  Bottom panel: EGFP-Cys326-hOGG1 transfected KO MEF 
cells. 
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5.2.8 Bimolecular fluorescence complementation (BiFC) 
analysis of hOGG1-hOGG1 interactions in MEF cells 
Purified Cys326-hOGG1 has been shown to exist as a homo-dimer that is dependent on 
residues including and C-terminal to cys326 (Hill J.W. and Evans M.K. 2006).  Using 
BiFC the ability of hOGG1 proteins to interact in MEF cells in the presence and absence 
of oxidants was investigated.  As described in section 2.7, hOGG1 cDNA was fused to 
the N-terminal and C-terminal fragments of YFP and the expression plasmids were 
transiently co-transfected into KO MEF cells.  Following treatment with 1000 µM BSO 
and 250 µM diamide, which oxidises thiols, any fluorescence resulting from the 
reconstitution of the two YFP half molecules was quantified by flow cytometry (exactly 
as for FITC-derived fluorescence as described in section 2.9.2) and imaged by confocal 
microscopy (as described in section 2.14).  To detect background fluorescence arising 
from non-specific association of the two YFP half molecules, cells were co-transfected 
with plasmids expressing untagged YFP-N and YFP-C.   
Fluorescence above background was detected in all cells transfected with YFP-
containing vectors, including those transfected with the YFP-N and YFP-C control 
vectors (Figure 5.18A and B).  Data are displayed as the number of cells with 
fluorescence above 10
1
.  There was no statistically significant difference between 
fluorescence detected in cells transfected with YFP-N and YFP-C control vectors and 
those transfected with YFP-hOGG1 vectors, or following treatment with 1000 µM BSO 
or 250 µM diamide (P > 0.05 as determined by 2-tailed student‟s t-test). 
Confocal microscopy analysis confirmed the absence of fluorescence in untransfected 
MEF cells (Figure 5.19) and the presence of faint fluorescence in YFP-N and YFP-C 
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(Figure 5.20), YFP-N-Ser326-hOGG1 and YFP-C-Ser326-hOGG1 transfected MEF cells 
(Figure 5.21).  Fluorescence appeared greater in YFP-N-Cys326-hOGG1 and YFP-C-
Cys326-hOGG1 transfected MEF cells (Figure 5.22) however the staining pattern was 
not nuclear, as expected, but instead appeared to be dispersed throughout the cytoplasm 
with no evidence of fluorescent foci, suggesting it may just be background fluorescence. 
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Figure ‎5.18: hOGG1 protein interactions following 24 h BSO treatment (1000 µM) and 30 
minute diamide treatment (250 µM). 
A: Representative histograms are displayed.  B: Data are plotted as fluorescence intensity ±SEM 
from 3 independent experiments. 
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Figure ‎5.19: Confocal microscopy analysis of background YFP fluorescence in 
untransfected KO MEF cells following 24 h BSO treatment (1000 µM) and 30 minute 
diamide treatment (250 µM). 
 Background fluorescence was visualised by YFP fluorescence (yellow channel).  The nucleus 
was visualised by Hoechst stain (blue channel). 
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Figure ‎5.20:  Confocal microscopy analysis of non-specific YFP fluorescence in YFP-N and 
YFP-C transfected KO MEF cells following 24 h BSO treatment (1000 µM) and 30 minute 
diamide treatment (250 µM). 
 YFP-N and YFP-C interactions were visualised by YFP fluorescence (yellow channel).  The 
nucleus was visualised by Hoechst stain (blue channel). 
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Figure ‎5.21: Confocal microscopy analysis of YFP fluorescence in YFP-N-Ser326-hOGG1 
and YFP-C-Ser326-hOGG1 transfected KO MEF cells following 24 h BSO treatment (1000 
µM) and 30 minute diamide treatment (250 µM). 
YFP-N-Ser326-hOGG1 and YFP-C-Ser326-hOGG1 interactions were visualised by YFP 
fluorescence (yellow channel).  The nucleus was visualised by Hoechst stain (blue channel). 
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Figure ‎5.22: Confocal microscopy analysis of YFP fluorescence in YFP-N-Cys326-hOGG1 
and YFP-C-Cys326-hOGG1 transfected KO MEF cells following 24 h BSO treatment (1000 
µM) and 30 minute diamide treatment (250 µM).  
YFP-N-Cys326-hOGG1 and YFP-C-Cys326-hOGG1 interactions were visualised by YFP 
fluorescence (yellow channel).  The nucleus was visualised by Hoechst stain (blue channel). 
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5.2.9 Ser326- and Cys326-hOGG1 retention within an insoluble 
nuclear fraction  
As nuclear localisation of hOGG1 was found to be unaffected by BSO treatment, 
retention within the nucleus following BSO treatment was investigated.  Wild-type 
hOGG1-GFP protein has previously been shown to remain soluble in the nucleus of 
untreated cells but to be retained in an insoluble nuclear fraction, containing chromatin- 
and matrix-associated proteins, following treatment with the pro-oxidant potassium 
bromate (Amouroux R. et al. 2010).  To investigate whether there was a difference 
between retention of Ser326- and Cys326-hOGG1 in this insoluble nuclear fraction 
following BSO treatment, KO MEF cells were transiently transfected with plasmids 
expressing EGFP-Ser326-hOGG1 or EGFP-Cys326-hOGG1.  Following BSO treatment 
(1000 µM, 24 h) cells were incubated with CSK buffer to remove soluble proteins, 
washed, then fixed with paraformaldehyde (as described in sections 2.11.3 and 2.14).  
Any remaining insoluble EGFP-hOGG1 was observed by confocal microscopy 8 h, 16 h 
and 24 h post treatment. 
There was no difference between nuclear expression of Ser326- and Cys326-EGFP-
hOGG1 prior to the CSK wash, indicating similar transfection efficiency (Figure 5.23).  
Following the CSK wash, very little EGFP-hOGG1 remained in the nucleus in untreated 
cells.  However, BSO treatment resulted in retention of EGFP-hOGG1 in the insoluble 
fraction (Figure 5.24).  Interestingly, EGFP-Ser326-hOGG1 was retained within the 
insoluble fraction to a far greater extent than EGFP-Cys326-hOGG1, particularly 8 h 
post treatment.   
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To further investigate this, soluble and insoluble protein fractions from KO MEF cells 
transiently transfected with plasmids expressing EGFP-Ser326-hOGG1 or EGFP-
Cys326-hOGG1 were analysed by western blotting (as described in section 2.13).  
EGFP-Ser326-hOGG1 protein was detected in both insoluble and soluble fractions in 
control and treated cells at all time points investigated.  EGFP-Cys326-hOGG1 protein 
was also detected in soluble fractions in control and treated cells at all time points 
investigated but was not detected in insoluble fractions in any sample (Figure 5.25). 
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Figure ‎5.23: Confocal microscopy analysis of total (soluble and insoluble, -CSK wash) 
EGFP-Ser326- and EGFP-Cys326-hOGG1 in control and BSO treated (1000 µM) KO MEF 
cells. 
EGFP-hOGG1 proteins were visualised by EGFP fluorescence (green channel).  The nucleus was 
visualised by Hoechst stain (blue channel). 
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Figure ‎5.24: Confocal microscopy analysis of insoluble (+CSK wash) EGFP-Ser326- and 
EGFP-Cys326-hOGG1 8 h, 16 h and 24 h post treatment in control and BSO treated (1000 
µM) KO MEF cells.  
EGFP-hOGG1 proteins were visualised by EGFP fluorescence (green channel).  The nucleus was 
visualised by Hoechst stain (blue channel). 
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Figure ‎5.25: Ser326- and Cys326-hOGG1 protein in soluble (S1) and insoluble (P1) 
fractions following 24 h BSO treatment (1000 µM).   
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5.3 Discussion 
Epidemiological evidence indicates increased cancer risk in individuals that are Cys326-
hOGG1 homozygotes and it is becoming increasingly clear from functional studies that 
any reduced repair ability of Cys326-hOGG1 becomes most apparent under conditions of 
cellular oxidative stress.  The work described in chapter 3 showed that oxidative stress 
induced by BSO resulted in increased mOGG1 activity which was not related to 
increased gene expression.  To investigate wild-type and variant hOGG1 regulation and 
activity under oxidising conditions MEF cells expressing Ser326- and Cys326-hOGG1 
were generated (chapter 4).  Human OGG1 activity, gene expression, protein expression, 
protein localisation and ability to form dimers following BSO treatment were measured.  
Treatment of Ser326- and Cys326-hOGG1 MEF cells with BSO resulted in a 
concentration-dependent depletion of glutathione and increase in ROS with no effect on 
cell viability at any concentration investigated.  As observed for mouse OGG1 (chapter 
3), treatment with BSO resulted in a concentration dependent increase in Ser326- and 
Cys326-hOGG1 activity, with no change in gene expression or protein levels.  The 
expression of hOGG1 is not believed to vary during the cell cycle and this, combined 
with the lack of TATA or CAAT boxes within the promoter, indicates that it is a 
constitutively expressed gene (Dhénaut A. et al 2000).  The OGG1 promoter does 
however contain SP1 transcription factor binding sites and a Nrf2 antioxidant response 
element and expression of OGG1 can be modulated by a range of cellular stresses 
(Cortina M.S. et al. 2005; Hodges N.J. and Chipman J.C. 2002; Imai K. et al. 2005; Lee 
A. et al. 2004; Potts R.J. et al. 2003; Youn C.K. et al. 2005).  In this study, expression of 
ser326- and cys326-hOGG1 were under the control of the CMV promoter and not subject 
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to regulation at the transcriptional level, as shown in section 5.2.5.  The data presented 
here support other studies which show that oxidative stress has the ability to modulate 
OGG1 activity post-transcriptionally (Mirbahai L. et al. 2010; Conlon K.A. et al. 2003; 
Silva J.P. et al. 2009; Bhakat K.K. et al. 2006).   
Although Ser326- and Cys326-hOGG1 protein levels increased slightly 12 and 24 hours 
post BSO treatment, no statistically significant change in protein levels was observed 
between BSO treated and untreated control samples at any time point investigated.  It 
seems likely therefore that post-translational modifications are responsible for the 
activity modulation observed in this study.  It has been shown that OGG1 activity can be 
stimulated by phosphorylation (Hu J. et al. 2005) and acetylation (Bhakat K.K. et al. 
2006).  Further work remains to be done to investigate the phosphorylation and 
acetylation status of the hOGG1 protein following oxidative stress.  The process of BER 
is highly coordinated and involves multiple interactions between the proteins of the 
pathway.  The activity of OGG1 has previously been shown to be enhanced by 
apurinic/apyrimidinic endonuclease 1 (APE1) (Hill J.W. et al. 2001; Vidal A.E. et al. 
2001), Nei-like glycosylase 1 (NEIL1) (Mokkapati S.K. et al. 2004), X-ray cross 
complementing protein 1 (XRCC1) (Marsin S. et al. 2003) and RAD52 (de Souza-Pinto 
N.C. et al. 2009).  It is therefore also possible that oxidative stress induced by BSO 
treatment could affect the interaction with one of these protein partners. 
In the current study BSO treatment resulted in an increased activity response of Cys326-
hOGG1 which was delayed relative to that of Ser326-hOGG1.  To ensure this was not a 
clone-specific effect we repeated the activity measurements using two independent MEF 
cell lines expressing Ser326- and Cys326-hOGG1 and observed the same trend (see 
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appendix, page 224).  The data suggests altered kinetics of Ser326- and Cys326-hOGG1 
in response to the same oxidative stress.  Cys326-hOGG1 has previously been shown to 
have decreased 8-oxo dG binding affinity and reduced 8-oxo dG excision catalytic 
efficiency (Dherin C. et al. 1999; Hill J.W. and Evans M. K. 2006).  Interestingly, 
although Cys326-hOGG1 was shown to be less efficient than wild-type hOGG1 
removing 8-oxo dG:C from oligodeoxynucleotide substrates, the effect was far more 
pronounced when removing 8-oxo dG from high molecular weight DNA (Sidorenko V.S. 
et al. 2009).  The data presented in this study are in agreement with functional studies 
observing reduced rate of repair of Cys326-hOGG1 and thus support epidemiological 
evidence suggesting increased risk of cancer in individuals homozygous for the Cys326-
hOGG1 allele. 
The human OGG1 gene undergoes alternative splicing generating two major isoforms; α-
hOGG1 (hOGG1-1a) and β-hOGG1 (hOGG1-2a).  The first 316 amino acids are 
identical and contain a mitochondrial targeting sequence however the carboxy-terminal 
ends differ extensively, with that of α-hOGG1 containing a C-terminal nuclear 
localisation sequence absent from β-hOGG1 (Boiteux S. and Radicella J.P. 2000) which 
targets it to the nucleus (Takao M. et al. 1998) and suppresses the mitochondrial 
targeting sequence which targets β-hOGG1 to the mitochondria (Nishioka K. et al. 
1999).  Little is known about the function of the β-form as surprisingly, it has been 
shown to lack repair activity (Hashiguchi K. et al. 2004) but to have an effect on the 
mechanism of cell death in MEF cells (Oka S. et al. 2008).  Although mainly located in 
the nucleus, it is thought that the alpha form is responsible for both nuclear and 
mitochondrial 8-oxo dG repair.  The current study used MEF cells expressing the α-
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hOGG1 isoform and analysis by confocal microscopy revealed that, as expected, in both 
Ser326- and Cys326-hOGG1 MEF cells the cleaved beacon was mainly located in the 
nucleus.  Furthermore, fluorescence of nuclear localised beacon increased in intensity in 
a concentration dependent manner following BSO treatment.   Interestingly, this is in 
contrast to previous observations which showed mitochondrial beacon localisation 
following treatment of MEF cells expressing endogenous mOGG1 with potassium 
bromate (Mirbahai L. et al. 2010).  Mouse OGG1 exists as only a single isoform 
responsible for both nuclear and mitochondrial BER.  The staining pattern observed 
using the positive control beacon shows that in the current study the beacon is present in 
the nucleus and cytoplasm, as well as in mitochondrial sized organelles.   Based on these 
observations we propose that the localisation difference may either be a species specific 
response or a result of hOGG1 overexpression.  Alternatively, it is possible that in these 
cells, in contrast to potassium bromate treatment, it is genomic rather than mitochondrial 
DNA that is preferentially oxidatively damaged following BSO treatment, resulting in an 
accumulation of cleaved beacon in the nucleus; the site of greatest damage.   
The mechanism underlying the repair difference between Ser326- and Cys326-hOGG1 
observed is unknown and as no crystal structure exists that includes amino acids beyond 
position 325 no information can be obtained from structural studies.  Two major 
hypotheses have been proposed to explain repair differences; the introduction of a redox-
sensitive cysteine residue, or the loss of a serine residue whose phosphorylation may be 
important for OGG1 localisation or activity.  An increasing body of evidence supports 
the theory that the Cys326 residue, present in a highly positively charged sequence 
environment (ADLRQ[ser326cys]RHAQ), is redox sensitive and susceptible to the 
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formation of a reactive thiolate anion (Giustarini D. et al. 2004) which can be oxidatively 
modified and form disulphide bonds (Bravard A. et al. 2009).  The Cys326 residue is 
present in a disordered and highly mobile region (Bruner S.D. et al. 2000) suggesting 
that this residue may be located in an accessible part of the molecule, rendering it a likely 
target for redox modification.  Hill and Evans (2006) used purified hOGG1 protein to 
show Cys326-hOGG1 exists as a homo-dimer, which may explain a reduction in activity, 
however no clear evidence of hOGG1 homo-dimer formation was detected in the current 
study using BiFC in MEF cells following treatment with either BSO or diamide.    
It is possible that homo-dimer formation was observed by Hill and Evans (2006) and not 
in the current study because hOGG1 does not form a dimer in its native cellular 
environment.  hOGG1 may form a dimer with other proteins in vivo which would not 
have been detected using BiFC, or limitations of the BiFC technique may have prevented 
the visualisation of any hOGG1 protein interactions.  The BiFC technique was used to 
measure hOGG1 protein interactions in live cells as it has been successfully used to 
investigate a variety of protein – protein interactions in mammalian cells (Hu C.D. et al. 
2002; de Virgilio M. et al. 2004; Shaffer J.M. et al. 2009).  Dimer formation could also 
be further investigated using Förster resonance energy transfer (FRET).  In contrast to 
FRET techniques, where changes in existing fluorescence are measured, the 
complementation process of BiFC produces a new fluorescent signal, hence it is a more 
sensitive method (Ciruela F. 2008).  However, non-specific interactions and spontaneous 
association of the YFP half molecules, such as those observed in the current study, are a 
limitation (Cabantous S. et al. 2005; Zhang S. et al. 2004) and may mask any true 
fluorescence due to hOGG1 protein interaction.  For the current study, although not 
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possible during the time available, the generation of a positive control using two proteins 
known to interact within mammalian cells would have allowed easy differentiation 
between non-specific YFP fluorescence and fluorescence resulting from a specific 
protein – protein interaction. 
A further limitation of BiFC using YFP half molecules is that the maturation of the YN-
YC complex to produce an active fluorophore is enhanced by temperatures below 30°C.  
As mammalian cells are cultured at 37°C initial trial experiments using Drosophila 
Schneider 2 (S2) cells, which are cultured at 27°C, were conducted however no 
fluorescence above background could be detected following YFP-hOGG1 transfection in 
these cells (data not shown).  Furthermore, the cells did not respond well to BSO, 
showing reduced viability at low concentrations without significantly increased ROS.  
These studies were not pursued further and the technique was optimised in MEF cells by 
incubating cells for 5 hours at 27°C prior to fluorescence detection.  This allowed the 
detection of some YFP fluorescence however it is possible that this incubation time was 
too short for maturation which may explain the low fluorescence observed.  
Unfortunately longer incubation times reduced cell viability and were therefore not 
possible.  To overcome this barrier a modified version of YFP such as the Venus protein 
for which the maturation process occurs at a higher temperature could be used (Shyu Y.J. 
et al. 2006).  This was not possible in the current study due to time constraints.  
Previous studies have shown that the localisation of OGG1 varies throughout the cell 
cycle (Dantzer F. et al. 2002; Luna L. et al. 2005).  During interphase hOGG1 is 
associated with the soluble chromatin and nuclear matrix, whereas during mitosis it 
associates with condensed chromosomes and relocalises to the nucleoli during S-phase.  
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All of these relocalisation processes have been shown to be mediated through the 
phosphorylation of serine326, with the subcellular localisation of Cys326-hOGG1 
disrupted by exclusion from the nucleoli during S-phase (Luna L. et al. 2005).  As 
expected, the localisation of both EGFP-Ser326- and EGFP-Cys326-hOGG1 in MEF 
cells was predominantly nuclear and concentrated on regions of heterochromatin.  The 
nuclear, heterochromatin concentrated localisation of the proteins did not change either 
12 or 24 hours post BSO treatment, when the activity difference was detected, suggesting 
that BSO treatment does not affect the localisation of Ser326- or Cys326-hOGG1 and 
that the activity induction was not as a result of any change in hOGG1 cellular 
localisation.  There is increasing interest in the sub nuclear distribution of BER proteins 
following oxidative stress but our data do not support any difference in hOGG1 
localisation to the nucleus or nucleoli between the two proteins or following BSO 
treatment.   
Interestingly, hOGG1 has been shown to be recruited to nuclear speckles via a ROS-
mediated mechanism (Campalans A. et al. 2007) and to rapidly accumulate at sites of 
laser irradiation induced-DNA damage (Zielinska A.E. et al. 2011).  A recent report also 
demonstrated that hOGG1 is recruited to regions of open chromatin following exposure 
to high concentrations of potassium bromate.  The study showed that in unstressed cells 
hOGG1 exists in a soluble cellular fraction containing the cytoplasm and nucleoplasm.  
Following treatment with high concentrations of potassium bromate, hOGG1, along with 
APE1 and XRCC1, was recruited to and retained within an insoluble cellular fraction 
containing chromatin- and matrix-associated proteins (Amouroux R. et al. 2010).  This 
recruitment was not cell-cycle dependent.  The data presented in the current study are in 
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agreement with Amouroux et al. (2010), showing that following treatment with high dose 
BSO a fraction of the hOGG1-EGFP protein is retained within a nuclear fraction resistant 
to the detergent wash.  The confocal microscopy images further suggest that there may 
be a difference in the retention of hOGG1 in this insoluble fraction between the wild-type 
and variant protein, with Ser326-hOGG1 retained to a much greater extent than Cys326-
hOGG1.  Western blotting analysis indicated that Ser326-hOGG1 was present in both 
soluble and insoluble fractions before and after BSO treatment.  It is possible that this is 
due to contamination of the fractions during the extraction process or the combination of 
over-expression of the OGG1 protein and the high sensitivity of the EGFP antibody.  
Interestingly, no Cys326-hOGG1 could be detected in the insoluble fraction.  Although 
further confirmation is required, both the microscopy images and western blotting data 
suggest that there is a difference in the retention of wild type and variant hOGG1 in the 
insoluble nuclear fraction.  It is possible that this difference could play a role in the 
delayed repair of Cys326-hOGG1 observed in this study. 
In conclusion, the data presented here provide further evidence for impaired Cys326-
hOGG1 repair ability under conditions of oxidative stress and suggest a potential 
mechanism underlying this repair difference. 
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Chapter 6 –General 
discussion  
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6.1 General Discussion 
Many normal cellular processes such as gene regulation, cell mediated immunity and cell 
signalling require low levels of reactive oxygen species which are generated by 
intracellular components and exogenous sources (as described in section 1.1.3).  A 
variety of physiological reactive species are produced, including O2
•-
 which can dis-
mutate to form H2O2 which easily diffuses across membranes and can function as a 
second messenger.  However, in the presence of transition metals H2O2 can generate 
highly reactive HO
•
 radicals, with the potential for toxicity.  An increase above 
physiological levels of intracellular ROS, for example via inflammation or exposure to 
environmental toxicants, is normally counter-balanced by various antioxidant defence 
mechanisms.  However, if these defences become overwhelmed, disruption of the critical 
redox balance results in cellular oxidative stress where ROS can react with and damage 
cellular components including DNA (as described in section 1.1.4).    
A range of DNA base lesions are induced by ROS but due to its low oxidation potential 
guanine is the most commonly oxidised base yielding fapyG and 8-oxo dG (Steenken S. 
and Jovanovic S.V. 1997).  As 8-oxo dG can mispair with adenine during DNA 
replication it is a potentially mutagenic lesion and its repair is essential to maintain 
genomic stability (as described in section 1.3).  Its relative abundance, potential for 
mutation and ease of detection make 8-oxo dG the best studied oxidative DNA lesion 
(David S.S. et al. 2007).  The repair of 8-oxo dG by the base excision repair pathway is 
mediated primarily by OGG1 which is the only known enzyme that recognises oxoG:C 
pairs and catalyses the removal of 8-oxo dG prior to nucleotide replacement by β-
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polymerase and DNA ligation by DNA ligase III and XRCC1 (Boiteux S. and Guillet M. 
2004; Hazra T.K. et al. 2007) (as described in section 1.5). 
Increased oxidative stress occurs in a variety of pathological conditions including cancer 
(Halliwell B. 2007), although it is unclear whether this is causative or a consequence of 
these conditions.  Regulation of OGG1 enzyme under conditions of oxidative stress is 
important as impaired 8-oxo dG removal could have implications for disease 
development and progression.  The work presented in this thesis investigated the 
response of OGG1 to oxidative stress and differences between the wild-type and 
common human variant Cys326-hOGG1.  Previous work in our laboratory (Mirbahai L. 
et al. 2010) and work presented in chapters three and five demonstrates that OGG1 
activity is modulated following treatment with the pro-oxidant potassium bromate and 
the glutathione depleting agent BSO in MEF cells.  Using MEF cells, for which we have 
a negative control mOgg1
-/-
 KO cell line, we showed that the activity of both mouse and 
human OGG1 increased following induction of cellular oxidative stress via treatment 
with BSO.  In contrast, no effect on rat OGG1 activity following identical treatment of 
MH1C1 cells was observed.  This may be related to the low ROS levels and high basal 
OGG1 activity we observed in this cell line (sections 3.2.3 and 3.2.9).  Our and other 
groups have shown OGG1 activity inhibition (Bravard A. et al. 2006; Hodges N.J. and 
Chipman J.K. 2002; Potts R.J. et al. 2003; Youn C.K. et al. 2005; Zharkov D.O. and 
Rosenquist T.A. 2002) and induction (Ma H. et al. 2008; Silva J.P. et al. 2009) in various 
cellular models following treatment with a range of pro-oxidants.  Our findings confirm 
that the OGG1 response is complex and dependent on the pro-oxidant and study model 
chosen, as noted by van Loon et al. (2010).   
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Regulation of OGG1 activity under conditions of oxidative stress represents an important 
adaptive response to the increased requirement of a cell to repair 8-oxo dG lesions.  Our 
data indicate that the increased repair activity in MEF cells following BSO treatment is 
not due to any alteration of gene transcription.  This suggests that the change in activity 
is mediated by post-translational modification, interaction with other protein partners, 
protein stabilisation or altered protein localisation.  Work presented in chapter five shows 
that no detectable change in human OGG1 protein levels was observed following BSO 
treatment, suggesting increased repair activity was not the result of OGG1 protein 
stabilisation (section 5.2.6).  The OGG1 protein is known to be post-translationally 
modified, and both acetylation (Bhakat K.K. et al. 2006) and phosphorylation (Hu J. et 
al. 2005) have been shown to modify activity.  Further studies are required to determine 
the nature of OGG1 post-translational modifications in oxidative stress conditions, 
however it is possible that when an immediate increase in 8-oxo dG repair is required, 
post-translational modification could be favoured over increased gene expression.  It is 
also possible that interaction with other proteins could modulate OGG1 activity as 
enhanced activity has been shown by OGG1 interaction with APE1, NEIL1, XRCC1 and 
RAD52 (de Souza-Pinto N.C. et al. 2009; Hill J.W. et al. 2001; Marsin S. et al. 2003; 
Mokkapati S.K. et al. 2004; Vidal A.E. et al. 2001.2). 
Data presented in chapter three showing post transcriptional activation of OGG1 
following BSO treatment, justified the generation and use of transgenic MEF cells 
constitutively expressing hOGG1 under the control of the CMV promoter for the 
investigation into potential differences between wild-type and variant hOGG1 repair 
acitivity.  As described in detail in section 1.6, the S326C hOGG1 variant, which arises 
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due to a CG substitution at position 1245 in exon 7, has been linked with increased 
cancer susceptibility (Cho E.Y. et al. 2003; Elahi A. et al. 2002; Kohno T. et al. 2006; Le 
Marchand L.L. et al. 2002; Park J. et al. 2004; Sugimura H. et al. 1999; Xing D.Y. et al. 
2001) and reduced functional activity, particularly in oxidising conditions (Bravard A. et 
al. 2009; Chen S.K. et al. 2003; Hill J.W. and Evans M.K. 2006; Lee A. et al. 2005; 
Smart D.J. et al. 2006; Yamane A. et al. 2004).   
Previous work in our laboratory investigated the effect of oxidative stress on the human 
OGG1 protein using transiently transfected KO MEF cells (Smart D.J. et al. 2006).  In 
order to eliminate transfection efficiency variability, data presented in chapter four shows 
that we have improved this model and successfully generated KO MEF cells which 
stably express both wild-type (Ser326) and variant (Cys326) hOGG1.  Our transgenic 
cell model has advantages compared with previous models as KO MEF cells exhibit no 
background OGG1 expression and are karyotypically normal.  The generation of Ser326- 
and Cys326-hOGG1-expressing MEF cells with similar OGG1 repair activities allowed 
us to investigate any differences in response to oxidative stress, as presented in chapter 
five.   
Interestingly, following BSO treatment, we did not observe reduced repair activity in 
Cys326-hOGG1 MEF, but a delay in the increased activity response to oxidative 
treatment (section 5.2.4).  This is in agreement with other functional studies which show 
decreased 8-oxo dG binding affinity and reduced excision efficiency for Cys326-hOGG1 
(Dherin C. et al. 1999; Hill J.W. and Evans M.K. 2006; Sidorenko V.S. et al. 2009).  The 
8-oxo dG-containing molecular beacon assay, recently optimised in our laboratory, offers 
several advantages over traditional activity assays as the OGG1 protein is retained within 
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its intracellular environment and activity and location can be monitored in real time.  As 
expected, the repair activity increase observed was not a result of increased hOGG1 gene 
expression and further supports evidence for post-transcriptional OGG1 activity 
modulation following acute oxidative stress.   
Recent evidence suggests that any difference between Ser326- and Cys326-hOGG1 
activity is due to the additional redox sensitive cysteine residue (Bravard A. et al. 2006; 
Bravard A. et al. 2009; Smart D.J. et al. 2006) and may be as a result of OGG1 dimer 
formation (Hill J.W. and Evans M.K. 2006; Simonelli V. et al. 2011).  However, as 
shown in chapter five, we failed to demonstrate conclusive evidence for hOGG1 homo-
dimer formation in live cells following BSO or diamide treatment (section 5.2.8).  Whilst 
this could be due to limitations of the BiFC technique employed, it is also possible that 
hOGG1 does not form a dimer in native intracellular conditions.  In support of our data, 
other groups have also been unable to demonstrate OGG1 dimer formation in live cells 
(Anne Bravard, pers. comm.).  Indeed it seems more likely that a heterodimer with 
another protein could form and this could be investigated by immunoprecipitation 
coupled with mass spectrometry or by a yeast two hybrid assay.   
Recent research by Amouroux et al. (2010) has demonstrated that following exposure to 
the pro-oxidant potassium bromate, hOGG1 is recruited to sites of repair in insoluble 
nuclear structures containing chromatin- and matrix-associated proteins.  This prompted 
us to investigate hOGG1 retention in this insoluble nuclear fraction following BSO 
treatment.  In agreement with Amouroux et al. (2010), we also found that Ser326- and 
Cys326-hOGG1 proteins were present in the soluble fraction in untreated cells and that 
wild-type hOGG1 was retained in the insoluble fraction following BSO treatment.  
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However, in contrast, the Cys326-hOGG1 protein was retained to a much lesser extent 
than the wild-type protein (section 5.2.9).  This localisation difference is supported by 
previous studies showing impaired localisation of Cys326-hOGG1 (Dantzer F. et al. 
2002; Luna L. et al. 2005).  Although further work remains to be done to confirm these 
findings, we hypothesise that this difference in retention in the insoluble nuclear fraction 
may in part underlie the difference in repair activity we observed.   
Our data, in agreement with many other studies, are strongly supportive of reduced repair 
ability of Cys326-hOGG1 compared with wild-type under conditions of oxidative stress.  
As the evidence for a repair difference is less convincing in the absence of oxidative 
stress, the relationship between possession of the cys326 allele and the ability of OGG1 
to repair 8-oxo dG is complicated by interactions with the environment.  Lifestyle 
choices such as smoking status and diet, or exposure to environmental toxicants could 
have an impact on mutation frequency in individuals who possess the variant protein.  
Therefore risk of cancer development does not simply depend on the possession of the 
variant allele, but on a variety of factors including the individual‟s exposure to 
carcinogens.  
Our data suggest that although the OGG1 protein is required to respond to 8-oxo dG 
arising from a variety of cellular stresses during an individual‟s lifetime, in cell culture 
models the regulation of OGG1 is complex, cell type and compound specific.  The repair 
of damaged DNA takes place in a complex cellular environment and is associated with 
many other cellular processes.  In such an environment any dramatic change in gene 
expression or protein activity could have profound effects on other vital cellular 
processes and must therefore be tightly regulated.  The viability of the OGG1 KO mouse 
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and the prevalence of the Cys326-hOGG1 variant highlight the potential redundancy in 
the base excision repair system and suggest that there is a degree of compensation in 
DNA repair mechanisms.  In support of this there is slow removal of 8-oxo dG from 
genomic DNA in proliferating KO MEF cells (Klungland A. et al. 1999).  Whilst 
glycosylase enzymes have substrate preference, they do not have absolute specificity, for 
example the NEILs are known to repair oxidised bases during transcription and DNA 
replication (Dou H. et al. 2003).  There is also integration between different DNA repair 
pathways and DNA glycosylases interact with components from MMR and NER as well 
as BER pathways (reviewed by Kovtun I.V. and McMurray C.T. 2007).  It has been 
shown that Msh2 defective mouse embryonic stem cells accumulate 8-oxo dG more than 
wild-type cells (Colussi C. et al. 2002) and that exposure to γ-irradiation in MSH2 or 
MutL homologue (MLH1) deficient tumour cell lines or MEF cells resulted in increased 
8-oxo dG levels (DeWeese T.L. et al. 1998) suggesting that interaction of MMR with 
BER plays a role in the reduction of 8-oxo dG levels in mammalian cells.   
Evidence for such cross-talk and intracellular communication emphasises that although 
studies investigating polymorphisms in a single gene are important, DNA repair does not 
occur by a single enzyme in isolation.  Polymorphisms exist in a variety of other BER 
repair proteins including XRCC1 and APE1 (Hung R.J. et al. 2005) and an individual 
with a combination of mutant, potentially deficient, repair proteins could be more at risk 
of disease development.  This may explain why there is conflicting epidemiological 
evidence linking possession of the cys326 allele with increased cancer risk.  Increasingly, 
epidemiology studies are addressing this issue by investigating the risk of cancer in 
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individuals with multiple BER protein polymorphic variants (e.g. Klinchid J. et al. 2009; 
Stanczyk M. et al. 2011).   
In summary, the data presented in this thesis provide further evidence of modulation of 
OGG1 activity, not due to transcriptional change, following exposure to oxidative stress.  
We have successfully developed Ser326-hOGG1 and Cys326-hOGG1 expressing MEF 
cells which provide a useful tool for the continued study of the hOGG1 protein.  Our data 
further support the growing evidence for impaired Cys326-hOGG1 repair activity under 
conditions of oxidative stress which may have important implications for individual 
susceptibility to diseases including cancer. 
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6.2 Future work 
The work presented in chapter three using MH1C1 cells could be extended to determine 
what underlies the differential response of mOGG1 and rOGG1 to BSO treatment.  Using 
MH1C1 cells, the concentration of BSO could be increased or alternative oxidants could 
be used to attempt to induce greater levels of ROS.  Additionally, the experiments 
described in chapter three could be conducted with non-tumorous rOGG1-expressing 
cells and/or rOGG1-expressing cells with lower basal OGG1 activity.   
The work presented in chapter five reveals three major areas which could be further 
investigated; hOGG1 dimer formation, hOGG1 retention within the insoluble nuclear 
fraction and hOGG1 post translational modification following oxidative stress.  As 
described in section 5.3 there are several modifications required for a successful study 
into OGG1 dimerisation using BiFC.  The current model using YFP could be improved 
by the use of positive control vectors and cross linking agents.  Alternatively, the study 
could be completely modified to use a different version of YFP such as the Venus 
protein, which is better suited to the mammalian cell system.  The formation of a hetero-
dimer with other cellular proteins could be investigated using immunoprecipitation 
coupled with mass spectrometry or a yeast two hybrid assay.   
The difference in retention of Ser326- and Cys326-hOGG1 within the insoluble nuclear 
fraction is potentially very interesting but due to time restraints it was not possible to 
fully complete the western blotting section of the investigation.  A combination of 
optimised western blotting and more advanced use of confocal microscopy imaging 
would allow quantification of hOGG1 fluorescence in each fraction.  Western blotting 
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could also be used to investigate hOGG1 post translational modifications such as 
acetylation and phosphorylation status following BSO treatment.   
Finally, as described in chapter five, we found that following BSO treatment of Ser326- 
and Cys326-hOGG1 MEF cells the cleaved beacon localised in the nucleus, in contrast to 
previously observed mitochondrial beacon localisation following potassium bromate 
treatment of WT MEF cells (Mirbahai L. et al. 2010).  This interesting observation is 
currently the subject of investigation within our laboratory. 
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Vector map of pcDNA3© (Invitrogen). 
 Ser326- and Cys326-hOGG1 cDNA molecules were cloned into the BamHI and EcoRI sites of the 
multiple cloning site. 
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Vector map of pcDNA3.1/Hygro©(+) (Invitrogen).  
Ser326- and Cys326-hOGG1 cDNA molecules were sub-cloned from pcDNA3© into the BamHI 
and XhoI sites of the multiple cloning site.  
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Vector map of pIREShyg3 (B.D. Clontech). 
Ser326- and Cys326-hOGG1 cDNA molecules were sub-cloned from pcDNA3.1/Hygro(+)© into 
the AflII and BamHI sites of the multiple cloning sites.  
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Vector map of pEGFP-N1 (B.D. Clontech). 
 Ser326- and Cys326-hOGG1 cDNA molecules were inserted into the KpnI and AgeI sites of the 
multiple cloning site. 
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Vector map of pBluescript II KS(-).  
The N and C terminal cDNA of YFP had previously been cloned into the BamHI site of the multiple 
cloning site. Ser326- and Cys326-hOGG1 cDNA molecules were cloned into the BamHI sites of the 
same multiple cloning site, C-terminal to the YFP cDNA. 
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Mouse MLFRSWLPSSMRHRTLSSSPALWASIPCPRSELRLDLVLASGQSFRWKEQSPAHWSGVLA 60 
Rat   MLFSSSLSSSMRHRTLTSSPALWASIPCPRSELRLDLVLASGQSFRWREQSPAHWSGVLA 60 
      *** * *.********:******************************:************ 
Mouse DQVWTLTQTEDQLYCTVYRGDDSQVSRPTLEELETLHKYFQLDVSLAQLYSHWASVDSHF 120 
Rat   DQVWTLTQTEDQLYCTVYRGDKGQVGRPTLEELETLHKYFQLDVSLTQLYSHWASVDSHF 120 
      *********************..**.********************:************* 
Mouse QRVAQKFQGVRLLRQDPTECLFSFICSSNNNIARITGMVERLCQAFGPRLIQLDDVTYHG 180 
Rat   QSVAQKFQGVRLLRQDPTECLFSFICSSNNNIARITGMVERLCQAFGPRLVQLDDVTYHG 180 
      * ************************************************:********* 
Mouse FPNLHALAGPEAETHLRKLGLGYRARYVRASAKAILEEQGGPAWLQQLRVAPYEEAHKAL 240 
Rat   FPNLHALAGPEVETHLRKLGLGXRARYVCASAKAILEEQGGPAWLQQLRVASYEEAHKAL 240 
      ***********.********** ***** **********************.******** 
Mouse CTLPGVGAKVADCICLMALDKPQAVPVDVHVWQIAHRDYGWHPKTSQAKGPSPLANKELG 300 
Rat   CTLPGVGTKVADCICLMALDKPQAVPVDIHVWQIAHRDYGWQPKTSQTKGPSPLANKELG 300 
      *******:********************:************:*****:************ 
Mouse NFFRNLWGPYAGWAQAVLFSADLRQPSLSREPPAKRKKGSKRPEG 345 
Rat   NFFRNLWGPYAGWAQAVLFSADLRQQNLSREPPAKRKKGSKKTEG 345 
      ************************* .**************:.** 
Multiple sequence alignment with the Clustal series of programs.  
Multiple alignment score = 93 (Chenna et al. 2003). 
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Time post treatment 
Ser326- hOGG1
Cys326-hOGG1
Ser326- and Cys326-hOGG1 activity in independent MEF cell clones following BSO 
treatment. Data are expressed as the number of positive beacon events as a percentage of untreated 
control, ±SEM from 4 independent experiments.  *,**: Significantly different from control (*P < 
0.05 **P < 0.01) as determined by 2-tailed Student‟s t-test.  
** * 
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